
<html lang="en"     class="pb-page"  data-request-id="34998653-4e94-4556-9a4b-8546a7867288"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.7b01520;issue:issue:10.1021/jmcmar.2017.60.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment" /></meta><meta name="dc.Creator" content="Jingjing  Xie" /></meta><meta name="dc.Creator" content="Xiaojia  Si" /></meta><meta name="dc.Creator" content="Shoulai  Gu" /></meta><meta name="dc.Creator" content="Mingliang  Wang" /></meta><meta name="dc.Creator" content="Jian  Shen" /></meta><meta name="dc.Creator" content="Haoyan  Li" /></meta><meta name="dc.Creator" content="Jian  Shen" /></meta><meta name="dc.Creator" content="Dan  Li" /></meta><meta name="dc.Creator" content="Yanjia  Fang" /></meta><meta name="dc.Creator" content="Cong  Liu" /></meta><meta name="dc.Creator" content="Jidong  Zhu" /></meta><meta name="dc.Description" content="SHP2, a cytoplasmic protein-tyrosine phosphatase encoded by the PTPN11 gene, is involved in multiple cell signaling processes including Ras/MAPK and Hippo/YAP pathways. SHP2 has been shown to contr..." /></meta><meta name="Description" content="SHP2, a cytoplasmic protein-tyrosine phosphatase encoded by the PTPN11 gene, is involved in multiple cell signaling processes including Ras/MAPK and Hippo/YAP pathways. SHP2 has been shown to contr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 7, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01520" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01520" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01520" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01520" /></link>
        
    
    

<title>Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01520" /></meta><meta property="og:title" content="Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0012.jpeg" /></meta><meta property="og:description" content="SHP2, a cytoplasmic protein-tyrosine phosphatase encoded by the PTPN11 gene, is involved in multiple cell signaling processes including Ras/MAPK and Hippo/YAP pathways. SHP2 has been shown to contribute to the progression of a number of cancer types including leukemia, gastric, and breast cancers. It also regulates T-cell activation by interacting with inhibitory immune checkpoint receptors such as the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA). Thus, SHP2 inhibitors have drawn great attention by both inhibiting tumor cell proliferation and activating T cell immune responses toward cancer cells. In this study, we report the identification of an allosteric SHP2 inhibitor 1-(4-(6-bromonaphthalen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (23) that locks SHP2 in a closed conformation by binding to the interface of the N-terminal SH2, C-terminal SH2, and phosphatase domains. Compound 23 suppresses MAPK signaling pathway and YAP transcriptional activity and shows antitumor activity in vivo. The results indicate that allosteric inhibition of SHP2 could be a feasible approach for cancer therapy." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01520"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01520">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01520&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01520&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01520&amp;href=/doi/10.1021/acs.jmedchem.7b01520" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 10205-10219</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01447" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00577" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jingjing++Xie">Jingjing Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaojia++Si">Xiaojia Si</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shoulai++Gu">Shoulai Gu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mingliang++Wang">Mingliang Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Shen">Jian Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haoyan++Li">Haoyan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jian++Shen">Jian Shen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan++Li">Dan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∇</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yanjia++Fang">Yanjia Fang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cong++Liu">Cong Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jidong++Zhu">Jidong Zhu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Interdisciplinary Research Center on Biology and Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201203, China</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">⊥</span> <span class="aff-text">University of the Chinese Academy of Sciences, 19 A Yuquan Road, Shijingshan District, Beijing 100049, China</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Natural Products Chemistry, Fudan University, 826 Zhangheng Road, Shanghai 201203, China</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">§</span> <span class="aff-text">Viva Biotech Ltd. 334 Aidisheng Road, Shanghai 201203, China</span></div><div class="aff-info" id="aff5"><span class="aff-symbol">∥</span> <span class="aff-text">Organisch-Chemisches Institut, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 270, 69120 Heidelberg, Germany</span></div><div class="aff-info" id="aff6"><span class="aff-symbol">∇</span> <span class="aff-text">Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Bio-X Institutes, Shanghai Jiao Tong University, Shanghai 200240, China</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#c1bba9b4aba581b2a8aea2efa0a2efa2af"><span class="__cf_email__" data-cfemail="2f55475a454b6f5c46404c014e4c014c41">[email protected]</span></a> (J.Z.).</div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#8ee2e7fbe2efeccefde7e1eda0efeda0ede0"><span class="__cf_email__" data-cfemail="cca0a5b9a0adae8cbfa5a3afe2adafe2afa2">[email protected]</span></a> (C.L.).</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01520&amp;href=/doi/10.1021%2Facs.jmedchem.7b01520" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 10205–10219</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 20, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 October 2017</li><li><span class="item_label"><b>Published</b> online</span>7 December 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 December 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01520" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01520</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10205%26pageCount%3D15%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJingjing%2BXie%252C%2BXiaojia%2BSi%252C%2BShoulai%2BGu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D24%26contentID%3Dacs.jmedchem.7b01520%26title%3DAllosteric%2BInhibitors%2Bof%2BSHP2%2Bwith%2BTherapeutic%2BPotential%2Bfor%2BCancer%2BTreatment%26numPages%3D15%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10219%26publicationDate%3DDecember%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01520"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5214</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">44</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01520" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jingjing&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Xiaojia&quot;,&quot;last_name&quot;:&quot;Si&quot;},{&quot;first_name&quot;:&quot;Shoulai&quot;,&quot;last_name&quot;:&quot;Gu&quot;},{&quot;first_name&quot;:&quot;Mingliang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Haoyan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Jian&quot;,&quot;last_name&quot;:&quot;Shen&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yanjia&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Cong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Jidong&quot;,&quot;last_name&quot;:&quot;Zhu&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;10205-10219&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01520&quot;},&quot;abstract&quot;:&quot;SHP2, a cytoplasmic protein-tyrosine phosphatase encoded by the PTPN11 gene, is involved in multiple cell signaling processes including Ras/MAPK and Hippo/YAP pathways. SHP2 has been shown to contribute to the progression of a number of cancer types including leukemia, gastric, and breast cancers. It also regulates T-cell activation by interacting with inhibitory immune checkpoint receptors such as the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA). Thus, SHP2 inhibitors have drawn great attention by both inhibiting tumor cell proliferation and activating T cell immune responses toward cancer cells. In this study, we report the identification of an allosteric SHP2 inhibitor 1-(4-(6-bromonaphthalen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (23) that locks SHP2 in a closed conformation by binding to the interface of the N-terminal SH2, C-terminal SH2, and phosphatase domains. Compound 23 suppresses MAPK signaling pathway and YAP transcriptional activity and shows antitumor activity &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01520&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01520" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01520&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01520" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01520&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01520" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01520&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01520&amp;href=/doi/10.1021/acs.jmedchem.7b01520" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01520" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01520" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01520%26sid%3Dliteratum%253Aachs%26pmid%3D29155585%26genre%3Darticle%26aulast%3DXie%26date%3D2017%26atitle%3DAllosteric%2BInhibitors%2Bof%2BSHP2%2Bwith%2BTherapeutic%2BPotential%2Bfor%2BCancer%2BTreatment%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D24%26spage%3D10205%26epage%3D10219%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/jmcmar.2017.60.issue-24/20171228/jmcmar.2017.60.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">SHP2, a cytoplasmic protein-tyrosine phosphatase encoded by the PTPN11 gene, is involved in multiple cell signaling processes including Ras/MAPK and Hippo/YAP pathways. SHP2 has been shown to contribute to the progression of a number of cancer types including leukemia, gastric, and breast cancers. It also regulates T-cell activation by interacting with inhibitory immune checkpoint receptors such as the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA). Thus, SHP2 inhibitors have drawn great attention by both inhibiting tumor cell proliferation and activating T cell immune responses toward cancer cells. In this study, we report the identification of an allosteric SHP2 inhibitor 1-(4-(6-bromonaphthalen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (<b>23</b>) that locks SHP2 in a closed conformation by binding to the interface of the N-terminal SH2, C-terminal SH2, and phosphatase domains. Compound <b>23</b> suppresses MAPK signaling pathway and YAP transcriptional activity and shows antitumor activity <i>in vivo</i>. The results indicate that allosteric inhibition of SHP2 could be a feasible approach for cancer therapy.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55071" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55071" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Protein tyrosine phosphorylation is a key modification controlling all aspects of crucial cellular processes including proliferation, differentiation, growth, and apoptosis. Dysregulation of tyrosine phosphorylation has been associated with the developmental pathologies of various human diseases such as cancer, diabetes, and autoimmune disorders.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Over the past decades, great success has been made to develop protein tyrosine kinase (PTK) inhibitors for clinical application; however, the attempts to develop protein tyrosine phosphatase (PTP) drugs have been hampered due to the less understanding of their biological functions and the poor pharmaceutical properties of PTP inhibitors. Accumulating evidence suggest that some PTPs, such as SHP2, PTP1B, and CDC25, are potential therapeutic targets.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> Thus, developing selective PTP inhibitors may open a new gate accessing more effective therapeutics for human diseases.</div><div class="NLM_p">SHP2 is a nonreceptor PTP that plays a positive role in cell signaling transduction by growth factors and is involved in cell survival, proliferation, and migration.<a onclick="showRef(event, 'ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8">(6-8)</a> Accumulated evidence demonstrate that SHP2 is critical for Ras/MAPK signaling downstream of receptor tyrosine kinases activation.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9-13)</a> SHP2 contains two tandem Src homology 2 (SH2) domains, a PTP domain and a C-terminal tail. At basal state, the N-SH2 domain of SHP2 protein binds to the PTP domain and blocks its substrate access, therefore, resulting in suppressed PTP activity. When the SH2 domains bind to specific phosphotyrosine motifs, the autoinhibitory interactions are abolished. The phosphatase is then in an open conformation that allows SHP2 activation.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Gain-of-function mutations in SHP2 that cause hyperactivation of its catalytic activity have been identified in the developmental disorder Noonan syndrome (∼50%)<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> and various cancer types.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The mutated residues are located in the interface between N-SH2 and PTP domains. Hyperactivated SHP2 also contributes to tumorigenesis of gastric<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> and breast cancers.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> SHP2 is implicated in promoting YAP oncoprotein transcriptional activity and stimulating TEAD target genes.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Moreover, SHP2 associates with PD-1 following PD-L1 stimulation and inhibits T cell activation,<a onclick="showRef(event, 'ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref22 ref23 ref24">(22-24)</a> which makes it a promising target for cancer immunotherapy.</div><div class="NLM_p">Development of small molecule inhibitors targeting PTPs has proven to be considerably difficult due to the highly conserved and positively charged nature of the PTP catalytic domain.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Indeed, the previously reported SHP2 inhibitors (<b>1</b>–<b>7</b>) have not achieved satisfactory selectivity over other PTPs (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).<a onclick="showRef(event, 'ref26 ref27 ref28 ref29 ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29 ref30 ref31 ref32">(26-32)</a> Until recently, an allosteric inhibitor, <b>8</b> (SHP099),<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> was reported to selectively block SHP2 phosphatase activity by stabilizing SHP2 in an autoinhibited conformation. Compound <b>8</b> inhibits cancer cell growth <i>in vitro</i> and in mouse tumor xenograft models, demonstrating that inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers. We describe here an independent identification of SHP2 allosteric inhibitors with 2-aminothiazole scaffold through a mutant E76A SHP2 biochemical assay. The inhibitor <b>23</b> has an IC<sub>50</sub> of 700 nM for SHP2 with more than 30-fold selectivity over other PTPs. The cocrystal structure reveals that the inhibitor binds to the same pocket formed by N-SH2, C-SH2, and PTP domains as that identified in <b>8</b>.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> We show that <b>23</b> not only inhibits RAS-ERK signaling but also suppresses YAP transcriptional activity. Compound <b>23</b> inhibits the proliferation of multiple cancer cell lines. In addition, it exhibits acceptable pharmacokinetic properties and inhibits tumor growth in mouse xenograft models, corroborating the potential of SHP2 allosteric inhibitors for the treatment of cancers.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative known SHP2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63085" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63085" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Discovery of SHP2 Allosteric Inhibitors through a Mutant E76A SHP2 Biochemical Screen</h3><div class="NLM_p">The catalytic sites of protein tyrosine phosphatases are highly conserved and polar, which make it very challenging to develop selective PTP inhibitors. Recently, a few phosphatase allosteric inhibitors<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35, 36)</a> have been reported to achieve great selectivity and cell permeability, which enlightened us to develop allosteric inhibitors that can freeze SHP2 in its autoinhibited state. Glutamate 76 plays a key role in bridging N-SH2 and PTP domains, including a hydrogen bond with S502 hydroxyl and a salt bridge interacting with R265. Substituting glutamate 76 leads to weakened interactions between these two domains and thus arouses the destabilization of the autoinhibited conformation.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Mutations of E76 residue have been frequently identified in Noonan syndrome and leukemia.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Indeed, mutant E76A full length SHP2 (SHP2<sup>E76A</sup>) exhibited much higher phosphatase activity than wild-type SHP2 (SHP2<sup>WT</sup>) in an <i>in vitro</i> biochemical assay using DIFMUP as a surrogate substrate. In contrast, C459S SHP2 (SHP2<sup>C459S</sup>),<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> which replaces the catalytic center cysteine to serine, totally abolished its phosphatase activity (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). A biochemical screen against SHP2<sup>E76A</sup> was conducted with a library of about 20,000 compounds at 20 μM. The hits from the primary screen were further profiled in a phosphatase assay using SHP2 PTP domain (SHP2<sup>PTP</sup>)<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> to filter out the catalytic inhibitors and nonspecific binders. One compound, <b>9</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B), was identified to show inhibition against SHP2<sup>E76A</sup> with an IC<sub>50</sub> of 19.1 μM, but no effect on SHP2<sup>PTP</sup> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). Thus, <b>9</b> could serve as a starting point to develop SHP2 allosteric inhibitors. We speculated that the amine part may gain certain hydrogen bonds critical for the interaction. Therefore, we kept the amine part intact and enriched the complexity of <b>9</b> by changing the phenyl with several common aryl groups. A brief replacement of phenyl with biphenyl (<b>10</b> and <b>11</b>) or naphthyl (<b>12</b>) led to improved potency with IC<sub>50</sub> of 3.27, 5.32, and 2.55 μM, respectively (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>D).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Identification of SHP2 inhibitors through SHP2E76A biochemical screening. (A) Catalytic activity of purified SHP2E76A, SHP2WT, and SHP2C459S. Phosphatase assays were conducted using the artificial substrate DIFMUP, and data represents mean ± SD (<i>n</i> = 3). (B) Structure of <b>9</b>. (C) Compound <b>9</b> inhibited SHP2E76A with moderate potency (a) but had no effect on SHP2PTP (b). Data represents mean ± SD (<i>n</i> = 3). (D) Structures and IC<sub>50</sub>s of <b>10</b>, <b>11</b>, and <b>12</b>. Each IC<sub>50</sub> is the mean of at least three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Atomic Structure of SHP2 in Complex with <b>10</b></h3><div class="NLM_p">To elucidate the structural basis underlying recognition of inhibitors to SHP2, we determined the crystal structure of SHP2<sup>E76A</sup> in complex with <b>10</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). SHP2<sup>E76A</sup> adopted an autoinhibited conformation as previously observed in wild-type SHP2 and SHP2<sup>E76Q</sup> structures (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A).<a onclick="showRef(event, 'ref14 ref37 ref39'); return false;" href="javascript:void(0);" class="ref ref14 ref37 ref39">(14, 37, 39)</a> Compound <b>10</b> is accommodated in the same pocket, as previously described for <b>8</b> but with distinct binding features (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B).<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> The amino linker of <b>10</b> forms a hydrogen bond with the main-chain carbonyl of Arg111, and the methyl groups of tetramethylpiperidine make several van der Waals contacts with Thr108, Glu110, His114, Glu249, and Thr253. The diphenyl moiety is sandwiched between side-chains of Arg111 and Lys492 via cation−π interaction,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and the hydrophobic patch formed by the side chains of Leu254, Gln257, Pro491, and Gln495 further stabilizes the diphenyl moiety (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C). Compared with the six-membered aminopyrazine core in <b>8</b>, the five-membered thiazole core of <b>10</b> provides a different trajectory for both the aryl and the piperidine regions, which may result in a distinct structure–activity relationship (SAR). The hydrogen bond between the amino linker and Arg111 is unique to <b>10</b>, although this interaction is relatively weak as indicated by the 3.5 Å distance between the donor and the acceptor, possibly due to the steric hindrance between the tetramethylpiperidine group and side-chain of His114. The cation−π interaction by the diphenyl moiety is more toward the terminal phenyl ring and involves both Arg111 and Lys492, consistent with the six-fold increase of potency from <b>9</b> to <b>10</b>. The central binding pocket located in the interface of the three domains (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_001.pdf" class="ext-link">Figure S1</a>) is within the hinge region of SHP2, which is proposed to rearrange upon substrate binding. From SHP1 structures,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> the hinge region is observed to undergo dramatic conformational changes to release PTP from the N-SH2 domain for substrate binding (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_001.pdf" class="ext-link">Figure S1</a>). The binding of <b>10</b> in the central pocket of SHP2 locks the hinge region and prevents the substrate binding and phosphatase activity of PTP domain by allosteric regulation. Thus, the complex structure provided structural basis of allosteric inhibition of <b>10</b> to SHP2, which served as a guideline for improvement of allosteric inhibitors with higher potency by structure-based design.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of SHP2E76A in complex with <b>10</b> and a working model of allosteric inhibition of SHP2 E76A by <b>10</b>. (A) Interaction between E76 and S502 in the structure of SHP2WT (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>) in pale green, which is absent in the structure of SHP2E76A (purple). (B) Compound <b>10</b> settles in the central pocket formed by three domains as shown in the surface representation. (C) Complex structure of SHP2E76A and <b>10</b> (N-SH2 in light blue; PTP in brown; C-SH2 in cyan). The allosteric inhibitor <b>10</b> is in magenta. (D) Proposed model of conformational changes of SHP2E76A upon substrate binding and allosteric inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Data Collection and Refinement Statistics of SHP2<sup>E76A</sup></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Crystal Parameters</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>P</i>2<sub>1</sub>2<sub>1</sub>2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cell dimensions</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>a</i>, <i>b</i>, <i>c</i> (Å)</td><td class="colsep0 rowsep0" align="left">55.8, 219.2, 41.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α, β, γ (deg)</td><td class="colsep0 rowsep0" align="left">90, 90, 90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">molecules in A.U.<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Data Collection</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Synchrotron beamline</td><td class="colsep0 rowsep0" align="left">BL19U1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">wavelength (Å)</td><td class="colsep0 rowsep0" align="left">0.97853</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution (Å)</td><td class="colsep0 rowsep0" align="left">2.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">reflections</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">observed/unique</td><td class="colsep0 rowsep0" align="left">82892/24013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness (%)</td><td class="colsep0 rowsep0" align="left">99.5 (99.7)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>merge</sub> (%)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">17.0 (58.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">⟨<i>I</i>/σ⟩</td><td class="colsep0 rowsep0" align="left">5.27 (1.63)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Refinement</b></td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution (Å)</td><td class="colsep0 rowsep0" align="left">19.8–2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>work</sub> (%)<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">24.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>free</sub> (%)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">28.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">No. of non-H atoms</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein</td><td class="colsep0 rowsep0" align="left">4094</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ligand</td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">water</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bond length (Å)</td><td class="colsep0 rowsep0" align="left">0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bond angle (deg)</td><td class="colsep0 rowsep0" align="left">0.659</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>PDB Accession Code</b></td><td class="colsep0 rowsep0" align="left"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XZR">5XZR</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">A.U. = asymmetric unit.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Values in parentheses correspond to the highest resolution shell.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last"><i>R</i><sub>merge</sub> = ∑|<i>I</i> – ⟨<i>I</i>⟩|/∑I.</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last"><i>R</i><sub>work</sub> = ∑|<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub>|/∑<i>F</i><sub>o</sub>.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last"><i>R</i><sub>free</sub> = ∑|<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub>|/∑<i>F</i><sub>o</sub>, calculated using a random set containing 5% reflections that were not included throughout structure refinement.</p></div></div></div></div><div id="sec2-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> SAR Analysis of SHP2 Inhibitors</h3><div class="NLM_p">Intrigued by the complex structure of <b>10</b> with SHP2<sup>E76A</sup>, we turned our focus to improve its potency. Since the aminothiazole core of <b>10</b> provides a different binding trajectory compared with <b>8</b>, we decided to maintain the aminothiazole core and independently explore the SAR of the aryl and the piperidine regions (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9</b>–<b>19</b>, <b>23</b>, and <b>24</b><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KSCN, EtOH, 85 °C, 2 h, 82–99%; (b) 30% HBr, AcOH, r.t., overnight, 78–90%; (c) NHR1R2, <i>t</i>-BuONa, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, toluene, 120 °C, 2.5–16 h, 32–52%; (d) TFA, DCM, r.t., 2 h, 91%; (e) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 130 °C, 8 h, 31%.</p></p></figure><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>20</b>–<b>22</b> and <b>25</b>–<b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TEA, DMF, 90 °C, 8 h, 87%; (b) Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF:H<sub>2</sub>O, 80 °C, 16 h, 53–78%; (c) TFA, DCM, r.t., 1–5 h, 85–96%; (d) KOH, 1,4-dioxane:H<sub>2</sub>O, 70 °C, 1 h, 86%; (e) LiAlH<sub>4</sub>, THF, r.t., 3 h, 76%.</p></p></figure><div class="NLM_p">In our approach to build SAR on amine regions, we synthesized 2-bromo-4-(naphthalene-2-yl)thiazole (<b>38d</b>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) as a key intermediate to enrich the diversity of amine by Buchwald reaction. The commercial available amines were coupled with <b>38d</b> followed by deprotection when necessary as exampled in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Similarly, in order to explore SAR on the aryl substitutions, a different synthetic approach (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) was deployed. Dibromothiazole <b>43</b> was substituted with amine (exampled as <b>44</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) followed by Suzuki coupling with various boronic acids, to afford compounds <b>20–22</b>, <b>25</b>, and <b>28–35</b>.</div><div class="NLM_p">The brief SAR was summarized in <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Removal of four methyl groups in piperidine increased compound activity by 3.5-fold (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, e.g., <b>12</b>, <b>13</b>), likely due to the improved H-bond interaction between the amino linker and Arg111 by removing the steric hindrance to His114. Increasing the nitrogen substitution reduced inhibition (e.g., <b>13</b>, <b>14</b>), suggesting the terminal NH group may be involved in important interactions such as hydrogen bond with surrounding residues, which most likely involve water molecules since we did not observe any direct interaction in the crystal structure. Replacement of piperidine with pyrrolidine or adding one CH<sub>2</sub> in a N linker is tolerable for SHP2 inhibition (e.g., <b>15</b>, <b>16</b>). We then directly linked thiazole with piperidine. Compound <b>17</b> compensates the loss of hydrogen-bond between the amino linker and Arg111 with a potentially more favorable hydrogen-bonding interaction by the terminal NH<sub>2</sub> group, resulting in slightly improved activity as compared to <b>12</b>. The amine functional group of <b>17</b> is the same as that of <b>8</b>, suggesting the amino group is optimal to capture the H-bond interactions with surrounding residues.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Other substitutions on piperidine resulted in compromised activity against SHP2 (e.g., <b>18</b>, <b>19</b>). Compounds <b>12</b>–<b>17</b> showed comparable activity; however, some of the compounds (e.g., <b>13</b>) were not stable in DMSO solution even at −20 °C stock. Compound <b>17</b> showed stable chemical stability and good bioactivity; therefore, we chose compound <b>17</b> as a template to further optimize the aryl region. In general, substitutions on naphthaline such as F, Cl, Br, OMe, CN, and CO<sub>2</sub>Me were well accepted to inhibit SHP2, suggesting the hydrophobic cleft is tolerable to electron donating and withdrawing groups (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>, e.g., <b>20</b>–<b>25</b>). However, polar substitutions with acid or hydroxyl abolished the compound activity, consistent to the nonpolar environment of the hydrophobic cleft (e.g., <b>26</b>, <b>27</b>). The potency of 1,3-diphenyl substitutions was generally better than that of 1,4-diphenyl, suggesting that the terminal phenyl in 1,3-diphenyl adopted a favorable position for π–cation interaction with the side chain of Arg111 (e.g., <b>28</b>–<b>32</b>). Other aryl groups we tested led to dramatic reduced inhibition against SHP2 (<b>33</b>–<b>35</b>). After two rounds of optimization and SAR study, we identified compound <b>23</b> as a SHP2 allosteric inhibitor with an IC<sub>50</sub> of 0.7 μM for SHP2<sup>E76A</sup> but no inhibition on SHP2<sup>PTP</sup> (<a class="ref internalNav" href="#notes1" aria-label="Figure S2">Figure S2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the Amine Region<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0009.gif" alt="" id="GRAPHIC-d88e1239-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup>Table a</sup><p class="last">Each IC<sub>50</sub> is the mean of at least three determinations.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of the Aryl Region<a class="ref internalNav" href="#tbl3-fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0010.gif" alt="" id="GRAPHIC-d88e1256-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0011.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl3-fn1"><div class="footnote" id="tbl3-fn1"><sup>Table a</sup><p class="last">Each IC<sub>50</sub> is the mean of at least three determinations.</p></div></div><div></div></div><div class="NLM_p">To compare the reported biochemical assay using SHP2<sup>WT</sup> stimulated with 2P-IRS-1 peptide<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31, 32)</a> with that using SHP2<sup>E76A</sup> in this study, we tested <b>23</b> and <b>8</b> in both assay formats (<a class="ref internalNav" href="#notes1" aria-label="Figure S3">Figure S3</a>). Compound <b>8</b> exhibited an IC<sub>50</sub> of 0.06 μM for SHP2<sup>WT</sup> (2P-IRS-1) and 0.12 μM for SHP2<sup>E76A</sup>. Similarly, <b>23</b> showed comparable IC<sub>50</sub>s in the two assays, suggesting that both assays are able to identify SHP2 allosteric inhibitors with similar sensitivity. Selectivity profiling revealed that <b>23</b> exhibited more than 30-fold selectivity over other PTPs, including LmwPTP, MKP3, PTP1B, TC-PTP, etc. (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>). Of particular note, <b>23</b> displayed a 48-fold preference for SHP2 over its closely related homologue SHP1.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Selectivity of <b>23</b> against a Panel of Phosphatases<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">phosphatase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LmwPTP</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MKP3</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PTP1B</td><td class="colsep0 rowsep0" align="left">31.23 ± 1.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TC-PTP</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SHP1</td><td class="colsep0 rowsep0" align="left">34.62 ± 3.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VHR</td><td class="colsep0 rowsep0" align="left">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDC25A</td><td class="colsep0 rowsep0" align="left">27.46 ± 2.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SHP2<sup>E76A</sup></td><td class="colsep0 rowsep0" align="left">0.71 ± 0.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Each IC<sub>50</sub> is the mean of at least three determinations.</p></div></div></div></div><div id="sec2-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Compound <b>23</b> Inhibits MAPK Signaling Pathway and Antagonizes YAP Transcription Activity</h3><div class="NLM_p">To examine if <b>23</b> could interfere with ERK activation in cancer cells, we treated a large-cell lung carcinoma cell line NCI-H661 with <b>23</b> at indicated concentrations. NCI-H661 cells harbor SHP2 N58S gain-of-function mutation, whose activity was inhibited by <b>23</b> with an IC<sub>50</sub> of 1.2 μM (<a class="ref internalNav" href="#notes1" aria-label="Figure S4">Figure S4</a>). As shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A, the levels of both phosphorylated ERK and AKT were downregulated upon <b>23</b> treatment, whereas the inactive compound <b>34</b> had no effect even at 20 μM (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>A). The inhibition of ERK activation by <b>23</b> was time dependent, reaching max inhibition at 60 min (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>B). SHP2 plays a key role in RAS-MAPK activation mediated by receptor tyrosine kinases.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9-13)</a> We then tested <b>23</b> in H1975 cells harboring the T790M mutation in EGFR, whose proliferation was reported to be dependent on SHP2.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Treatment of <b>23</b> diminished the immunofluorescence of p-ERK1/2, indicating that <b>23</b> effectively blocked MAPK signaling pathway mediated by activated SHP2 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>C).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>23</b> suppresses RAS-MAPK signaling pathway. (A) Western blot of p-ERK1/2, ERK1/2, p-AKT, and AKT from NCI-H661 cells treated with DMSO or indicated concentrations of <b>23</b> for 2 h. Compound <b>34</b> served as a negative control. (B) Western blot of p-ERK1/2, ERK1/2, p-AKT, and AKT from NCI-H661 cells treated with DMSO or 10 μM <b>23</b> at different time points. (C) NCI-H1975 cells treated with DMSO or 10 μM <b>23</b> were stained with p-ERK1/2 antibody and DAPI. The scale bars represent 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">SHP2 has been shown to physically associate with the oncoprotein YAP and potentiate its transcriptional coactivator function.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Indeed, we found that Flag-YAP could be coimmunoprecipitated by HA-SHP2 and <i>vice versa</i> in HEK293T cells (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). To ask if SHP2 phosphatase activity is involved in regulation of Hippo/YAP signaling pathway, we then tested <b>23</b> in a YAP-dependent luciferase reporter assay. SF268, a neuroblastoma cell line harboring YAP amplification, was stably expressed with a luciferase reporter driven by YAP responsive promoter. The luciferase activity was decreased by <b>23</b> treatment in a dose-dependent manner but not by the negative compound <b>34</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>B). Moreover, the mRNA levels of YAP target genes <i>CTGF</i>, <i>CYR61</i>, and <i>ANKRD1</i>,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> but not YAP itself, were downregulated by the treatment of <b>23</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>C). Notably, <b>23</b> elevated the level of tyrosine phosphorylation on YAP (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>D). It has been shown that c-Abl antagonizes the YAP oncogenic function by phosphorylating YAP at Y357.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> We then asked if SHP2 could regulate YAP Y357 phosphorylation. Indeed, treatment of A549 cells harboring KRAS mutation with <b>23</b> increased Y357 phosphorylation (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>E), while p-ERK1/2 was not obviously affected. To further investigate whether YAP is a direct substrate of SHP2, we performed <i>in vitro</i> dephosphorylation assay using phosphorylated Y357 peptide. SHP2<sup>E76A</sup> decreased the phosphorylation level of the peptide, which was reversed in the presence of <b>23</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>F).</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>23</b> antagonizes YAP transcriptional activity and promotes phosphorylated Y357 of YAP. (A) Interaction of SHP2 and YAP. Flag-YAP and HA-SHP2 were cotransfected into HEK293T cells. YAP and SHP2 interaction was examined by reciprocal coimmunoprecipitation as indicated. (B) SF268 cells stably expressing a YAP-dependent luciferase reporter were treated with indicated concentrations of <b>23</b>. Compound <b>34</b> served as a negative control. Normalized Luciferase = Renilla luciferase/CellTiter-Glo. Error bars show mean ±SD (<i>n</i> = 3); *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ns = not significant. (C) qPCR analysis of CTGF, CYR61, ANKRD1, and YAP mRNA levels in SF268 cells treated with DMSO and <b>23</b> for 2 h. Error bars show mean ± SD (<i>n</i> = 3); *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ns = not significant. (D) SF268 cells were treated with DMSO or <b>23</b> at indicated concentrations for 2 h. The immunoprecipitates with anti-YAP antibody were analyzed by immunoblotting using pY-100 phosphotyrosine antibody. YAP harbors only one tyrosine residue in motif YXXP (tyrosine 357), which can be examined by pY-100 phosphotyrosine antibody. (E) Western blot of indicated proteins from A549 cells treated with DMSO or <b>23</b> for 2 h. (F) In vitro dephosphorylation experiments were performed to examine the putative substrate of SHP2 using 357Y peptide (SGLSMSSYSVPRTPD), phosphorylated 357Y peptide (SGLSMSSpYSVPRTPD) of YAP, and purified SHP2E76A protein. Dot blot results of indicated treatments were analyzed by p-YAP(Y357) antibody. pY357 peptide (100 μM) was incubated with 0.5 nM SHP2E76A (+) and 1.5 nM SHP2E76A (++) for 15 min, and 20 μM <b>23</b> was pretreated with 1.5 nM SHP2E76A (++) for 15 min before the peptide was added.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Compound <b>23</b> Inhibits Cancer Cell Proliferation <i>in Vitro</i> and Tumor Growth <i>in Vivo</i></h3><div class="NLM_p">Because <b>23</b> effectively inhibited pro-survival and pro-growth signaling pathways such as MAPK and YAP, we then examined its effect on cancer cell proliferation. We tested <b>23</b> activity in a panel of cancer cell lines including lung, breast, esophageal, and hematopoietic tumors. The SHP2 inhibitor exhibited a broad antitumor activity with great potency in a subset of leukemia cell lines such as MV4;11 and MOLM-13, which contain FLT3-ITD mutation (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>A). Compound <b>23</b> also attenuated the colony formation of H1975 cells, showing that <b>23</b> inhibited anchorage-independent cancer cell growth (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>B).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>23</b> inhibits cancer cell proliferation in vitro and tumor growth in vivo. (A) Panel of cancer cell lines was treated with <b>23</b> for 48 h. Cell survival was measured by CellTiter-Glo. Data represent mean ± SD (<i>n</i> = 3). (B) NCI-H1975 cells treated with <b>23</b> at indicated concentrations were subjected to a soft agar assay. The number of colonies is shown in the graph. Error bars show mean ± SD (<i>n</i> = 3); ***<i>p</i> < 0.001. (C) Efficacy study of <b>23</b> on MV4;11 xenograft tumor. Tumor volume was assessed by a caliper in two dimensions for mice treated with vehicle and <b>23</b> (10 or 30 mg/kg, po, qd) twice weekly. Data represents mean ± SEM. (inset) Body weights of mice bearing MV4;11 xenografts. Body weight was measured twice a week for mice treated with vehicle and <b>23</b> (10 or 30 mg/kg po, qd). Data represents mean ± SEM. (D) Statistical significance of the antitumor effect on day 14. Data represents mean ± SEM; *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Pharmacokinetics studies revealed that <b>23</b> had good oral exposure (10 mg/kg, PO AUC: 9860 nM·h) and bioavailability (67% F) with half-life of 13.3 h (<a class="ref internalNav" href="#notes1" aria-label="Table S1">Table S1</a>). The promising PK properties stimulated us to further evaluate the antitumor activity of <b>23</b><i>in vivo</i>. We chose MV4;11 cells to establish a xenograft model by subcutaneously implanting cells into immunocompromised mice. A daily oral dose of 10 or 30 mg/kg of <b>23</b> led to 44.6% and 56.0% tumor growth inhibition, respectively, while the body weight was not significantly affected (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>C). The tumor volumes on the last day of treatment and the statistical analysis were presented in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>D.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Discussion and Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">SHP2 has drawn great attention as an antitumor target due to its direct genetic link to cancer and critical function in pro-survival signaling pathways. In our study, we established a new screen strategy for SHP2 allosteric inhibitors using SHP2<sup>E76A</sup> protein and successfully discovered <b>9</b> as a novel allosteric inhibitor of SHP2. Further optimization led to a more potent compound <b>23</b> with an IC<sub>50</sub> of 0.7 μM. The IC<sub>50</sub>s of <b>23</b> or <b>8</b> in SHP2<sup>E76A</sup> and SHP2<sup>WT</sup> (2P-IRS-1) biochemical assays were comparable (<a class="ref internalNav" href="#notes1" aria-label="Figure S3">Figure S3</a>), suggesting that either assay format can serve as a feasible approach to identify SHP2 allosteric inhibitors. Compound <b>23</b> effectively suppressed ERK1/2 and AKT activation in cancer cells. SHP2 has been involved in regulation of YAP oncogene transcriptional activity; however, it is not elucidated if the regulation is SHP2 phosphatase activity dependent. Our data showed that <b>23</b> inhibited YAP-dependent reporter and the expression of YAP target genes, suggesting that YAP activity is modulated by SHP2 PTP catalytic function. Compound <b>23</b> inhibited the proliferation of a variety of cancer cell lines and suppressed the colony formation of lung cancer cell H1975. It exhibited good PK profiling and antitumor activity in a MV4;11 xenograft model. Our study described herein corroborates that allosteric inhibition of SHP2 could be a feasible approach to develop novel anticancer therapies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44617" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44617" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4-1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Materials</h3><div class="NLM_p last">DIFMUP (6,8-difluoro-4-methylumbelliferyl phosphate) was purchased from Thermo Fisher Scientific. Rabbit antiphospho-AKT, antitotal AKT, antiphospho-ERK1/2, antitotal ERK1/2, and mouse antiphosphotyrosine pY-100 were purchased from Cell Signaling Technology. Mouse anti-YAP was from Santa Cruze Biotechnology. Rabbit antiphospho-YAP(Y357) was from Abcam.</div></div><div id="sec4-2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Methods for Chemistry</h3><div class="NLM_p">All reagents and starting materials were obtained from commercial suppliers and used without further purification unless otherwise stated. Reaction progress was monitored by thin layer chromatography (TLC) on preloaded silica gel 60 F254 plates. Visualization was achieved with UV light and iodine vapor. All reactions involving oxygen- or moisture-sensitive compounds were carried out under a dry N<sub>2</sub> atmosphere. THF was distilled from sodium/benzophenone immediately prior to use. Toluene was distilled from sodium immediately prior to use. Yields were of purified product and were not optimized. <sup>1</sup>H NMR and <sup>13</sup>C NMR were recorded on Bruker AM-400 and Agilent-NMR-vnmrs 400 spectrometers in the corresponding solvent. <sup>1</sup>H NMR spectra were referenced to the residual solvent peaks as internal standards (7.26 ppm for CDCl<sub>3</sub>, 2.50 ppm for DMSO-<i>d</i><sub>6</sub>, and 3.34 ppm for CD<sub>3</sub>OD). <sup>13</sup>C NMR spectra were referenced to the residual solvent peaks as internal standards (39.52 ppm for DMSO-<i>d</i><sub>6</sub>), NMR data were recorded as follows: multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet or unresolved, coupling constant (solid) in Hz, integration). Mass spectra were determined on an Agilent 5973N MSD (EI), Shimadzu LCMS-2010EV (ESI) mass spectrometer, or Agilent G6100 LC/MSD (ESI) single Quand mass spectrometer and IonSpec HiResMALDI. High-resolution mass spectra were recorded on Waters Micromass GCT Premier (EI), Bruker Daltonics, Inc., APEXIII 7.0 TESLA FTMS (ESI) mass spectrometers, and IonSpec 4.7 T FTMS (MALDI). The purity was determined by high-performance liquid chromatography (HPLC). Purity of all final compounds was 95% or higher. The instrument was an Agilent Technologies 6120 LC/MS system. The column was a Phenomenex Luna C18, 100A, 2.0 50 mm, 5 μm.</div><div id="sec4-2-1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Procedure A: Buchwald–Hartwig Coupling</h4><div class="NLM_p last">To an oven-dried round-bottomed flask equipped with a stir bar was added Pd<sub>2</sub>(dba)<sub>3</sub> (23 mg, 0.025 mmol, 5 mol %), Xantphos (29 mg, 0.05 mmol, 10 mol %), sodium <i>tert</i>-butoxide (96 mg, 1.0 mmol, 2.0 equiv), and the aryl bromide (0.5 mmol, 1.0 equiv). Toluene (0.5 M) was added followed by the amine (1.5 mmol, 3.0 equiv), and the reaction mixture was degassed by sparging with N<sub>2</sub>(g) for 10 min, and the resulting suspension was heated at 120 °C for 3–12 h, the reaction mixture was allowed to cool to r.t., then diluted with ethyl acetate and subsequently filtered with Celite. After the filtrate was concentrated under reduced pressure, the resulting residue was purified by chromatography as specified.</div></div><div id="sec4-2-2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> General Procedure B: Suzuki-Coupling and Boc-Deprotection</h4><div class="NLM_p last">The corresponding brominated aromatic compound (0.5 mmol, 1.0 equiv) was dissolved in THF (10 mL/mmol), the corresponding boronic acid or boronic acid ester (0.6 mmol, 1.2 equiv) and an aqueous 2.0 M Na<sub>2</sub>CO<sub>3</sub> solution (0.75 mL, 3.0 equiv) were added. The mixture was deoxygenated under reduced pressure and flushed with nitrogen. After having repeated this cycle several times, Pd(PPh<sub>3</sub>)<sub>4</sub> (29 mg, 0.025 mmol, 5 mol %) was added, and the resulting suspension was heated at 80 °C for 12–16 h. After cooling, ethyl acetate and water were added, and the organic phase was separated. The water phase was extracted with ethyl acetate. The combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated in vacuo, and purified by chromatography to afford Boc-protected product, which was treated with trifluoroacetic acid to get Boc-deprotected product.</div></div><div id="sec4-2-3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 4-Phenyl-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)thiazol-2-amine (<b>9</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>38a</b> and 2,2,6,6-tetramethylpiperidin-4-amine following general procedure A. Yellow solid (66 mg, 42% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.37 (s, 1H), 7.85–7.80 (m, 3H), 7.37 (t, <i>J</i> = 7.6 Hz, 2H), 7.26 (t, <i>J</i> = 7.2 Hz, 1H), 7.10 (s, 1H), 4.18–4.11 (m, 1H), 2.13 (dd, <i>J</i> = 3.2 Hz, <i>J</i> = 5.2 Hz,2H), 1.59–1.53 (m, 2H), 1.47 (d, <i>J</i> = 18.4 Hz, 12H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 166.88, 149.77, 134.80, 128.47, 127.30, 125.59, 101.26, 56.68, 45.11, 40.54, 29.73, 24.26. HRMS-ESI: calcd. for C<sub>18</sub>H<sub>26</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 316.1842; found, 316.1845.</div></div><div id="sec4-2-4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-([1,1′-Biphenyl]-3-yl)-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)thiazol-2-amine (<b>10</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>38b</b> and 2,2,6,6-tetramethylpiperidin-4-amine following general procedure A. Yellow solid (90 mg, 46% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.15 (s, 1H), 7.82 (d, <i>J</i> = 8.0 Hz, 1H), 7.69 (d, <i>J</i> = 7.2 Hz, 2H), 7.61–7.55 (m, 2H), 7.49–7.44 (m, 3H), 7.40–7.34 (m, 1H), 7.19 (s, 1H), 4.03–3.90 (m, 1H), 1.97 (dd, <i>J</i> = 2.4 Hz, <i>J</i> = 12.0 Hz, 2H), 1.25 (s, 6H), 1.09 (s, 6H), 1.05–0.98 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 167.36, 149.66, 140.29, 140.18, 135.52, 129.12, 128.91, 127.52, 126.63, 125.51, 124.54, 124.03, 101.04, 51.04, 47.71, 43.91, 34.04, 28.19. HRMS-ESI: calcd. for C<sub>24</sub>H<sub>30</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 392.2155; found, 392.2153.</div></div><div id="sec4-2-5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 4-([1,1′-Biphenyl]-4-yl)-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)thiazol-2-amine (<b>11</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>38c</b> and 2,2,6,6-tetramethylpiperidin-4-amine following general procedure A. Yellow solid (100 mg, 51% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.38 (s, 1H), 7.93 (d, <i>J</i> = 8.4 Hz, 2H), 7.83 (d, <i>J</i> = 7.2 Hz, 1H), 7.71–7.68 (m, 4H), 7.47 (t, <i>J</i> = 7.6 Hz, 2H), 7.36 (t, <i>J</i> = 7.6 Hz, 1H), 7.17 (s, 1H), 4.22–4.12 (m, 1H), 2.14 (dd, <i>J</i> = 2.4 Hz, <i>J</i> = 13.2 Hz, 2H), 1.56–1.40 (m, 14H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 166.93, 149.42, 139.70, 138.81, 133.93, 128.95, 127.74, 126.70, 126.16, 101.54, 56.63, 45.17, 40.60, 29.81, 24.33. HRMS-ESI: calcd. for C<sub>24</sub>H<sub>30</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 392.2155; found, 392.2157.</div></div><div id="sec4-2-6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-(Naphthalen-2-yl)-<i>N</i>-(2,2,6,6-tetramethylpiperidin-4-yl)thiazol-2-amine (<b>12</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>38d</b> and 2,2,6,6-tetramethylpiperidin-4-amine following general procedure A. White solid (97 mg, 53% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.35 (s, 1H), 7.98 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 8.0 Hz, 1H), 7.90–7.83 (m, 3H), 7.65 (d, <i>J</i> = 8.0 Hz, 1H), 7.64–7.49 (m ,2H), 7.20 (s, 1H), 3.98–3.94 (m, 1H), 1.95 (dd, <i>J</i> = 4.0 Hz, <i>J</i> = 8.0 Hz, 1H), 1.24 (s, 6H), 1.09–1.03 (m, 8H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 167.62, 149.87, 133.16, 132.43, 132.35, 128.07, 127.93, 127.58, 126.38, 125.83, 124.08, 101.40, 50.81, 48.08, 44.24, 34.42, 28.52. HRMS-ESI: calcd. for C<sub>22</sub>H<sub>28</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 366.1998; found, 366.1995.</div></div><div id="sec4-2-7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 4-(Naphthalen-2-yl)-<i>N</i>-(piperidin-4-yl)thiazol-2-amine (<b>13</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>38d</b> and piperidin-4-amine following general procedure A. Yellow solid (56 mg, 36% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.32 (s, 1H), 7.98–7.72 (m, 4H), 7.46–7.44 (m, 2H), 6.81 (s, 1H), 5.52 (s, 1H), 3.53 (s, 1H), 3.13 (d, <i>J</i> = 12.0 Hz, 2H), 2.74 (t, <i>J</i> = 11.3 Hz, 2H), 2.48 (s, 1H), 2.15 (d, <i>J</i> = 11.3 Hz, 2H), 1.52–1.41 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 167.06, 149.85, 133.15, 132.36, 132.29, 128.02, 127.89, 126.35, 125.83, 124.14, 124.06, 102.12, 48.73, 41.78, 21.13. HRMS-ESI: calcd. for C<sub>18</sub>H<sub>20</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 310.1372; found, 310.1369.</div></div><div id="sec4-2-8" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>N</i>-(1-Methylpiperidin-4-yl)-4-(naphthalen-2-yl)thiazol-2-amine (<b>14</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>38d</b> and 1-methylpiperidin-4-amine following general procedure A. Yellow solid (79 mg, 49% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.29 (s, 1H), 7.88–7.79 (m, 4H), 7.49–7.40 (m, 2H), 6.80 (s, 1H), 5.88 (s, 1H), 3.71 (s, 1H), 3.13–3.09 (m, 2H), 2.58–2.43 (m, 5H), 2.26 (d, <i>J</i> = 11.7 Hz, 2H), 1.96–1.85 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 167.31, 149.88, 133.15, 132.35, 132.34, 128.03, 127.89, 126.34, 125.81, 124.15, 124.01, 101.87, 54.92, 52.94, 44.40, 30.06. HRMS-ESI: calcd. for C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 324.1529; found, 324.1531.</div></div><div id="sec4-2-9" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-(Naphthalen-2-yl)-<i>N</i>-(pyrrolidin-3-yl)thiazol-2-amine (<b>15</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>38d</b> and pyrrolidin-3-amine following general procedure A. Yellow solid (60 mg, 41% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.40 (s, 1H), 8.37 (s, 1H), 8.13 (d, <i>J</i> = 5.2 Hz, 1H), 7.99 (d, <i>J</i> = 1.2 Hz, <i>J</i> = 8.4 Hz, 1H), 7.94–7.88 (m, 3H), 7.53–7.46 (m, 2H), 7.30 (s, 1H), 4.49–4.43 (m, 1H), 3.57–3.52 (m, 1H), 3.39–3.26 (m, 3H), 2.33–2.24 (m, 1H), 2.07–2.00 (m, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 167.59, 150.33, 133.63, 132.87, 132.61, 128.52, 128.45, 128.05, 126.87, 126.37, 124.59, 124.57, 103.38, 53.83, 49.85, 43.98, 30.55. HRMS-ESI: calcd. for C<sub>17</sub>H<sub>18</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 296.1216; found, 296.1213.</div></div><div id="sec4-2-10" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(Naphthalen-2-yl)-<i>N</i>-(piperidin-3-ylmethyl)thiazol-2-amine (<b>16</b>)</h4><div class="NLM_p last">Following the general procedure A, <b>38d</b> and <i>tert</i>-butyl 3-(aminomethyl)piperidine-1-carboxylate were combined to afford <i>tert</i>-butyl 3-(((4-(naphthalen-2-yl)thiazol-2-yl)amino)methyl)piperidine-1-carboxylate, which was treated with trifluoroacetic acid to get compound <b>16</b>. Yellow solid (58 mg, 36% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.92 (s, 1H), 8.36 (s, 1H), 7.99–7.87 (m, 4H), 7.53–7.45 (m, 2H), 7.22 (s, 1H), 3.22–3.19 (m, 2H), 2.80–2.65 (m, 2H), 2.18–2.14 (m, 1H), 1.87–1.80 (m, 2H), 1.67–1.64 (m, 2H), 1.30–1.23 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 168.44, 149.85, 133.18, 132.37, 132.32, 128.09, 127.91, 127.57, 126.36, 125.85, 124.15, 124.12, 101.96, 47.33, 46.42, 43.36, 33.56, 26.11, 21.50. HRMS-ESI: calcd. for C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 324.1529; found, 324.1527.</div></div><div id="sec4-2-11" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 4-Methyl-1-(4-(naphthalen-2-yl)thiazol-2-yl)piperidin-4-amine (<b>17</b>)</h4><div class="NLM_p last">Following the general procedure A, <b>38d</b> and <i>tert</i>-butyl (4-methylpiperidin-4-yl)carbamate were combined to afford <i>tert</i>-butyl (4-methyl-1-(4-(naphthalen-2-yl)thiazol-2-yl)piperidin-4-yl)carbamate, which was treated with trifluoroacetic acid to get compound <b>17</b>. White solid (73 mg, 45% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.40 (s, 1H), 8.32 (s, 2H), 8.01–7.89 (m, 4H), 7.53–7.47 (m, 2H), 7.44 (s, 1H), 3.88–3.84 (m, 2H), 3.46–3.36 (m, 2H), 1.94–1.90 (m, 2H), 1.83–1.80 (m, 2H), 1.40 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.05, 150.56, 133.16, 132.48, 132.08, 128.10, 128.02, 127.59, 126.45, 125.98, 124.24, 124.08, 103.60, 51.80, 44.13, 33.76, 22.06. HRMS-ESI: calcd. for C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 324.1529; found, 324.1525.</div></div><div id="sec4-2-12" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-(3,5-Dimethylpiperazin-1-yl)-4-(naphthalen-2-yl)thiazole (<b>18</b>)</h4><div class="NLM_p last">Following the general procedure A, <b>38d</b> and <i>tert-</i>butyl 2,6-dimethylpiperazine-1-carboxylate were combined to afford <i>tert</i>-butyl 2,6-dimethyl-4-(4-(naphthalen-2-yl)thiazol-2-yl)piperazine-1-carboxylate, which was treated with trifluoroacetic acid to get compound <b>18</b>. White solid (76 mg, 47% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.40 (s, 1H), 8.01–7.89 (m, 4H), 7.53–7.46 (m, 2H), 7.44 (s, 1H), 3.95 (dd, <i>J</i> = 2.4 Hz, <i>J</i> = 12.0 Hz,2H), 3.07 (s, 2H), 2.77 (t, <i>J</i> = 11.2 Hz, 2H), 1.17 (d, <i>J</i> = 6.0 Hz, 6H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.08, 150.50, 133.14, 132.46, 132.05, 128.09, 127.98, 127.56, 126.40, 125.95, 124.23, 124.08, 103.48, 53.00, 50.02, 17.70. HRMS-ESI: calcd. for C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 324.1529; found, 324.1525.</div></div><div id="sec4-2-13" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (1-(4-(Naphthalen-2-yl)thiazol-2-yl)piperidin-3-yl)methanamine (<b>19</b>)</h4><div class="NLM_p last">Following the general procedure A, <b>38d</b> and <i>tert-</i>butyl(piperidin-3-ylmethyl)carbamate were combined to afford <i>tert</i>-butyl 2,6-dimethyl-4-(4-(naphthalen-2-yl)thiazol-2-yl)piperazine-1-carboxylate, which was treated with trifluoroacetic acid to get compound <b>19</b>. White solid (69 mg, 43% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.42 (s, 1H), 8.01 (dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.8 Hz, 1H), 7.95–7.89 (m, 3H), 7.54–7.47 (m, 2H), 7.44 (s, 1H), 4.10 (dd, <i>J</i> = 2.4 Hz, <i>J</i> = 12.8 Hz, 1H), 3.96–3.87 (m, 1H), 3.49–3.30 (m, 2H), 3.23–3.05 (m, 1H), 2.92–2.72 (m, 3H), 1.92–1.79 (m, 3H), 1.62–1.53 (m, 1H), 1.27–1.23 (m, 1H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.94, 150.93, 133.64, 132.93, 132.61, 128.53, 128.41, 128.04, 126.87, 126.39, 124.73, 124.57, 103.63, 52.13, 49.23, 40.63, 34.93, 27.94, 23.99. HRMS-ESI: calcd. for C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 324.1529; found, 324.1525.</div></div><div id="sec4-2-14" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-(4-(6-Chloronaphthalen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (<b>20</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and 2-(6-chloronaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane following general procedure B. White solid (111 mg, 62% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.29 (s, 1H), 7.91–7.73 (m, 4H), 7.56 (s, 2H), 7.39 (d, <i>J</i> = 8.0 Hz, 1H), 7.02 (s, 1H), 4.00–3.89 (m, 2H), 3.46–3.31 (m, 2H), 2.01–1.85 (m, 4H), 1.47 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.12, 150.19, 133.08, 132.59, 131.56, 130.38, 130.26, 127.35, 126.89, 126.23, 125.27, 124.13, 103.92, 50.95, 44.28, 34.49, 23.44. HRMS-ESI: calcd. for C<sub>19</sub>H<sub>21</sub>N<sub>3</sub>ClS [M + H]<sup>+</sup>, 358.1139; found, 358.1137.</div></div><div id="sec4-2-15" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-(4-(6-Fluoronaphthalen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (<b>21</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and 2-(6-fluoronaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane following general procedure B. White solid (116 mg, 68% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.44 (s, 1H), 8.38 (s, 2H), 8.05–8.02 (m, 2H), 7.91 (d, <i>J</i> = 8.8 Hz, 1H), 7.70 (dd, <i>J</i> = 2.0 Hz, <i>J</i> = 10.0 Hz,1H), 7.43–7.40 (m, 2H), 3.89–3.84 (m, 2H), 3.45–3.40 (m, 2H), 1.95–1.90 (m, 2H), 1.83–1.80 (m, 2H), 1.40 (s, 3H). <sup>19</sup>F-NMR: −114.43 to −114.49. <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.07, 160.03 (d, <i>J</i> = 242.4 Hz), 150.31, 133.16 (d, <i>J</i> = 9.4 Hz), 131.62 (d, <i>J</i> = 2.6 Hz), 130.98 (d, <i>J</i> = 9.0 Hz), 130.33, 127.51 (d, <i>J</i> = 5.3 Hz), 125.19, 124.29, 116.53 (d, <i>J</i> = 25.0 Hz), 110.72 (d, <i>J</i> = 20.6 Hz), 103.54, 51.83, 44.10, 33.71, 21.98. HRMS-ESI: calcd. for C<sub>19</sub>H<sub>21</sub>FN<sub>3</sub>S [M + H]<sup>+</sup>, 342.1435; found, 342.1437.</div></div><div id="sec4-2-16" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-(4-(6-Methoxynaphthalen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (<b>22</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and 2-(6-methoxynaphthalen-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane following general procedure B. White solid (104 mg, 59% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.31 (s, 1H), 7.94 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.8 Hz, 1H), 7.86–7.80 (m, 2H), 7.33 (s, 1H), 7.31 (d, J = 2.4 Hz, 1H), 7.16 (dd, <i>J</i> = 2.4 Hz, <i>J</i> = 8.8 Hz, 1H), 3.88 (s, 3H), 3.84–3.79 (m, 2H), 3.50–3.37 (m, 2H), 1.89–1.76 (m, 4H), 1.36 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.00, 157.39, 150.77, 133.78, 130.01, 129.63, 128.48, 126.90, 124.55, 124.18, 118.89, 106.03, 102.40, 55.22, 51.28, 44.24, 34.22, 22.89. HRMS-ESI: calcd. for C<sub>20</sub>H<sub>24</sub>N<sub>3</sub>OS [M + H]<sup>+</sup>, 354.1635; found, 354.1630.</div></div><div id="sec4-2-17" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-(4-(6-Bromonaphthalen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (<b>23</b>)</h4><div class="NLM_p last">Compound <b>42</b> was treated with trifluoroacetic acid to get compound <b>23</b>. White solid (174 mg, 87% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.41 (s, 1H), 8.18 (s, 1H), 8.13 (s, 2H), 8.05 (d, J = 8.8 Hz, 1H), 7.91 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.8 Hz, 1H), 7.47 (s, 1H), 3.90–3.80 (m, 2H), 3.44–3.36 (m, 2H), 1.90–1.80 (m, 4H), 1.39 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.07, 150.22, 133.61, 132.65, 131.71, 130.33, 129.51, 129.41, 127.33, 125.23, 124.20, 119.07, 104.22, 51.91, 44.19, 33.67, 21.71. HRMS-ESI: calcd. for C<sub>19</sub>H<sub>21</sub>N<sub>3</sub>BrS [M + H]<sup>+</sup>, 402.0634; found, 402.0635.</div></div><div id="sec4-2-18" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 6-(2-(4-Amino-4-methylpiperidin-1-yl)thiazol-4-yl)-2-naphthonitrile (<b>24</b>)</h4><div class="NLM_p last">To an oven-dried round-bottomed flask was added compound <b>42</b> (50 mg, 0.1 mmol), Zn(CN)<sub>2</sub> (14 mg, 0.15 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (58 mg, 0.05 mmol), then DMF (5 mL) was added, and the reaction mixture was degassed by sparging with N<sub>2</sub>(g) for 10 min, at which time it was equipped with a condenser and placed in a preheated 130 °C oil-bath. After 8 h, the reaction mixture was allowed to cool to r.t., then diluted with ethyl acetate, and the reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed with water and brine successively, dried over anhydrous sodium sulfate, and concentrated in vacuum. The resulting residue was purified by silica gel chromatography (dichloromethane/methanol, v/v, 99:1 to 95:5) to give the desired product <b>24</b>. Yellow solid (10 mg, 29% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.54 (s, 1H), 8.50 (s, 1H), 8.17–8.12 (m, 2H), 8.06 (d, <i>J</i> = 8.8 Hz, 1H), 7.77 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 8.4 Hz,1H), 7.55 (s, 1H), 3.70–3.65 (m, 2H), 3.56–3.39 (m, 2H), 1.66–1.64 (m, 4H), 1.22 (s, 3H) ; <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.30, 149.81, 135.07, 134.73, 134.01, 131.28, 129.56, 128.76, 126.83, 125.74, 124.11, 119.30, 107.99, 105.12, 48.90, 44.73, 36.34, 26.94. HRMS-ESI: calcd. for C<sub>20</sub>H<sub>21</sub>N<sub>4</sub>S [M + H]<sup>+</sup>, 349.1481; found, 349.1483.</div></div><div id="sec4-2-19" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl 6-(2-(4-Amino-4-methylpiperidin-1-yl)thiazol-4-yl)-2-naphthoate (<b>25</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and methyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-naphthoate following general procedure B. White solid (124 mg, 65% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.62 (s, 1H), 8.47 (s, 1H), 8.15 (d, <i>J</i> = 8.8 Hz, 1H), 8.10 (dd, <i>J</i> = 1.2 Hz, <i>J</i> = 8.4 Hz, 1H), 8.06–8.02 (m, 3H), 7.98 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 9.6 Hz,1H), 7.57 (s, 1H), 3.94 (s, 3H), 3.92–3.85 (m, 2H), 3.50–3.40 (m, 2H), 1.90–1.80 (m, 4H), 1.40 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.08, 166.33, 150.11, 135.39, 134.42, 131.52, 130.29, 129.64, 128.64, 126.70, 125.29, 125.01, 123.95, 105.11, 52.24, 51.88, 44.18, 33.66, 21.70. HRMS-ESI: calcd. for C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 382.1584; found, 382.1583.</div></div><div id="sec4-2-20" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 6-(2-(4-Amino-4-methylpiperidin-1-yl)thiazol-4-yl)-2-naphthoic Acid (<b>26</b>)</h4><div class="NLM_p last">To an oven-dried round-bottomed flask was added compound <b>25</b> (76 mg, 0.2 mmol) and KOH (34 mg, 0.6 mmol), then 1,4-dioxane (3 mL) and MeOH (3 mL) were added, and the reaction mixture was degassed by sparging with N<sub>2</sub>(g) for 10 min and stirred at 70 °C for 2 h. The reaction mixture was allowed to cool to r.t., water (10 mL) was added and acidified with 1 N HCl to pH to 2, then diluted with ethyl acetate, and the reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed with water and brine successively, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, and concentrated in vacuum. The resulting residue was purified by silica gel chromatography (dichloromethane/methanol, v/v, 99:1 to 95:5) to give the desired product <b>26</b>. Yellow solid (56 mg, 76%yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 13.04 (s, 1H), 8.57 (s, 1H), 8.46 (s, 1H), 8.39 (s, 2H), 8.12–8.09 (m, 2H), 8.07–7.95 (m, 2H), 7.54 (s, 1H), 3.89–3.86 (m, 2H), 3.46–3.37 (m, 2H), 1.97–1.93 (m, 2H), 1.90–1.81 (m, 2H), 1.41 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.08, 167.39, 150.16, 135.24, 134.17, 131.57, 130.25, 129.54, 128.41, 127.88, 125.66, 124.84, 123.95, 104.85, 51.85, 44.11, 33.86, 21.93. HRMS-ESI: calcd. for C<sub>20</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 368.1427; found, 368.1423.</div></div><div id="sec4-2-21" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (6-(2-(4-Amino-4-methylpiperidin-1-yl)thiazol-4-yl)naphthalen-2-yl)methanol (<b>27</b>)</h4><div class="NLM_p last">To the solution of compound <b>25</b> (76 mg, 0.2 mmol) in THF (10 mL) was added LiAlH<sub>4</sub> (1 M THF, 0.5 mL) at 0 °C, then stirred at 25 °C for 2 h. The reaction mixture was allowed to cool to r.t., Na<sub>2</sub>SO<sub>4</sub>·10H<sub>2</sub>O was added, and then diluted with ethyl acetate and subsequently filtered with Celite. After the filtrate was concentrated under reduced pressure, the resulting residue was purified by chromatography to give the desired product <b>27</b>. Yellow solid (57 mg, 81% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.43 (s, 1H), 8.10 (s, 2H), 8.10 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.4 Hz, 1H), 8.04–7.95 (m, 3H), 8.10 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.4 Hz, 1H), 7.49 (s, 1H), 5.60 (s, 2H), 3.88–3.84 (m, 2H), 3.50–3.40 (m, 2H), 1.90–1.79 (m, 4H), 1.40 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.04, 150.33, 133.15, 132.81, 132.03, 131.18, 128.73, 128.29, 128.03, 126.70, 124.67, 124.06, 104.14, 69.94, 51.92, 44.19, 33.65, 22.06. HRMS-ESI: calcd. for C<sub>20</sub>H<sub>24</sub>N<sub>3</sub>OS [M + H]<sup>+</sup>, 354.1635; found, 354.1631.</div></div><div id="sec4-2-22" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 1-(4-([1,1′-Biphenyl]-3-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (<b>28</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and 2-([1,1′-biphenyl]-3-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane following general procedure B. White solid (129 mg, 74% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.11 (brs, 3H), 7.86 (d, <i>J</i> = 6.8 Hz, 1H), 7.73–7.67 (m, 2H), 7.60–7.55 (m, 1H), 7.51–7.46 (m, 3H), 7.44 (s, 1H), 7.42–7.36 (m, 1H), 3.85–3.79 (m, 2H), 3.42–3.35 (m, 2H), 1.89–1.78 (m, 4H), 1.38 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 169.98, 150.51, 140.56, 140.17, 135.26, 129.20, 128.96, 127.57, 126.82, 126.01, 124.89, 123.95, 103.36, 51.90, 44.16, 33.65, 21.68. HRMS-ESI: calcd. for C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>S [M + H]<sup>+</sup>, 350.1685; found, 350.1679.</div></div><div id="sec4-2-23" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 3′-(2-(4-Amino-4-methylpiperidin-1-yl)thiazol-4-yl)-[1,1′-biphenyl]-4-carbonitrile (<b>29</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and 3′-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1′-biphenyl]-4-carbonitrile following general procedure B. White solid (129 mg, 69% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.25–8.11 (m, 3H), 8.01–7.89 (m, 5H), 7.66 (d, <i>J</i> = 8.8 Hz, 1H), 7.53 (t, <i>J</i> = 7.6 Hz, 1H), 7.48 (s, 1H), 3.83–3.80 (m, 2H), 3.53–3.39 (m, 2H), 1.89–1.78 (m, 4H), 1.38 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.05, 150.19, 144.63, 138.67, 135.52, 132.91, 129.52, 127.75, 126.33, 126.17, 124.20, 118.93, 110.17, 103.76, 51.86, 44.17, 33.68, 21.68. HRMS-ESI: calcd. for C<sub>22</sub>H<sub>23</sub>N<sub>4</sub>S [M + H]<sup>+</sup>, 375.1638; found, 375.1635.</div></div><div id="sec4-2-24" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Methyl 3′-(2-(4-Amino-4-methylpiperidin-1-yl)thiazol-4-yl)-[1,1′-biphenyl]-4-carboxylate (<b>30</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and methyl 3′-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1′-biphenyl]-4-carboxylate following general procedure B. White solid (132 mg, 65% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.22 (s, 1H), 8.06 (brs, 2H), 8.01–7.95 (m, 4H), 7.74 (d, <i>J</i> = 8.4 Hz, 2H), 7.64 (t, <i>J</i> = 8.0 Hz, 1H), 7.39 (s, 1H), 3.90 (s, 3H), 3.84–3.81 (m, 2H), 3.42–3.39 (m, 2H), 1.89–1.78 (m, 4H), 1.39 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.02, 166.19, 150.10, 140.28, 137.94, 134.24, 131.37, 130.39, 129.58, 128.12, 126.95, 126.89, 126.41, 103.46, 52.31, 51.94, 44.18, 33.63, 21.66. HRMS-ESI: calcd. for C<sub>23</sub>H<sub>26</sub>N<sub>3</sub>O<sub>2</sub>S [M + H]<sup>+</sup>, 408.1740; found, 408.1745.</div></div><div id="sec4-2-25" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 1-(4-(4′-Fluoro-[1,1′-biphenyl]-4-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (<b>31</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and methyl 2-(4′-fluoro-[1,1′-biphenyl]-4-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane following general procedure B. White solid (127 mg, 69% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.51 (s, 3H), 7.94 (d, <i>J</i> = 8.0 Hz, 2H), 7.74–7.66 (m, 4H), 7.35–7.27 (m, 3H), 3.84–3.81 (m, 2H), 3.42–3.37 (m, 2H), 1.97–1.92 (m, 2H), 1.80–1.79 (m, 2H), 1.40 (s, 3H). <sup>19</sup>F-NMR: −115.42 to −115.50. <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.04, 161.87 (d, <i>J</i> = 242.9 Hz), 150.14, 138.00, 136.17 (d, <i>J</i> = 3.0 Hz), 133.74, 128.49 (d, <i>J</i> = 8.1 Hz), 126.72, 126.29, 116.76 (d, <i>J</i> = 21.2 Hz), 102.96, 51.70, 44.04, 33.74, 22.10. HRMS-ESI: calcd. for C<sub>21</sub>H<sub>23</sub>FN<sub>3</sub>S [M + H]<sup>+</sup>, 368.1591; found, 368.1593.</div></div><div id="sec4-2-26" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4′-(2-(4-Amino-4-methylpiperidin-1-yl)thiazol-4-yl)-[1,1′-biphenyl]-4-ol (<b>32</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and 4′-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-[1,1′-biphenyl]-4-ol following general procedure B. White solid (130 mg, 71% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.60 (s, 1H), 7.88 (d, <i>J</i> = 8.4 Hz, 2H), 7.59 (d, <i>J</i> = 8.4 Hz, 2H), 7.52 (d, <i>J</i> = 8.4 Hz, 2H), 7.21 (s, 1H), 6.85 (d, <i>J</i> = 8.8 Hz, 2H), 3.57–3.49 (m, 4H), 1.57–1.47 (m, 4H), 1.10 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.24, 157.21, 150.41, 139.07, 132.89, 130.42, 127.56, 126.16, 125.88, 101.60, 46.85, 45.05, 38.16, 30.44. HRMS-ESI: calcd. for C<sub>21</sub>H<sub>24</sub>N<sub>3</sub>OS [M + H]<sup>+</sup>, 366.1635; found, 366.1631.</div></div><div id="sec4-2-27" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-Methyl-1-(4-(quinolin-3-yl)thiazol-2-yl)piperidin-4-amine (<b>33</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and quinolin-3-ylboronic acid following general procedure B. Yellow solid (115 mg, 71% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 9.41 (d, <i>J</i> = 1.6 Hz, 1H), 8.72 (s, 1H), 8.02 (t, <i>J</i> = 6.8 Hz, 2H), 7.73 (t, <i>J</i> = 7.2 Hz, 1H), 7.63–7.48 (m, 4H), 3.84–3.81 (m, 2H), 3.50–3.35 (m, 2H), 1.87–1.75 (m, 4H), 1.35 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.43, 148.86, 147.89, 146.84, 131.29, 129.32, 128.75, 128.37, 127.66, 127.09, 104.69, 50.95, 44.33, 34.49, 23.46. HRMS-ESI: calcd. for C<sub>18</sub>H<sub>21</sub>N<sub>4</sub>S [M + H]<sup>+</sup>, 325.1481; found, 325.1479.</div></div><div id="sec4-2-28" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1-(4-(Benzo[<i>b</i>]thiophen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (<b>34</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and benzo[<i>b</i>]thiophen-2-ylboronic acid following general procedure B. Yellow solid (95 mg, 58% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.10 (s, 2H), 7.93–7.91 (m, 1H), 7.83–7.81 (m, 1H), 7.75 (s, 1H), 7.39–7.31 (m, 3H), 3.82–3.77 (m, 2H), 3.43–3.34 (m, 2H), 1.89–1.78 (m, 4H), 1.39 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 169.98, 145.20, 140.02, 138.61, 138.57, 124.65, 124.48, 123.63, 122.43, 119.68, 103.93, 51.85, 39.94, 33.58, 21.61. HRMS-ESI: calcd. for C<sub>17</sub>H<sub>20</sub>N<sub>3</sub>S<sub>2</sub> [M + H]<sup>+</sup>, 330.1093; found, 330.1095.</div></div><div id="sec4-2-29" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 1-(4-(Bibenzo[<i>b</i>,<i>d</i>]furan-4-yl)thiazol-2-yl)-4-methylpiperidin-4-amine (<b>35</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>45</b> and dibenzo[<i>b,d</i>]furan-4-ylboronic acid following general procedure B. Yellow solid (126 mg, 69% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.19–8.16 (m, 2H), 8.12–8.09 (m, 3H), 7.82–7.45 (m, 2H), 7.57 (t, <i>J</i> = 8.0 Hz, 1H), 7.49–7.43 (m, 2H), 3.89–3.85 (m, 2H), 3.47–3.37 (m, 2H), 1.92–1.80 (m, 4H), 1.40 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 169.43, 155.40, 152.03, 145.44, 127.72, 126.06, 124.12, 123.39, 123.30, 123.12, 121.21, 120.15, 119.27, 111.84, 107.49, 51.91, 44.21, 33.65, 21.67. HRMS-ESI: calcd. for C<sub>21</sub>H<sub>22</sub>N<sub>3</sub>OS [M + H]<sup>+</sup>, 364.1478; found, 364.1473.</div></div><div id="sec4-2-30" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1-(Naphthalen-2-yl)-2-thiocyanatoethan-1-one (<b>37d</b>)</h4><div class="NLM_p last">A solution of 2-bromo-1-(naphthalen-2-yl) ethan-1-one (<b>36d</b>) (249 mg, 1.0 mmol) and potassium thiocyanate (194 mg, 2 mmol) in ethanol (5 mL) was stirred at 85 °C for 2 h. The reaction was extracted with diethyl ether and dried with MgSO<sub>4</sub>, and then the solvent was removed at low pressure. The crude product was purified by chromatography to get compound <b>37d</b> (225 mg, 99% yield) as white solid. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 8.45 (s, 1H), 7.95 (dd, <i>J</i> = 20.5, 11.0 Hz, 4H), 7.65 (dt, <i>J</i> = 15.0, 6.9 Hz, 2H), 4.89 (s, 2H).</div></div><div id="sec4-2-31" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-Bromo-4-(naphthalen-2-yl)thiazole (<b>38d</b>)</h4><div class="NLM_p last">A suspension of <b>37d</b> (227 mg, 1.0 mmol) in 2 mL of 30% hydrogen bromide in acetic acid and 3 mL of acetic acid was stirred under nitrogen at room temperature overnight. The mixture was quenched with Na<sub>2</sub>CO<sub>3</sub> aqueous solution, then extracted with ethyl acetate and washed with water and brine. The organic was dried with MgSO<sub>4</sub>, and solvent was removed at low pressure. The crude product was purified by chromatography to get compound <b>38d</b> (261 mg, 90% yield) as white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.43 (s, 1H), 7.93–7.83 (m, 4H), 7.53–7.49 (m, 3H).</div></div><div id="sec4-2-32" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-Bromo-4-(6-bromonaphthalen-2-yl)thiazole (<b>41</b>)</h4><div class="NLM_p last">The compound was prepared by following a procedure similar to that of <b>38d</b>. White solid (321 mg, 87% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.51 (s, 1H), 8.32 (s, 1H), 8.23 (d, <i>J</i> = 1.6 Hz, 1H), 8.09 (dd, <i>J</i> = 8.4 Hz, <i>J</i> = 1.6 Hz, 1H), 8.01–7.97 (m, 2H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 154.01, 136.53, 133.94, 131.66, 130.87, 130.65, 129.69, 129.59, 127.85, 124.92, 124.89, 119.78, 119.73.</div></div><div id="sec4-2-33" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>tert</i>-Butyl (1-(4-(6-Bromonaphthalen-2-yl)thiazol-2-yl)-4-methylpiperidin-4-yl)carbamate (<b>42</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>41</b> and <i>tert</i>-butyl (4-methylpiperidin-4-yl)carbamate following general procedure A. Yellow solid (245 mg, 56% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 8.41 (s, 1H), 8.18(d, <i>J</i> = 0.8 Hz, 1H), 8.04 (dd, <i>J</i> = 1.6 Hz, <i>J</i> = 8.8 Hz, 1H), 7.94–7.89 (m, 2H), 7.62 (dd, <i>J</i> = 2.0 Hz, <i>J</i> = 8.8 Hz, 1H), 7.43 (s, 1H), 6.68 (s, 1H), 3.68–3.64 (m, 2H), 3.34–3.28 (m, 2H), 2.18–2.15 (m, 2H), 1.59–1.52 (m, 2H), 1.39 (s, 9H), 1.27 (s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.38, 150.18, 133.58, 132.75, 131.75, 130.39, 129.50, 129.37, 127.28, 125.24, 124.11, 119.01, 103.65, 77.49, 49.73, 44.56, 34.26, 28.32, 25.98.</div></div><div id="sec4-2-34" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>tert</i>-Butyl (1-(4-Bromothiazol-2-yl)-4-methylpiperidin-4-yl)carbamate (<b>45</b>)</h4><div class="NLM_p last">A mixture of 2,4-dibromothiazole (<b>43</b>) (1.22 g, 5.0 mmol) and <i>tert</i>-butyl (4-methylpiperidin-4-yl)carbamate (<b>44</b>) (1.61 g, 7.5 mmol) in DMF (50 mL) and TEA (3.0 mL, 15 mmol) was heated to 90 °C for 8 h. The reaction mixture was cooled to room temperature, diluted with water, and extracted with ethyl acetate and washed with water and brine. The organic was dried with MgSO<sub>4</sub>, and solvent was removed at low pressure. The crude product was purified by chromatography to get compound 7 (1.65 g, 87%) as light yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 6.84 (s, 1H), 6.66 (s, 1H), 3.51–3.41 (m, 2H), 3.24–3.17 (m, 2H), 2.11–2.08 (m, 2H), 1.52–1.45 (m, 2H), 1.38 (s, 9H), 1.24(s, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 170.18, 154.51, 120.57, 104.23, 77.51, 56.06, 49.59, 44.15, 34.07, 28.31.</div></div></div><div id="sec4-3" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Biological Evaluation. SHP2 Protein Expression and Purification</h3><div class="NLM_p last">Genes encoding SHP2<sup>WT</sup>, SHP2<sup>E76A</sup>, SHP2<sup>C459S</sup>, and SHP2<sup>PTP</sup> were inserted into pET28a. These constructs were used to transform BL21(DE3) competent cells and cultured at 37 °C in Luria broth (LB). When OD<sub>600</sub> reached 0.6, 0.5 mM IPTG was added to induce SHP2 protein expression for 5 h at 30 °C. Cells were collected by centrifugation (4500 rpm, 15 min) and resuspended in lysis buffer containing 20 mM Tris-HCl (pH7.5), 500 mM NaCl, and 0.1 mM PMSF. After the cell lysis by ultrasonication, cell lysates were centrifuged at 4 °C for 40 min at 16000 rpm. Then the supernatants were loaded onto HisTrap HP column and the gradient was eluted by 25, 50, 100, and 250 mM imidazole. Eluents containing SHP2 protein were further loaded onto HiLoad Superdex 200PG column. Fractions were collected according to the results of SDS-PAGE, and then the protein was concentrated to 10 mg/mL or more.</div></div><div id="sec4-4" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>In Vitro</i> Phosphatase Assay</h3><div class="NLM_p last">Artificial substrate 6,8-difluoro-4-methylumbelliferyl phosphate (DIFMUP) (Invitrogen) was used to examine the catalytic activity of phosphatases. Reactions were performed at room temperature in a 96-well black polystyrene plate with a final volume of 100 μL. The SHP2<sup>E76A</sup> enzyme (1.5 nM) and various concentrations of compounds were preincubated for 20 min (buffer condition: 0.1 M sodium acetate, pH 5.0), then the substrate DIFMUP was added, incubated another 20 min, and Ex/Em at 358/455 was measured. For selectivity study, different phosphatases including LmwPTP, MKP3, PTP1B, TC-PTP, SHP1, VHR, and CDC25A were purified from <i>E. coli</i> and measured as the same condition as SHP2<sup>E76A</sup>, with the exception of the DIFMUP concentration corresponding to their respective <i>K</i><sub>m</sub> value. For IC<sub>50</sub> determination, eight concentrations of compounds at three-fold dilution were tested. Each experiment was performed in duplicate, and IC<sub>50</sub> data were derived from at least three independent experiments. The curve fitting program Prism 4 (GraphPad Software) was used to calculate the IC<sub>50</sub> value.</div></div><div id="sec4-5" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Immunoblot Analysis</h3><div class="NLM_p last">NCI-H661 cells were cultured in a six-well plate and treated with SHP2 inhibitors for 2 h at 37 °C. Cells were lysed with RIPA buffer. After centrifugation at 4 °C for 30 min at 12000 rpm, three volumes of protein extracts were mixed with one volume of 4× loading buffer and loaded onto the SDS-PAGE gel. Proteins were then transferred to PVDF membranes (Millipore), blocked with 5% nonfat milk, and incubated with pERK1/2, ERK1/2, pAKT, and AKT (Cell Signaling Technology) and other antibodies overnight at 4 °C. Corresponding secondary antibodies were applied and further detected using Amersham Imager 600. The results have been repeated for at least three times.</div></div><div id="sec4-6" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Immunofluorescence Cell Staining</h3><div class="NLM_p last">NCI-H1975 cells were seeded in 24-well plate with a coverslip in each well and grown overnight. After the treatment of 10 μM SHP2 inhibitor for 2 h, the medium was aspirated, and the cells were fixed with 4% PFA. The coverslip was treated with 0.4% Triton X-100 and blocked with 5% BSA. Diluted phospho-ERK1/2 antibody (Cell Signaling Technology) was applied to the coverslip and incubated overnight at 4 °C. After PBS washing, corresponding fluorochrome-labeled secondary antibody was applied at room temperature for 1 h and further PBS washed. After mounting with DAPI, the slides were examined under the fluorescence microscope. The results have been repeated at least three times.</div></div><div id="sec4-7" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Luciferase Reporter Assay</h3><div class="NLM_p last">SF268 cells stably expressing Yap-Luc reporter were plated out onto 96-well plate in RPMI-1640. On day 1, SHP2 inhibitors at the concentrations of 3, 6, and 12 μM were added. Twelve hours later, cells in each well were lysed and used to measure Renilla luciferase (Promega) and CellTiter-Glo (Promega), respectively. Luciferase of the Yap reporter was normalized by the luciferase of CellTiter-Glo.</div></div><div id="sec4-8" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> RT-PCR Experiments</h3><div class="NLM_p last">RNA was extracted from SF268 cells treated with DMSO and 10 μM or 20 μM SHP2 inhibitor for 2 h and then cDNA synthesis was performed. Quantstudio 6 Flex was used to conduct quantitative PCR (qPCR) analysis, and the primer pairs used were as follows:<div class="NLM_array"><table class="array-table"><tbody><tr>gene (human)forward primerreverse primer</tr><tr><td class="align-left">CTGF</td><td class="align-left">5′-GAAGCTGACCTGGAAGAGAACA-3′</td><td class="align-left">5′-CGTCGGTACATACTCCACAGAA-3′</td></tr><tr><td class="align-left">ANKRD1</td><td class="align-left">5′-AAACATCCAGGTTTCCTCCA-3′</td><td class="align-left">5′-TTTGGCAATTGTGGAGAAGTTA-3′</td></tr><tr><td class="align-left">YAP1</td><td class="align-left">5′-GCAAATTCTCCAAAATGTCAGG-3′</td><td class="align-left">5′-CGGGAGAAGACACTGGATTT-3′</td></tr><tr><td class="align-left">GAPDH</td><td class="align-left">5′-GCAAATTCCATGGCACCGT-3′</td><td class="align-left">5′-TCGCCCCACTTGATTTTGG-3′</td></tr></tbody></table></div></div></div><div id="sec4-9" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Cell Proliferation Assay</h3><div class="NLM_p last">Cells (3000 cells/well) of each cell line were seeded in 96-well plates and grown overnight. The cells were treated with SHP2 inhibitors at indicated concentrations for 2 days. Cell viability was examined by CellTiter-Glo (Promega).</div></div><div id="sec4-10" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Soft Agar Assay</h3><div class="NLM_p last">Soft agar assay was performed in a six-well plate and consisted of two layers. The bottom layer was filled with 2 mL of 1% low melting temperature agarose. In the top layer, cells were resuspended in media containing 0.4% agarose and seeded at 10,000 cells per well in a volume of 2 mL. Varying concentrations of SHP2 inhibitors were applied and supplemented as 3–5 drops twice a week. Two weeks later, colonies were stained with iodonitrotetrazolium chloride (Sigma) and visualized with Gel Imager (Bio-Rad).</div></div><div id="sec4-11" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>In Vitro</i> Dephosphorylation</h3><div class="NLM_p last">YAP Y357 peptide (SGLSMSSYSVPRTPD) and pY 357 peptide (SGLSMSSpYSVPRTPD) were synthesized to perform <i>in vitro</i> dephosphorylation experiments with purified SHP2<sup>E76A</sup> protein. The SHP2<sup>E76A</sup> enzyme (1.5 nM) and 20 μM <b>23</b> were preincubated for 15 min (buffer condition: 20 mM Tris-HCl pH 7.4, 100 mM NaCl, 1 mM EDTA, 2 mM DTT), then the substrate, 100 μM pY357 peptide, was added and incubated another 15 min. The reactions were stopped by separating the SHP2<sup>E76A</sup> phosphatase from the mixture using 30KD filters and then the results were analyzed using p-YAP(Y357) antibody (Abcam).</div></div><div id="sec4-12" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Dot Blot</h3><div class="NLM_p last">Two microliters of the reaction products from <i>in vitro</i> dephosphorylation experiments were loaded onto nitrocellulose membrane using narrow-mouth pipet tip and let the membrane dry. Nonspecific sites were blocked by soaking in 5% BSA in TBST for 1 h, then diluted (1:1000) p-YAP(Y357) antibody (Abcam) was applied for 1 h at room temperature. After three times of TBST washing, secondary antibody was incubated, and after another three times of TBST washing, it was incubated in ECL reagent for 1 min, and covered with Saran-wrap, and the X-ray film was exposed in the dark room.</div></div><div id="sec4-13" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> Crystallization and X-ray Data Collection</h3><div class="NLM_p last">Hanging drop vapor diffusion was applied to crystallize SHP2<sup>E76A</sup>(1–534). The reservoir solution consisted of 0.2 M sodium formate, 0.1 M Bicine pH 8.5, and 15% w/v PEG 5000MME. One microliter of SHP2<sup>E76A</sup> (1–534) (8.8 mg/mL) was mixed with 2 μL of reservoir solution. Crystal appeared in about 3 days at 18 °C, and then was soaked in the crystallization solution with different concentrations of SHP2 inhibitors. To obtain X-ray data, crystals were transferred into cryoprotection buffer containing crystallization solution added with 20% glycerol and then flash-cooled by liquid nitrogen. X-ray data were collected at BL19U1 beamline at Shanghai Synchrotron Radiation Facility. Data were processed using the XDS/XSCALE program.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div></div><div id="sec4-14" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> Structure Determination and Refinements</h3><div class="NLM_p last">Experimental phases were obtained by molecular replacement using the program Phaser<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> with a structural model of SHP2 (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>). Crystallographic refinements were performed with the program PHENIX.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Model building was performed using COOT.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> Data processing and refinement statistics are reported in <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</div></div><div id="sec4-15" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Pharmacokinetics</h3><div class="NLM_p last">During the study, the care and use of animals will be conducted in accordance with the regulations of the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), laboratory animal administration in China, and the Guide for the Care and Use of Laboratory Animals. Female nu/nu nude mice were obtained from Shanghai SLAC Laboratory Animal Co., Ltd. Following IV administration (via tail vein) at 5 mg/kg, approximately 50 μL of whole blood was collected from the eyes and heart at 0.083, 0.25, 0.5, 1, 2, 4, 8, and 24 h postdose. Nonterminal blood samples were taken via orbital sinus vein puncture, and study end blood samples were taken via cardiac puncture with EDTA-2K as anticoagulant. Oral administration (10 mg/kg) and collection procedures were same for IV. The blood was centrifuged at 5000 rpm, 4 °C for 15 min, and plasma was transferred to an Eppendorf tube and stored frozen. Samples were precipitated and diluted with acetonitrile containing internal standard and prepared for LC/MS/MS. Twenty microliters of each sample was injected into an API4000 LC/MS/MS system for analysis, and transitions of 352.05 amu (Q1) and 267.10 amu (Q3) were monitored. Noncompartmental analyses were used to obtain the pharmacokinetic parameters here, and all the calculations derived from the computer program WinNonlin (Version 6.4).</div></div><div id="sec4-16" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Tumor Xenograft Experiments</h3><div class="NLM_p last">During the study, the care and use of animals will be conducted in accordance with the regulations of the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), laboratory animal administration in China, and the Guide for the Care and Use of Laboratory Animals. Female BALB/c nude mice were inoculated subcutaneously (5 × 10<sup>6</sup> cells) in a suspension containing 50% phenol red-free matrigel (BD Biosciences) in PBS with MV4;11 cells. In efficacy studies, mice were measured twice a week by calipering in two dimensions. When tumors reached roughly 230 mm<sup>3</sup>, mice were randomly assigned to three treatment groups: vehicle and 10 and 30 mg/kg (10 mL/kg, qd) by oral gavage. Tumor volume and mouse body weight were assessed twice weekly.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01520">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01520" class="ext-link">10.1021/acs.jmedchem.7b01520</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Additional pharmacology results and NMR spectra for final compound (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_001.pdf">jm7b01520_si_001.pdf (5.77 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_002.csv">jm7b01520_si_002.csv (1.6 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID Code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XZR">5XZR</a> for SHP2 in complex with compound <b>10</b>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b01520" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cong Liu</span> - <span class="hlFld-Affiliation affiliation">Interdisciplinary
Research Center on Biology and Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic
Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#274b4e524b464567544e4844094644094449"><span class="__cf_email__" data-cfemail="066a6f736a676446756f6965286765286568">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jidong Zhu</span> - <span class="hlFld-Affiliation affiliation">Interdisciplinary
Research Center on Biology and Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic
Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#255f4d504f4165564c4a460b44460b464b"><span class="__cf_email__" data-cfemail="314b59445b557142585e521f50521f525f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jingjing Xie</span> - <span class="hlFld-Affiliation affiliation">Interdisciplinary
Research Center on Biology and Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic
Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University of the Chinese Academy of Sciences, 19 A Yuquan Road, Shijingshan
District, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaojia Si</span> - <span class="hlFld-Affiliation affiliation">Organisch-Chemisches Institut, Ruprecht-Karls-Universität
Heidelberg, Im Neuenheimer
Feld 270, 69120 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shoulai Gu</span> - <span class="hlFld-Affiliation affiliation">Interdisciplinary
Research Center on Biology and Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic
Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mingliang Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Natural Products Chemistry, Fudan University, 826 Zhangheng Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Shen</span> - <span class="hlFld-Affiliation affiliation">Interdisciplinary
Research Center on Biology and Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic
Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University of the Chinese Academy of Sciences, 19 A Yuquan Road, Shijingshan
District, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haoyan Li</span> - <span class="hlFld-Affiliation affiliation">Interdisciplinary
Research Center on Biology and Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic
Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201203, China</span>; 
    <span class="hlFld-Affiliation affiliation">University of the Chinese Academy of Sciences, 19 A Yuquan Road, Shijingshan
District, Beijing 100049, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian Shen</span> - <span class="hlFld-Affiliation affiliation">Viva Biotech
Ltd. 334 Aidisheng Road, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Li</span> - <span class="hlFld-Affiliation affiliation">Key Laboratory for
the Genetics of Developmental and Neuropsychiatric Disorders (Ministry
of Education), Bio-X Institutes, Shanghai
Jiao Tong University, Shanghai 200240, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanjia Fang</span> - <span class="hlFld-Affiliation affiliation">Interdisciplinary
Research Center on Biology and Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic
Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201203, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>These authors contributed equally. J.X., X.S., and J.Z. designed research; J.X., X.S., S.G., and H.L. performed research; S.G., J.S., M.W., and J.S. contributed new reagents/analytic tools; D.L. helped to refine the structure; J.X., Y.F., C.L., and J.Z. analyzed data; and J.X, X.S., M.W., and J.Z. wrote the paper.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i69">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05436" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05436" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Prof. Jiahai Zhou and Prof. Lifeng Pan (Shanghai Institute of Organic Chemistry) for helpful discussions on protein purification and crystallization. This work was supported by the “100 Talents” Program of Chinese Academy of Sciences, the “Personalized Medicines-Molecular Signature-based Drug Discovery and Development” Strategic Priority Research Program of the Chinese Academy of Sciences (Grant No. XDA12000000), Shanghai Municipal Committee of Science and Technology (No: 14ZR1448600, 15ZR1449000), a State High-Tech Development Plan (the ″863 Program”) Award (grand 2015AA020907), and The National Key Research and Development Program (2016YFA0501900).</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i70" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i70"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i71" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i71"> ABBREVIATIONS USED</h2><tr><td class="NLM_term">PTP</td><td class="NLM_def"><p class="first last">protein tyrosine phosphatase</p></td></tr><tr><td class="NLM_term">RAS</td><td class="NLM_def"><p class="first last">rat sarcoma protein</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinases</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinases</p></td></tr><tr><td class="NLM_term">YAP</td><td class="NLM_def"><p class="first last">Yes associated protein</p></td></tr><tr><td class="NLM_term">FLT3-ITD</td><td class="NLM_def"><p class="first last">FMS-like tyrosine kinase 3-internal tandem duplications.</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Tonks, N. K.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: from genes, to function, to disease</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.1038/nrm2039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnrm2039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=17057753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=833-846&author=N.+K.+Tonks&title=Protein+tyrosine+phosphatases%3A+from+genes%2C+to+function%2C+to+disease&doi=10.1038%2Fnrm2039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: from genes, to function, to disease</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">833-846</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatase (PTP) superfamily of enzymes functions in a coordinated manner with protein tyrosine kinases to control signalling pathways that underlie a broad spectrum of fundamental physiol. processes.  In this review, I describe recent breakthroughs in our understanding of the role of the PTPs in the regulation of signal transduction and the etiol. of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NdnwoKCC1bVg90H21EOLACvtfcHk0ljAeI8wOLjv5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I&md5=20a078267093bb8415d9035a13b8ad17</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm2039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2039%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520from%2520genes%252C%2520to%2520function%252C%2520to%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D833%26epage%3D846%26doi%3D10.1038%2Fnrm2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">van Huijsduijnen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombrun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinnen, D.</span><span> </span><span class="NLM_article-title">Selecting protein tyrosine phosphatases as drug targets</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span><span class="refDoi"> DOI: 10.1016/S1359-6446(02)02438-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2FS1359-6446%2802%2902438-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=12546919" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=1013-1019&author=R.+H.+van+Huijsduijnenauthor=A.+Bombrunauthor=D.+Swinnen&title=Selecting+protein+tyrosine+phosphatases+as+drug+targets&doi=10.1016%2FS1359-6446%2802%2902438-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2802%2902438-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252802%252902438-8%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DBombrun%26aufirst%3DA.%26aulast%3DSwinnen%26aufirst%3DD.%26atitle%3DSelecting%2520protein%2520tyrosine%2520phosphatases%2520as%2520drug%2520targets%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2002%26volume%3D7%26spage%3D1013%26epage%3D1019%26doi%3D10.1016%2FS1359-6446%2802%2902438-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases ☆</span> <span class="citation_source-journal">Semin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1006/smim.2000.0209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1006%2Fsmim.2000.0209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10723800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFartrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=75-84&author=L.+Liauthor=J.+E.+Dixon&title=Form%2C+function%2C+and+regulation+of+protein+tyrosine+phosphatases+and+their+involvement+in+human+diseases+%E2%98%86&doi=10.1006%2Fsmim.2000.0209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases</span></div><div class="casAuthors">Li, Liwu; Dixon, Jack E.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-84</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 64 refs.  Protein tyrosine phosphatases (PTPs) are a family of enzymes that modulate the cellular level of tyrosine phosphorylation.  Based on cellular location, they are classified as receptor-like or intracellular PTPs.  Structure and function studies have led to the understanding of the enzymic mechanism of this class of enzymes.  Proper targeting of PTPs is essential for many cellular signaling events including antigen induced proliferative responses of B and T cells.  The physiol. significance of PTPs is further unveiled through mice gene knockout studies and human genome sequencing and mapping projects.  Several PTPs are shown to be crit. in the pathogenesis of human diseases.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBF9VyRAs7F7Vg90H21EOLACvtfcHk0lhIeRQm7e3G7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFartrY%253D&md5=684ff470facfd38cb1c0d8736ec0c135</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1006%2Fsmim.2000.0209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fsmim.2000.0209%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DForm%252C%2520function%252C%2520and%2520regulation%2520of%2520protein%2520tyrosine%2520phosphatases%2520and%2520their%2520involvement%2520in%2520human%2520diseases%2520%25E2%2598%2586%26jtitle%3DSemin.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D75%26epage%3D84%26doi%3D10.1006%2Fsmim.2000.0209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: prospects for therapeutics</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span><span class="refDoi"> DOI: 10.1016/S1367-5931(00)00223-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2FS1367-5931%2800%2900223-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=11470605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlyqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=416-423&author=Z.+Y.+Zhang&title=Protein+tyrosine+phosphatases%3A+prospects+for+therapeutics&doi=10.1016%2FS1367-5931%2800%2900223-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: prospects for therapeutics</span></div><div class="casAuthors">Zhang, Z.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">416-423</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  Protein tyrosine phosphatases (PTPs) form a large family of enzymes that serve as key regulatory components in signal transduction pathways.  Recent gene knockout studies in mice identify PTP1B as a promising target for anti-diabetes/obesity drug discovery.  PTPs are also implicated in a wide variety of other disorders, including cancer.  Significant progress has been made in identifying small mols. that simultaneously bind both the active site and a unique adjacent site that enables specific inhibition of individual PTP isoenzymes.  As a consequence, there are compelling reasons to believe that PTP inhibitors may ultimately serve as powerful therapeutic weapons in the authors' arsenal for battling human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgujWWYVWfjbVg90H21EOLACvtfcHk0lhIeRQm7e3G7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlyqsLs%253D&md5=eee42d18a57b314321cffca4e3892ac1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2800%2900223-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252800%252900223-4%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520prospects%2520for%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2001%26volume%3D5%26spage%3D416%26epage%3D423%26doi%3D10.1016%2FS1367-5931%2800%2900223-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bialy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Inhibitors of protein tyrosine phosphatases: next-generation drugs?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3814</span><span class="NLM_x">–</span> <span class="NLM_lpage">3839</span><span class="refDoi"> DOI: 10.1002/anie.200461517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1002%2Fanie.200461517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFGisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=3814-3839&author=L.+Bialyauthor=H.+Waldmann&title=Inhibitors+of+protein+tyrosine+phosphatases%3A+next-generation+drugs%3F&doi=10.1002%2Fanie.200461517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of protein tyrosine phosphatases: Next-generation drugs?</span></div><div class="casAuthors">Bialy, Laurent; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3814-3839</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatases (PTPs) constitute a family of closely related key regulatory enzymes that dephosphorylate phosphotyrosine residues in their protein substrates.  Malfunctions in PTP activity are linked to various diseases, ranging from cancer to neurol. disorders and diabetes.  Consequently, PTPs have emerged as promising targets for therapeutic intervention in recent years.  In this review, general aspects of PTPs and the development of small-mol. inhibitors of PTPs by both academic research groups and pharmaceutical companies are discussed.  Different strategies have been successfully applied to identify potent and selective inhibitors.  These studies constitute the basis for the future development of PTP inhibitors as drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9K3DIu_xX_LVg90H21EOLACvtfcHk0lhIeRQm7e3G7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFGisr8%253D&md5=a8bcd03851b638cc6d3e6ab2466eb97b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fanie.200461517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200461517%26sid%3Dliteratum%253Aachs%26aulast%3DBialy%26aufirst%3DL.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DInhibitors%2520of%2520protein%2520tyrosine%2520phosphatases%253A%2520next-generation%2520drugs%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D3814%26epage%3D3839%26doi%3D10.1002%2Fanie.200461517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mohi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The role of Shp2 (PTPN11) in cancer</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/j.gde.2006.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2Fj.gde.2006.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=17227708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=23-30&author=M.+G.+Mohiauthor=B.+G.+Neel&title=The+role+of+Shp2+%28PTPN11%29+in+cancer&doi=10.1016%2Fj.gde.2006.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Mohi, M. Golam; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-30</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs), regulates numerous cellular processes.  Altered expression and/or mutations in PTKs are linked to many forms of cancer, yet until recently little was known about the roles of PTPs in normal cells or in cancer.  Earlier work established that a member of the PTP superfamily, PTEN, is an important tumor suppressor gene.  We now know that at least one other PTP, the SH2 domain-contg. phosphatase Shp2, is a bona fide oncogene that is mutated in several types of leukemia and hyperactivated by other mechanisms in some solid tumors.  Understanding how Shp2 and other PTPs contribute to oncogenesis should provide new insights into pathogenesis and might suggest new targets for anti-neoplastic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ0V_cNPfFwLVg90H21EOLACvtfcHk0ljZBDfVQqdMpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslOgtQ%253D%253D&md5=a571192d3fffdff69ddfc264bb9108ce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2006.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2006.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520role%2520of%2520Shp2%2520%2528PTPN11%2529%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2007%26volume%3D17%26spage%3D23%26epage%3D30%26doi%3D10.1016%2Fj.gde.2006.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G. S.</span><span> </span><span class="NLM_article-title">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.1182/blood-2006-07-028829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1182%2Fblood-2006-07-028829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=17053061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+first+identified+proto-oncogene+that+encodes+a+tyrosine+phosphatase&doi=10.1182%2Fblood-2006-07-028829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span></div><div class="casAuthors">Chan, Rebecca J.; Feng, Gen-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-867</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Elucidation of the mol. mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes.  One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homol. 2 (SH2) domains (Shp2).  This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis.  More recently, somatic missense PTPN11 gain-of-function mutations were detected in leukemias and rarely in solid tumors, and were found to induce aberrant hyperactivation of the Ras-Erk pathway.  This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the mol. mechanisms underlying cell transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqsuOora-d37Vg90H21EOLACvtfcHk0ljZBDfVQqdMpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D&md5=8c5760a6ac385635f9794acbf5b64a03</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-028829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-028829%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520first%2520identified%2520proto-oncogene%2520that%2520encodes%2520a%2520tyrosine%2520phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867%26doi%3D10.1182%2Fblood-2006-07-028829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Matozaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, H.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1786</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2009.01257.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1111%2Fj.1349-7006.2009.01257.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=19622105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12qs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2009&pages=1786-1793&author=T.+Matozakiauthor=Y.+Murataauthor=Y.+Saitoauthor=H.+Okazawaauthor=H.+Ohnishi&title=Protein+tyrosine+phosphatase+SHP-2%3A+a+proto-oncogene+product+that+promotes+Ras+activation&doi=10.1111%2Fj.1349-7006.2009.01257.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatase SHP-2: A protooncogene product that promotes Ras activation</span></div><div class="casAuthors">Matozaki, Takashi; Murata, Yoji; Saito, Yasuyuki; Okazawa, Hideki; Ohnishi, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1786-1793</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  SHP-2 is a cytoplasmic protein tyrosine phosphatase (PTP) that contains two Src homol. 2 (SH2) domains.  Although PTPs are generally considered to be neg. regulators on the basis of their ability to oppose the effects of protein tyrosine kinases, SHP-2 is unusual in that it promotes the activation of the Ras-MAPK signaling pathway by receptors for various growth factors and cytokines.  The mol. basis for the activation of SHP-2 is also unique: In the basal state, the NH2-terminal SH2 domain of SHP-2 interacts with the PTP domain, resulting in autoinhibition of PTP activity; the binding of SHP-2 via its SH2 domains to tyrosine-phosphorylated growth factor receptors or docking proteins, however, results in disruption of this intramol. interaction, leading to exposure of the PTP domain and catalytic activation.  Indeed, SHP-2 proteins with artificial mutations in the NH2-terminal SH2 domain have been shown to act as dominant active mutants in vitro.  Such activating mutations of PTPN11 (human SHP-2 gene) were subsequently identified in individuals with Noonan syndrome, a human developmental disorder that is sometimes assocd. with juvenile myelomonocytic leukemia.  Furthermore, somatic mutations of PTPN11 were found to be assocd. with pediatric leukemia.  SHP-2 is also thought to participate in the development of other malignant disorders, but in a manner independent of such activating mutations.  Biochem. and functional studies of SHP-2 and genetic anal. of PTPN11 in human disorders have thus converged to provide new insight into the pathogenesis of cancer as well as potential new targets for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqagV6o3osbrVg90H21EOLACvtfcHk0ljZBDfVQqdMpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12qs7vI&md5=d4f294641af7b4283f0ed30ce0208bee</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2009.01257.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2009.01257.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatozaki%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DOkazawa%26aufirst%3DH.%26aulast%3DOhnishi%26aufirst%3DH.%26atitle%3DProtein%2520tyrosine%2520phosphatase%2520SHP-2%253A%2520a%2520proto-oncogene%2520product%2520that%2520promotes%2520Ras%2520activation%26jtitle%3DCancer%2520Sci.%26date%3D2009%26volume%3D100%26spage%3D1786%26epage%3D1793%26doi%3D10.1111%2Fj.1349-7006.2009.01257.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span><span class="refDoi"> DOI: 10.1038/ncb867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fncb867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=12402043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=850-858&author=H.+Hanafusaauthor=S.+Toriiauthor=T.+Yasunagaauthor=E.+Nishida&title=Sprouty1+and+Sprouty2+provide+a+control+mechanism+for+the+Ras%2FMAPK+signalling+pathway&doi=10.1038%2Fncb867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway</span></div><div class="casAuthors">Hanafusa, Hiroshi; Torii, Satoru; Yasunaga, Takayuki; Nishida, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">850-858</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sprouty (Spry) inhibits signaling by receptor tyrosine kinases; however, the mol. mechanism underlying this function has not been defined.  Here we show that after stimulation by growth factors Spry1 and Spry2 translocate to the plasma membrane and become phosphorylated on a conserved tyrosine.  Next, they bind to the adaptor protein Grb2 and inhibit the recruitment of the Grb2-Sos complex either to the fibroblast growth factor receptor (FGFR) docking adaptor protein FRS2 or to Shp2.  Membrane translocation of Spry is necessary for its phosphorylation, which is essential for its inhibitor activity.  A tyrosine-phosphorylated octapeptide derived from mouse Spry2 inhibits Grb2 from binding FRS2, Shp2 or mouse Spry2 in vitro and blocks activation of the extracellular-signal-regulated kinase (ERK) in cells stimulated by growth factor.  A non-phosphorylated Spry mutant cannot bind Grb2 and acts as a dominant neg., inducing prolonged activation of ERK in response to FGF and promoting the FGF-induced outgrowth of neurites in PC12 cells.  Our findings suggest that Spry functions in a neg. feedback mechanism in which its inhibitor activity is controlled rapidly and reversibly by post-translational mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpLO_810Tlg7Vg90H21EOLACvtfcHk0ljZBDfVQqdMpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVKmsw%253D%253D&md5=3f496bfc4a46a3e86d6ea1b8b489c04b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fncb867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb867%26sid%3Dliteratum%253Aachs%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DTorii%26aufirst%3DS.%26aulast%3DYasunaga%26aufirst%3DT.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DSprouty1%2520and%2520Sprouty2%2520provide%2520a%2520control%2520mechanism%2520for%2520the%2520Ras%252FMAPK%2520signalling%2520pathway%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2002%26volume%3D4%26spage%3D850%26epage%3D858%26doi%3D10.1038%2Fncb867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">8497</span><span class="NLM_x">–</span> <span class="NLM_lpage">8505</span><span class="refDoi"> DOI: 10.1074/jbc.M312575200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1074%2Fjbc.M312575200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=8497-8505&author=Y.+Renauthor=S.+Mengauthor=L.+Meiauthor=Z.+J.+Zhaoauthor=R.+Joveauthor=J.+Wu&title=Roles+of+Gab1+and+SHP2+in+paxillin+tyrosine+dephosphorylation+and+Src+activation+in+response+to+epidermal+growth+factor&doi=10.1074%2Fjbc.M312575200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312575200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312575200%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DMei%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DRoles%2520of%2520Gab1%2520and%2520SHP2%2520in%2520paxillin%2520tyrosine%2520dephosphorylation%2520and%2520Src%2520activation%2520in%2520response%2520to%2520epidermal%2520growth%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D8497%26epage%3D8505%26doi%3D10.1074%2Fjbc.M312575200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Montagner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynal, P.</span><span> </span><span class="NLM_article-title">A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5350</span><span class="NLM_x">–</span> <span class="NLM_lpage">5360</span><span class="refDoi"> DOI: 10.1074/jbc.M410012200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1074%2Fjbc.M410012200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=5350-5360&author=A.+Montagnerauthor=B.+Perretauthor=A.+Yartauthor=M.+Danceauthor=J.+P.+Sallesauthor=P.+Raynal&title=A+novel+role+for+Gab1+and+SHP2+in+epidermal+growth+factor-induced+Ras+activation&doi=10.1074%2Fjbc.M410012200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M410012200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M410012200%26sid%3Dliteratum%253Aachs%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DPerret%26aufirst%3DB.%26aulast%3DYart%26aufirst%3DA.%26aulast%3DDance%26aufirst%3DM.%26aulast%3DSalles%26aufirst%3DJ.%2BP.%26aulast%3DRaynal%26aufirst%3DP.%26atitle%3DA%2520novel%2520role%2520for%2520Gab1%2520and%2520SHP2%2520in%2520epidermal%2520growth%2520factor-induced%2520Ras%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D5350%26epage%3D5360%26doi%3D10.1074%2Fjbc.M410012200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Agazie, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayman, M. J.</span><span> </span><span class="NLM_article-title">Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7875</span><span class="NLM_x">–</span> <span class="NLM_lpage">7886</span><span class="refDoi"> DOI: 10.1128/MCB.23.21.7875-7886.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1128%2FMCB.23.21.7875-7886.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=14560030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=7875-7886&author=Y.+M.+Agazieauthor=M.+J.+Hayman&title=Molecular+mechanism+for+a+role+of+SHP2+in+epidermal+growth+factor+receptor+signaling&doi=10.1128%2FMCB.23.21.7875-7886.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling</span></div><div class="casAuthors">Agazie, Yehenew M.; Hayman, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7875-7886</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Src homol. 2-contg. phosphotyrosine phosphatase (SHP2) is primarily a pos. effector of receptor tyrosine kinase signaling.  However, the mol. mechanism by which SHP2 effects its biol. function is unknown.  The authors provide evidence that defines the mol. mechanism and site of action of SHP2 in the epidermal growth factor-induced mitogenic pathway.  The authors demonstrate that SHP2 acts upstream of Ras and functions by increasing the half-life of activated Ras (GTP-Ras) in the cell by interfering with the process of Ras inactivation catalyzed by Ras GTPase-activating protein (RasGAP).  It does so by inhibition of tyrosine phosphorylation-dependent translocation of RasGAP to the plasma membrane, to its substrate (GTP-Ras) microdomain.  Inhibition is achieved through the dephosphorylation of RasGAP binding sites at the level of the plasma membrane.  The authors have identified Tyr 992 of the epidermal growth factor receptor (EGFR) to be one such site, since its mutation to Phe renders the EGFR refractory to the effect of dominant-neg. SHP2.  To the authors' knowledge, this is the first report to outline the site and mol. mechanism of action of SHP2 in EGFR signaling, which may also serve as a model to describe its role in other receptor tyrosine kinase signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA5SXQ45HAFrVg90H21EOLACvtfcHk0lj6T51y9hMSqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFOgtLo%253D&md5=23e83e2e6ea24b006daa799b15a95981</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.21.7875-7886.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.21.7875-7886.2003%26sid%3Dliteratum%253Aachs%26aulast%3DAgazie%26aufirst%3DY.%2BM.%26aulast%3DHayman%26aufirst%3DM.%2BJ.%26atitle%3DMolecular%2520mechanism%2520for%2520a%2520role%2520of%2520SHP2%2520in%2520epidermal%2520growth%2520factor%2520receptor%2520signaling%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D7875%26epage%3D7886%26doi%3D10.1128%2FMCB.23.21.7875-7886.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kawabuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimonishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span> </span><span class="NLM_article-title">Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">404</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span><span class="refDoi"> DOI: 10.1038/35010121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2F35010121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=404&publication_year=2000&pages=999-1003&author=M.+Kawabuchiauthor=Y.+Satomiauthor=T.+Takaoauthor=Y.+Shimonishiauthor=S.+Nadaauthor=K.+Nagaiauthor=A.+Tarakhovskyauthor=M.+Okada&title=Transmembrane+phosphoprotein+Cbp+regulates+the+activities+of+Src-family+tyrosine+kinases&doi=10.1038%2F35010121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F35010121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35010121%26sid%3Dliteratum%253Aachs%26aulast%3DKawabuchi%26aufirst%3DM.%26aulast%3DSatomi%26aufirst%3DY.%26aulast%3DTakao%26aufirst%3DT.%26aulast%3DShimonishi%26aufirst%3DY.%26aulast%3DNada%26aufirst%3DS.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DTarakhovsky%26aufirst%3DA.%26aulast%3DOkada%26aufirst%3DM.%26atitle%3DTransmembrane%2520phosphoprotein%2520Cbp%2520regulates%2520the%2520activities%2520of%2520Src-family%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2000%26volume%3D404%26spage%3D999%26epage%3D1003%26doi%3D10.1038%2F35010121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Hof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Crystal structure of the tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+structure+of+the+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0lj6T51y9hMSqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520the%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450%26doi%3D10.1016%2FS0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgt, I. V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, S.</span><span> </span><span class="NLM_article-title">Mutations in the protein tyrosine kinase gene, PTPN11, cause Noonan syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span><span class="refDoi"> DOI: 10.1038/ng1201-491c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fng1201-491c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=491-491&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+V.+D.+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jeffery&title=Mutations+in+the+protein+tyrosine+kinase+gene%2C+PTPN11%2C+cause+Noonan+syndrome&doi=10.1038%2Fng1201-491c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the protein tyrosine kinase gene, PTPN11, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, M.; Mehler, E. L.; Goldberg, R.; Zmapino, G.; Brunner, H. G.; Kremer, H.; van der Burgt, I.; Crosby, A. H.; Ion, A.; Jeffery, S.; Kalidas, K.; Patton, M. A.; Kucherlapati, R. S.; Gelb, B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6qhY4DNI0RrVg90H21EOLACvtfcHk0lhnIOlsHbYEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGis7w%253D&md5=e27d7263f3dde87d622d4b95c8bc47de</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fng1201-491c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1201-491c%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3DBurgt%26aufirst%3DI.%2BV.%2BD.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26atitle%3DMutations%2520in%2520the%2520protein%2520tyrosine%2520kinase%2520gene%252C%2520PTPN11%252C%2520cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D491%26epage%3D491%26doi%3D10.1038%2Fng1201-491c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Bentiresalj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paez, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span> </span><span class="NLM_article-title">Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">8816</span><span class="NLM_x">–</span> <span class="NLM_lpage">8820</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-1923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1158%2F0008-5472.CAN-04-1923" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-8820&author=M.+Bentiresaljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbaker&title=Activating+mutations+of+the+noonan+syndrome-associated+SHP2%2FPTPN11+gene+in+human+solid+tumors+and+adult+acute+myelogenous+leukemia&doi=10.1158%2F0008-5472.CAN-04-1923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentiresalj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26atitle%3DActivating%2520mutations%2520of%2520the%2520noonan%2520syndrome-associated%2520SHP2%252FPTPN11%2520gene%2520in%2520human%2520solid%2520tumors%2520and%2520adult%2520acute%2520myelogenous%2520leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D8820%26doi%3D10.1158%2F0008-5472.CAN-04-1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Miyamoto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomogita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3508</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span><span class="refDoi"> DOI: 10.1038/sj.onc.1211019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+distinct+class+of+gain-of-function+SHP-2+mutants+with+oncogenic+RAS-like+transforming+activity+from+solid+tumors&doi=10.1038%2Fsj.onc.1211019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0lhnIOlsHbYEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520distinct%2520class%2520of%2520gain-of-function%2520SHP-2%2520mutants%2520with%2520oncogenic%2520RAS-like%2520transforming%2520activity%2520from%2520solid%2520tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515%26doi%3D10.1038%2Fsj.onc.1211019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+tyrosine+phosphatase+Shp2+%28PTPN11%29+in+cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0lgouvy4rW_Fig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520tyrosine%2520phosphatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Hatakeyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span> </span><span class="NLM_article-title">Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2005.00130.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1111%2Fj.1349-7006.2005.00130.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=16367902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=835-843&author=M.+Hatakeyamaauthor=H.+Higashi&title=Helicobacter+pylori+CagA%3A+a+new+paradigm+for+bacterial+carcinogenesis&doi=10.1111%2Fj.1349-7006.2005.00130.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Helicobacter pylori CagA: A new paradigm for bacterial carcinogenesis</span></div><div class="casAuthors">Hatakeyama, Masanori; Higashi, Hideaki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">835-843</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Infection with cagA-pos. Helicobacter pylori is assocd. with the development of gastric adenocarcinoma.  The cagA gene product CagA is injected directly from the bacterium into the bacterium-attached gastric epithelial cells via the type-IV secretion system.  Upon membrane localization and subsequent tyrosine phosphorylation by Src family kinases, CagA functions as a scaffolding adaptor and interacts with a no. of host proteins that regulate cell growth, cell motility and cell polarity in both CagA phosphorylation-dependent and phosphorylation-independent manners.  Of special interest is the interaction of CagA with the SHP-2 tyrosine phosphatase, gain-of-function mutations that of which have recently been found in a variety of human malignancies.  The CagA-SHP-2 interaction is entirely dependent on CagA tyrosine phosphorylation and, through the complex formation, SHP-2 is catalytically activated and induces morphol. transformation with elevated cell motility.  Intriguingly, structural diversity of the tyrosine phosphorylation sites of CagA accounts for the differential activity of individual CagA to bind and activate SHP-2.  Deregulation of SHP-2 and other intracellular signaling mols. by H. pylori CagA may predispose cells to accumulate multiple genetic and epigenetic changes involved in gastric carcinogenesis.  Furthermore, the differential potential of individual CagA to disturb cellular functions indicates that H. pylori strains carrying biol. more active CagA are more virulent than those with less active CagA and are more closely assocd. with gastric carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyPRFMVPCljrVg90H21EOLACvtfcHk0lgouvy4rW_Fig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFWitg%253D%253D&md5=60a51d84b2dcb7097f193cbb50ca4413</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2005.00130.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2005.00130.x%26sid%3Dliteratum%253Aachs%26aulast%3DHatakeyama%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DH.%26atitle%3DHelicobacter%2520pylori%2520CagA%253A%2520a%2520new%2520paradigm%2520for%2520bacterial%2520carcinogenesis%26jtitle%3DCancer%2520Sci.%26date%3D2005%26volume%3D96%26spage%3D835%26epage%3D843%26doi%3D10.1111%2Fj.1349-7006.2005.00130.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Aceto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausgruber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkhaus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidatzis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinybaron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzarol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalonieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balwierz, P. J.</span><span> </span><span class="NLM_article-title">Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1038/nm.2645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnm.2645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=22388088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1yisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=529-537&author=N.+Acetoauthor=N.+Sausgruberauthor=H.+Brinkhausauthor=D.+Gaidatzisauthor=G.+Martinybaronauthor=G.+Mazzarolauthor=S.+Confalonieriauthor=M.+Quartoauthor=G.+Huauthor=P.+J.+Balwierz&title=Tyrosine+phosphatase+SHP2+promotes+breast+cancer+progression+and+maintains+tumor-initiating+cells+via+activation+of+key+transcription+factors+and+a+positive+feedback+signaling+loop&doi=10.1038%2Fnm.2645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop</span></div><div class="casAuthors">Aceto, Nicola; Sausgruber, Nina; Brinkhaus, Heike; Gaidatzis, Dimos; Martiny-Baron, Georg; Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela; Hu, Guang; Balwierz, Piotr J.; Pachkov, Mikhail; Elledge, Stephen J.; van Nimwegen, Erik; Stadler, Michael B.; Bentires-Alj, Mohamed</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New cancer therapies are likely to arise from an in-depth understanding of the signaling networks influencing tumor initiation, progression and metastasis.  We show a fundamental role for Src-homol. 2 domain-contg. phosphatase 2 (SHP2) in these processes in human epidermal growth factor receptor 2 (HER2)-pos. and triple-neg. breast cancers.  Knockdown of SHP2 eradicated breast tumor-initiating cells in xenograft models, and SHP2 depletion also prevented invasion in three-dimensional cultures and in a transductal invasion assay in vivo.  Notably, SHP2 knockdown in established breast tumors blocked their growth and reduced metastasis.  Mechanistically, SHP2 activated stemness-assocd. transcription factors, including v-myc myelocytomatosis viral oncogene homolog (c-Myc) and zinc finger E-box binding homeobox 1 (ZEB1), which resulted in the repression of let-7 microRNA and the expression of a set of 'SHP2 signature' genes.  We found these genes to be simultaneously activated in a large subset of human primary breast tumors that are assocd. with invasive behavior and poor prognosis.  These results provide new insights into the signaling cascades influencing tumor-initiating cells as well as a rationale for targeting SHP2 in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGBsjLtiOIWbVg90H21EOLACvtfcHk0lgouvy4rW_Fig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1yisrg%253D&md5=ea1d756b2f9d21771ca5f25d2dfda798</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnm.2645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2645%26sid%3Dliteratum%253Aachs%26aulast%3DAceto%26aufirst%3DN.%26aulast%3DSausgruber%26aufirst%3DN.%26aulast%3DBrinkhaus%26aufirst%3DH.%26aulast%3DGaidatzis%26aufirst%3DD.%26aulast%3DMartinybaron%26aufirst%3DG.%26aulast%3DMazzarol%26aufirst%3DG.%26aulast%3DConfalonieri%26aufirst%3DS.%26aulast%3DQuarto%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DBalwierz%26aufirst%3DP.%2BJ.%26atitle%3DTyrosine%2520phosphatase%2520SHP2%2520promotes%2520breast%2520cancer%2520progression%2520and%2520maintains%2520tumor-initiating%2520cells%2520via%2520activation%2520of%2520key%2520transcription%2520factors%2520and%2520a%2520positive%2520feedback%2520signaling%2520loop%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D529%26epage%3D537%26doi%3D10.1038%2Fnm.2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Tsutsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masoudi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span><span class="refDoi"> DOI: 10.1016/j.devcel.2013.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2Fj.devcel.2013.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=24035415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=658-665&author=R.+Tsutsumiauthor=M.+Masoudiauthor=A.+Takahashiauthor=Y.+Fujiiauthor=T.+Hayashiauthor=I.+Kikuchiauthor=Y.+Satouauthor=M.+Tairaauthor=M.+Hatakeyama&title=YAP+and+TAZ%2C+Hippo+signaling+targets%2C+act+as+a+rheostat+for+nuclear+SHP2+function&doi=10.1016%2Fj.devcel.2013.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">YAP and TAZ, Hippo Signaling Targets, Act as a Rheostat for Nuclear SHP2 Function</span></div><div class="casAuthors">Tsutsumi, Ryouhei; Masoudi, Mohammad; Takahashi, Atsushi; Fujii, Yumiko; Hayashi, Takeru; Kikuchi, Ippei; Satou, Yumeko; Taira, Masanori; Hatakeyama, Masanori</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">658-665</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SHP2 is a ubiquitously expressed protein tyrosine phosphatase, deregulation of which is assocd. with malignant neoplasms and developmental disorders.  SHP2 is required for full activation of RAS-Erk signaling in the cytoplasm and is also present in the nucleus, where it promotes Wnt target gene activation through dephosphorylation of parafibromin.  SHP2 is distributed both to the cytoplasm and nucleus at low cell d. but is excluded from the nucleus at high cell d.  Here, we show that SHP2 phys. interacts with transcriptional coactivators YAP and TAZ, targets of the cell-d.-sensing Hippo signal.  Through the interaction, nonphosphorylated YAP/TAZ promote nuclear translocalization of SHP2, which in turn stimulates TCF/LEF- and TEAD-regulated genes via parafibromin dephosphorylation.  Conversely, YAP/TAZ phosphorylated by Hippo signaling sequester SHP2 in the cytoplasm, thereby preventing nuclear accumulation of SHP2.  Hence, YAP/TAZ serve as a rheostat for nuclear SHP2 function, which is switched off by the Hippo signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqYS_cEzmS8rVg90H21EOLACvtfcHk0lgyuLnT1hXkag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCls7bJ&md5=a97dc2ed314db28cb3594244fff2f5ff</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2013.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2013.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DTsutsumi%26aufirst%3DR.%26aulast%3DMasoudi%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DI.%26aulast%3DSatou%26aufirst%3DY.%26aulast%3DTaira%26aufirst%3DM.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DYAP%2520and%2520TAZ%252C%2520Hippo%2520signaling%2520targets%252C%2520act%2520as%2520a%2520rheostat%2520for%2520nuclear%2520SHP2%2520function%26jtitle%3DDev.%2520Cell%26date%3D2013%26volume%3D26%26spage%3D658%26epage%3D665%26doi%3D10.1016%2Fj.devcel.2013.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Gavrieli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loftin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. M.</span><span> </span><span class="NLM_article-title">Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1236</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2003.11.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2Fj.bbrc.2003.11.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2003&pages=1236-1243&author=M.+Gavrieliauthor=N.+Watanabeauthor=S.+K.+Loftinauthor=T.+L.+Murphyauthor=K.+M.+Murphy&title=Characterization+of+phosphotyrosine+binding+motifs+in+the+cytoplasmic+domain+of+B+and+T+lymphocyte+attenuator+required+for+association+with+protein+tyrosine+phosphatases+SHP-1+and+SHP-2&doi=10.1016%2Fj.bbrc.2003.11.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2003.11.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2003.11.070%26sid%3Dliteratum%253Aachs%26aulast%3DGavrieli%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DLoftin%26aufirst%3DS.%2BK.%26aulast%3DMurphy%26aufirst%3DT.%2BL.%26aulast%3DMurphy%26aufirst%3DK.%2BM.%26atitle%3DCharacterization%2520of%2520phosphotyrosine%2520binding%2520motifs%2520in%2520the%2520cytoplasmic%2520domain%2520of%2520B%2520and%2520T%2520lymphocyte%2520attenuator%2520required%2520for%2520association%2520with%2520protein%2520tyrosine%2520phosphatases%2520SHP-1%2520and%2520SHP-2%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D312%26spage%3D1236%26epage%3D1243%26doi%3D10.1016%2Fj.bbrc.2003.11.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Yokosuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashiimanishi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimototane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span> </span><span class="NLM_article-title">Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span><span class="refDoi"> DOI: 10.1084/jem.20112741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1084%2Fjem.20112741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=22641383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslShsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=1201-1217&author=T.+Yokosukaauthor=M.+Takamatsuauthor=W.+Kobayashiimanishiauthor=A.+Hashimototaneauthor=M.+Azumaauthor=T.+Saito&title=Programmed+cell+death+1+forms+negative+costimulatory+microclusters+that+directly+inhibit+T+cell+receptor+signaling+by+recruiting+phosphatase+SHP2&doi=10.1084%2Fjem.20112741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2</span></div><div class="casAuthors">Yokosuka, Tadashi; Takamatsu, Masako; Kobayashi-Imanishi, Wakana; Hashimoto-Tane, Akiko; Azuma, Miyuki; Saito, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1201-1217</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Programmed cell death 1 (PD-1) is a neg. costimulatory receptor crit. for the suppression of T cell activation in vitro and in vivo.  Single cell imaging elucidated a mol. mechanism of PD-1-mediated suppression.  PD-1 becomes clustered with T cell receptors (TCRs) upon binding to its ligand PD-L1 and is transiently assocd. with the phosphatase SHP2 (Src homol. 2 domain-contg. tyrosine phosphatase 2).  These neg. costimulatory microclusters induce the dephosphorylation of the proximal TCR signaling mols.  This results in the suppression of T cell activation and blockade of the TCR-induced stop signal.  In addn. to PD-1 clustering, PD-1-TCR colocalization within microclusters is required for efficient PD-1-mediated suppression.  This inhibitory mechanism also functions in PD-1hi T cells generated in vivo and can be overridden by a neutralizing anti-PD-L1 antibody.  Therefore, PD-1 microcluster formation is important for regulation of T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOfykLUUjaIbVg90H21EOLACvtfcHk0lgyuLnT1hXkag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslShsr4%253D&md5=5c1fad62b4e3e69e177be5718ce92d41</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1084%2Fjem.20112741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20112741%26sid%3Dliteratum%253Aachs%26aulast%3DYokosuka%26aufirst%3DT.%26aulast%3DTakamatsu%26aufirst%3DM.%26aulast%3DKobayashiimanishi%26aufirst%3DW.%26aulast%3DHashimototane%26aufirst%3DA.%26aulast%3DAzuma%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DT.%26atitle%3DProgrammed%2520cell%2520death%25201%2520forms%2520negative%2520costimulatory%2520microclusters%2520that%2520directly%2520inhibit%2520T%2520cell%2520receptor%2520signaling%2520by%2520recruiting%2520phosphatase%2520SHP2%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26spage%3D1201%26epage%3D1217%26doi%3D10.1084%2Fjem.20112741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Chemnitz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">June, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. L.</span><span> </span><span class="NLM_article-title">SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">954</span><span class="refDoi"> DOI: 10.4049/jimmunol.173.2.945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.4049%2Fjimmunol.173.2.945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15240681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVGhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2004&pages=945-954&author=J.+M.+Chemnitzauthor=R.+V.+Parryauthor=K.+E.+Nicholsauthor=C.+H.+Juneauthor=J.+L.+Riley&title=SHP-1+and+SHP-2+associate+with+immunoreceptor+tyrosine-based+switch+motif+of+programmed+death+1+upon+primary+human+T+cell+stimulation%2C+but+only+receptor+ligation+prevents+T+cell+activation&doi=10.4049%2Fjimmunol.173.2.945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation</span></div><div class="casAuthors">Chemnitz, Jens M.; Parry, Richard V.; Nichols, Kim E.; June, Carl H.; Riley, James L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">945-954</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">To study the cis- and trans-acting factors that mediate programmed death 1 (PD-1) signaling in primary human CD4 T cells, the authors constructed a chimeric mol. consisting of the murine CD28 extracellular domain and human PD-1 cytoplasmic tail.  When introduced into CD4 T cells, this construct mimics the activity of endogenous PD-1 in terms of its ability to suppress T cell expansion and cytokine prodn.  The cytoplasmic tail of PD-1 contains two structural motifs, an ITIM and an immunoreceptor tyrosine-based switch motif (ITSM).  Mutation of the ITIM had little effect on PD-1 signaling or functional activity.  In contrast, mutation of the ITSM abrogated the ability of PD-1 to block cytokine synthesis and to limit T cell expansion.  Further biochem. analyses revealed that the ability of PD-1 to block T cell activation correlated with recruitment of Src homol. region 2 domain-contg. phosphatase-1 (SHP-1) and SHP-2, and not the adaptor Src homol. 2 domain-contg. mol. 1A, to the ITSM domain.  In TCR-stimulated T cells, SHP-2 assocd. with PD-1, even in the absence of PD-1 engagement.  Despite this interaction, the ability of PD-1 to block T cell activation required receptor ligation, suggesting that colocalization of PD-1 with CD3 and/or CD28 may be necessary for inhibition of T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLiPMfGJ1GeLVg90H21EOLACvtfcHk0lgyuLnT1hXkag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVGhurc%253D&md5=204c373c1a728fc94c10db9de7804f50</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.173.2.945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.173.2.945%26sid%3Dliteratum%253Aachs%26aulast%3DChemnitz%26aufirst%3DJ.%2BM.%26aulast%3DParry%26aufirst%3DR.%2BV.%26aulast%3DNichols%26aufirst%3DK.%2BE.%26aulast%3DJune%26aufirst%3DC.%2BH.%26aulast%3DRiley%26aufirst%3DJ.%2BL.%26atitle%3DSHP-1%2520and%2520SHP-2%2520associate%2520with%2520immunoreceptor%2520tyrosine-based%2520switch%2520motif%2520of%2520programmed%2520death%25201%2520upon%2520primary%2520human%2520T%2520cell%2520stimulation%252C%2520but%2520only%2520receptor%2520ligation%2520prevents%2520T%2520cell%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D173%26spage%3D945%26epage%3D954%26doi%3D10.4049%2Fjimmunol.173.2.945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Butterworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overduin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, A. J.</span><span> </span><span class="NLM_article-title">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+protein+tyrosine+phosphatase+SHP2+for+therapeutic+intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0ljJCwaqwlq8Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520for%2520therapeutic%2520intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymanski, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4948</span><span class="NLM_x">–</span> <span class="NLM_lpage">4956</span><span class="refDoi"> DOI: 10.1021/jm8002526</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8002526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4948-4956&author=H.+R.+Lawrenceauthor=R.+Piredduauthor=L.+Chenauthor=Y.+Luoauthor=S.+S.+Sungauthor=A.+M.+Szymanskiauthor=M.+L.+Yipauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=J.+Wu&title=Inhibitors+of+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28Shp2%29+based+on+oxindole+scaffolds&doi=10.1021%2Fjm8002526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds</span></div><div class="casAuthors">Lawrence, Harshani R.; Pireddu, Roberta; Chen, Liwei; Luo, Yunting; Sung, Shen-Shu; Szymanski, Ann Marie; Yip, M. L. Richard; Guida, Wayne C.; Sebti, Said M.; Wu, Jie; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4948-4956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of the NCI diversity set of compds. has led to the identification of NSC-117199, which inhibits the protein tyrosine phosphatase (PTP) Shp2 with an IC50 of 47 μM.  A focused library incorporating an isatin scaffold was designed and evaluated for inhibition of Shp2 and Shp1 PTP activities.  Several compds. were identified that selectively inhibit Shp2 over Shp1 and PTP1B with low to submicromolar activity.  A model for the binding of the active compds. is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRqLAauyGNBbVg90H21EOLACvtfcHk0ljJCwaqwlq8Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D&md5=572227c5a8cfffb108388616bd36fdfe</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm8002526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002526%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DSzymanski%26aufirst%3DA.%2BM.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528Shp2%2529%2520based%2520on%2520oxindole%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4948%26epage%3D4956%26doi%3D10.1021%2Fjm8002526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Zeng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mali, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span> </span><span class="NLM_article-title">Therapeutic potential of targeting the oncogenic SHP2 phosphatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6594</span><span class="NLM_x">–</span> <span class="NLM_lpage">6609</span><span class="refDoi"> DOI: 10.1021/jm5006176</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006176" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6594-6609&author=L.+F.+Zengauthor=R.+Y.+Zhangauthor=Z.+H.+Yuauthor=S.+Liauthor=L.+Wuauthor=A.+M.+Gunawanauthor=B.+S.+Laneauthor=R.+S.+Maliauthor=X.+Liauthor=R.+J.+Chan&title=Therapeutic+potential+of+targeting+the+oncogenic+SHP2+phosphatase&doi=10.1021%2Fjm5006176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase</span></div><div class="casAuthors">Zeng, Li-Fan; Zhang, Ruo-Yu; Yu, Zhi-Hong; Li, Sijiu; Wu, Li; Gunawan, Andrea M.; Lane, Brandon S.; Mali, Raghuveer S.; Li, Xingjun; Chan, Rebecca J.; Kapur, Reuben; Wells, Clark D.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6594-6609</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol. 2 domain contg. protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase assocd. with various kinds of leukemia and solid tumors.  Thus, there is substantial interest in developing SHP2 inhibitors as potential anticancer and antileukemia agents.  Using a structure-guided and fragment-based library approach, we identified a novel hydroxyindole carboxylic acid-based SHP2 inhibitor (I), with an IC50 value of 200 nM and greater than 5-fold selectivity against 20 mammalian PTPs.  Structural and modeling studies reveal that the hydroxyindole carboxylic acid anchors the inhibitor to the SHP2 active site, while interactions of the oxalamide linker and the phenylthiophene tail with residues in the β5-β6 loop contribute to I's binding potency and selectivity.  Evidence suggests that I specifically attenuates the SHP2-dependent signaling inside the cell.  Moreover, I blocks growth factor mediated Erk1/2 and Akt activation and exhibits excellent antiproliferative activity in lung cancer and breast cancer as well as leukemia cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ko-q4-PSXbVg90H21EOLACvtfcHk0ljJCwaqwlq8Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtrvO&md5=ac8e5359387e614782c95c02f32fd97d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm5006176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006176%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%2BF.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DYu%26aufirst%3DZ.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DLane%26aufirst%3DB.%2BS.%26aulast%3DMali%26aufirst%3DR.%2BS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26atitle%3DTherapeutic%2520potential%2520of%2520targeting%2520the%2520oncogenic%2520SHP2%2520phosphatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6594%26epage%3D6609%26doi%3D10.1021%2Fjm5006176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Discovery of a novel shp2 protein tyrosine phosphatase inhibitor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1124/mol.106.025536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1124%2Fmol.106.025536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=16717135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=562-570&author=L.+Chenauthor=S.+S.+Sungauthor=M.+L.+Yipauthor=H.+R.+Lawrenceauthor=Y.+Renauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Discovery+of+a+novel+shp2+protein+tyrosine+phosphatase+inhibitor&doi=10.1124%2Fmol.106.025536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor</span></div><div class="casAuthors">Chen, Liwei; Sung, Shen-Shu; Yip, M. L. Richard; Lawrence, Harshani R.; Ren, Yuan; Guida, Wayne C.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">562-570</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Shp2 is a non-receptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene.  It is involved in growth factor-induced activation of mitogen-activated protein (MAP) kinases Erk1 and Erk2 (Erk1/2) and has been implicated in the pathogenicity of the oncogenic bacterium Helicobacter pylori.  Moreover, gain-of-function Shp2 mutations have been found in childhood leukemias and Noonan syndrome.  Thus, small mol. Shp2 PTP inhibitors are much needed reagents for evaluation of Shp2 as a therapeutic target and for chem. biol. studies of Shp2 function.  By screening the National Cancer Institute (NCI) Diversity Set chem. library, we identified 8-hydroxy-7-(6-sulfonaphthalen-2-yl)diazenyl-quinoline-5-sulfonic acid (NSC-87877) as a potent Shp2 PTP inhibitor.  Mol. modeling and site-directed mutagenesis studies suggested that NSC-87877 binds to the catalytic cleft of Shp2 PTP.  NSC-87877 cross-inhibited Shp1 in vitro, but it was selective for Shp2 over other PTPs (PTP1B, HePTP, DEP1, CD45, and LAR).  It is noteworthy that NSC-87877 inhibited epidermal growth factor (EGF)-induced activation of Shp2 PTP, Ras, and Erk1/2 in cell cultures but did not block EGF-induced Gab1 tyrosine phosphorylation or Gab1-Shp2 assocn.  Furthermore, NSC-87877 inhibited Erk1/2 activation by a Gab1-Shp2 chimera but did not affect the Shp2-independent Erk1/2 activation by phorbol 12-myristate 13-acetate.  These results identified NSC-87877 as the first PTP inhibitor capable of inhibiting Shp2 PTP in cell cultures without a detectable off-target effect.  Our study also provides the first pharmacol. evidence that Shp2 mediates EGF-induced Erk1/2 MAP kinase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4XVGUjw3W7Vg90H21EOLACvtfcHk0lgJlBYcVzQpVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D&md5=a2ce03150ecbe6937876bb292ced30dc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025536%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520shp2%2520protein%2520tyrosine%2520phosphatase%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D562%26epage%3D570%26doi%3D10.1124%2Fmol.106.025536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Nören-Müller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Corrêa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestweber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, O.</span><span> </span><span class="NLM_article-title">Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">10606</span><span class="NLM_x">–</span> <span class="NLM_lpage">10611</span><span class="refDoi"> DOI: 10.1073/pnas.0601490103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1073%2Fpnas.0601490103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=16809424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A280%3ADC%252BD28vhsVentg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=10606-10611&author=A.+N%C3%B6ren-M%C3%BCllerauthor=I.+Reis-Corr%C3%AAaauthor=H.+Prinzauthor=C.+Rosenbaumauthor=K.+Saxenaauthor=H.+J.+Schwalbeauthor=D.+Vestweberauthor=G.+Cagnaauthor=S.+Schunkauthor=O.+Schwarz&title=Discovery+of+protein+phosphatase+inhibitor+classes+by+biology-oriented+synthesis&doi=10.1073%2Fpnas.0601490103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis</span></div><div class="casAuthors">Noren-Muller Andrea; Reis-Correa Ivan Jr; Prinz Heino; Rosenbaum Claudia; Saxena Krishna; Schwalbe Harald J; Vestweber Dietmar; Cagna Guiseppe; Schunk Stefan; Schwarz Oliver; Schiewe Hajo; Waldmann Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10606-11</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Protein phosphatases have very recently emerged as important targets for chemical biology and medicinal chemistry research, and new phosphatase inhibitor classes are in high demand.  The underlying frameworks of natural products represent the evolutionarily selected fractions of chemical space explored by nature so far and meet the criteria of relevance to nature and biological prevalidation most crucial to inhibitor development.  We refer to synthesis efforts and compound collection development based on these criteria as biology-oriented synthesis.  For the discovery of phosphatase inhibitor classes by means of this approach, four natural product-derived or -inspired medium-sized compound collections were synthesized and investigated for inhibition of the tyrosine phosphatases VE-PTP, Shp-2, PTP1B, MptpA, and MptpB and the dual-specificity phosphatases Cdc25A and VHR.  The screen yielded four unprecedented and selective phosphatase inhibitor classes for four phosphatases with high hit rates.  For VE-PTP and MptpB the first inhibitors were discovered.  These results demonstrate that biology-oriented synthesis is an efficient approach to the discovery of new compound classes for medicinal chemistry and chemical biology research that opens up new opportunities for the study of phosphatases, which may lead to the development of new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNf4ONKii5590Q2ypr7jHkfW6udTcc2eYcEnBxf9iqwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vhsVentg%253D%253D&md5=76f28f79227b8261fd23e7dbf3e2d8e7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601490103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601490103%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25B6ren-M%25C3%25BCller%26aufirst%3DA.%26aulast%3DReis-Corr%25C3%25AAa%26aufirst%3DI.%26aulast%3DPrinz%26aufirst%3DH.%26aulast%3DRosenbaum%26aufirst%3DC.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DSchwalbe%26aufirst%3DH.%2BJ.%26aulast%3DVestweber%26aufirst%3DD.%26aulast%3DCagna%26aufirst%3DG.%26aulast%3DSchunk%26aufirst%3DS.%26aulast%3DSchwarz%26aufirst%3DO.%26atitle%3DDiscovery%2520of%2520protein%2520phosphatase%2520inhibitor%2520classes%2520by%2520biology-oriented%2520synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D10606%26epage%3D10611%26doi%3D10.1073%2Fpnas.0601490103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Hellmuth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosskopf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Würtele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kries, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7275</span><span class="NLM_x">–</span> <span class="NLM_lpage">7280</span><span class="refDoi"> DOI: 10.1073/pnas.0710468105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1073%2Fpnas.0710468105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=18480264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=7275-7280&author=K.+Hellmuthauthor=S.+Grosskopfauthor=C.+T.+Lumauthor=M.+W%C3%BCrteleauthor=N.+R%C3%B6derauthor=J.+P.+von+Kriesauthor=M.+Rosarioauthor=J.+Rademannauthor=W.+Birchmeier&title=Specific+inhibitors+of+the+protein+tyrosine+phosphatase+Shp2+identified+by+high-throughput+docking&doi=10.1073%2Fpnas.0710468105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span></div><div class="casAuthors">Hellmuth, Klaus; Grosskopf, Stefanie; Lum, Ching Tung; Wuertele, Martin; Roeder, Nadine; von Kries, Jens Peter; Rosario, Marta; Rademann, Jorg; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7275-7280</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The protein tyrosine phosphatase Shp2 is a pos. regulator of growth factor signaling.  Gain-of-function mutations in several types of leukemia define Shp2 as a bona fide oncogene.  We performed a high-throughput in silico screen for small-mol.-wt. compds. that bind the catalytic site of Shp2.  We have identified the phenylhydrazonopyrazolone sulfonate PHPS1 as a potent and cell-permeable inhibitor, which is specific for Shp2 over the closely related tyrosine phosphatases Shp1 and PTP1 B.  PHPS1 inhibits Shp2-dependent cellular events such as hepatocyte growth factor/scatter factor (HGF/SF)-induced epithelial cell scattering and branching morphogenesis.  PHPS1 also blocks Shp2-dependent downstream signaling, namely HGF/SF-induced sustained phosphorylation of the Erk1/2 MAP kinases and dephosphorylation of paxillin.  Furthermore, PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-assocd. Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines.  The PHPS compd. class is therefore suitable for further development of therapeutics for the treatment of Shp2-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGponh1kw_h7jrVg90H21EOLACvtfcHk0lhJCSFiicWG5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D&md5=39c7dda94e32134c305e135e4c48b9d1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710468105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710468105%26sid%3Dliteratum%253Aachs%26aulast%3DHellmuth%26aufirst%3DK.%26aulast%3DGrosskopf%26aufirst%3DS.%26aulast%3DLum%26aufirst%3DC.%2BT.%26aulast%3DW%25C3%25BCrtele%26aufirst%3DM.%26aulast%3DR%25C3%25B6der%26aufirst%3DN.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DSpecific%2520inhibitors%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520Shp2%2520identified%2520by%2520high-throughput%2520docking%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D7275%26epage%3D7280%26doi%3D10.1073%2Fpnas.0710468105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span> </span><span class="NLM_article-title">Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2482</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span><span class="refDoi"> DOI: 10.1021/jm901645u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-2493&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.+X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawan&title=Salicylic+acid+based+small+molecule+inhibitor+for+the+oncogenic+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28SHP2%29&doi=10.1021%2Fjm901645u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)</span></div><div class="casAuthors">Zhang, Xian; He, Yantao; Liu, Sijiu; Yu, Zhihong; Jiang, Zhong-Xing; Yang, Zhenyun; Dong, Yuanshu; Nabinger, Sarah C.; Wu, Li; Gunawan, Andrea M.; Wang, Lina; Chan, Rebecca J.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2482-2493</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol.-2 domain contg. protein tyrosine phosphatase-2 (SHP2) plays a pivotal role in growth factor and cytokine signaling.  Gain-of-function SHP2 mutations are assocd. with Noonan syndrome, various kinds of leukemias, and solid tumors.  Thus, there is considerable interest in SHP2 as a potential target for anticancer and antileukemia therapy.  We report a salicylic acid based combinatorial library approach aimed at binding both active site and unique nearby subpockets for enhanced affinity and selectivity.  Screening of the library led to the identification of a SHP2 inhibitor II-B08 (compd. 9) with highly efficacious cellular activity.  Compd. 9 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation, providing supporting evidence that chem. inhibition of SHP2 may be therapeutically useful for anticancer and antileukemia treatment.  X-ray crystallog. anal. of the structure of SHP2 in complex with 9 reveals mol. determinants that can be exploited for the acquisition of more potent and selective SHP2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC82T5JpCRArVg90H21EOLACvtfcHk0lhJCSFiicWG5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D&md5=6f87897eda38ea485dc08e189f1b5ca8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26atitle%3DSalicylic%2520acid%2520based%2520small%2520molecule%2520inhibitor%2520for%2520the%2520oncogenic%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D2493%26doi%3D10.1021%2Fjm901645u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Identification of Cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7212</span><span class="NLM_x">–</span> <span class="NLM_lpage">7221</span><span class="refDoi"> DOI: 10.1021/jm400474r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400474r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7212-7221&author=W.+Liuauthor=B.+Yuauthor=G.+Xuauthor=W.+R.+Xuauthor=M.+L.+Lohauthor=L.+D.+Tangauthor=C.+K.+Qu&title=Identification+of+Cryptotanshinone+as+an+inhibitor+of+oncogenic+protein+tyrosine+phosphatase+SHP2+%28PTPN11%29&doi=10.1021%2Fjm400474r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)</span></div><div class="casAuthors">Liu, Wei; Yu, Bing; Xu, Gang; Xu, Wei-Ren; Loh, Mignon L.; Tang, Li-Da; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7212-7221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are assocd. with Noonan syndrome, childhood leukemias, and sporadic solid tumors.  Virtual screening combined with exptl. assays was performed to identify inhibitors of SHP2 from a database of natural products.  This effort led to the identification of cryptotanshinone as an inhibitor of SHP2.  Cryptotanshinone inhibited SHP2 with an IC50 of 22.50 μM.  Fluorescence titrn. expts. confirmed that it directly bound to SHP2.  Enzymic kinetic analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor.  This drug was further verified for its ability to block SHP2-mediated cell signaling and cellular functions.  Furthermore, mouse myeloid progenitors and patient leukemic cells with the activating mutation E76K in PTPN11 were found to be sensitive to this inhibitor.  Since cryptotanshinone is used to treat cardiovascular diseases in Asian countries, this drug has a potential to be used directly or to be further developed to treat PTPN11-assocd. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYelS47QYHLVg90H21EOLACvtfcHk0lhJCSFiicWG5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN&md5=3bbbae68159ae4227bbf74d5573ca77a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm400474r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400474r%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%2BR.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DTang%26aufirst%3DL.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520Cryptotanshinone%2520as%2520an%2520inhibitor%2520of%2520oncogenic%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520%2528PTPN11%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7212%26epage%3D7221%26doi%3D10.1021%2Fjm400474r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Chen, Y. N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fekkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garciafortanet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonakos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, V. G.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">535</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-152&author=Y.+N.+P.+Chenauthor=M.+J.+Lamarcheauthor=H.+M.+Chanauthor=P.+Fekkesauthor=J.+Garciafortanetauthor=M.+G.+Ackerauthor=B.+Antonakosauthor=H.+T.+Chenauthor=Z.+Chenauthor=V.+G.+Cooke&title=Allosteric+inhibition+of+SHP2+phosphatase+inhibits+cancers+driven+by+receptor+tyrosine+kinases&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 μM), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0lh6eRMGInMK_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BN.%2BP.%26aulast%3DLamarche%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DH.%2BM.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarciafortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DAntonakos%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DH.%2BT.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCooke%26aufirst%3DV.%2BG.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%2520phosphatase%2520inhibits%2520cancers%2520driven%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D152%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Garcia Fortanet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fekkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridrich, C.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7773</span><span class="NLM_x">–</span> <span class="NLM_lpage">7782</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00680</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00680" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7773-7782&author=J.+Garcia+Fortanetauthor=C.+H.+Chenauthor=Y.+P.+Chenauthor=Z.+Chenauthor=Z.+Dengauthor=B.+Firestoneauthor=P.+Fekkesauthor=M.+Fodorauthor=P.+D.+Fortinauthor=C.+Fridrich&title=Allosteric+inhibition+of+SHP2%3A+identification+of+a+potent%2C+selective%2C+and+orally+efficacious+phosphatase+inhibitor&doi=10.1021%2Facs.jmedchem.6b00680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span></div><div class="casAuthors">Garcia Fortanet, Jorge; Chen, Christine Hiu-Tung; Chen, Ying-Nan P.; Chen, Zhouliang; Deng, Zhan; Firestone, Brant; Fekkes, Peter; Fodor, Michelle; Fortin, Pascal D.; Fridrich, Cary; Grunenfelder, Denise; Ho, Samuel; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Keen, Nick; LaBonte, Laura R.; Larrow, Jay; Lenoir, Francois; Liu, Gang; Liu, Shumei; Lombardo, Franco; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Ramsey, Timothy; Sellers, William R.; Shultz, Michael D.; Stams, Travis; Towler, Christopher; Wang, Ping; Williams, Sarah L.; Zhang, Ji-Hu; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7773-7782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway.  SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1).  Because it is an oncoprotein assocd. with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest.  Recently in our labs., a small mol. inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2.  A high throughput screen was performed to identify progressable chem. matter, and X-ray crystallog. revealed the location of binding in a previously undisclosed allosteric binding pocket.  Structure-based drug design was employed to optimize for SHP2 inhibition, and several new protein-ligand interactions were characterized.  These studies culminated in the discovery of 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (SHP099, 1), a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6RT7zfZnvfLVg90H21EOLACvtfcHk0lh6eRMGInMK_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP&md5=dfe43b5253e172576386f86797087f7b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%2BFortanet%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFridrich%26aufirst%3DC.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%253A%2520identification%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520phosphatase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7773%26epage%3D7782%26doi%3D10.1021%2Facs.jmedchem.6b00680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Krishnan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koveal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akshinthala, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kragelj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauss, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackledge, M.</span><span> </span><span class="NLM_article-title">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1038/nchembio.1528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnchembio.1528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=24845231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=558-566&author=N.+Krishnanauthor=D.+Kovealauthor=D.+H.+Millerauthor=B.+Xueauthor=S.+D.+Akshinthalaauthor=J.+Krageljauthor=M.+R.+Jensenauthor=C.+M.+Gaussauthor=R.+Pageauthor=M.+Blackledge&title=Targeting+the+disordered+C+terminus+of+PTP1B+with+an+allosteric+inhibitor&doi=10.1038%2Fnchembio.1528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span></div><div class="casAuthors">Krishnan, Navasona; Koveal, Dorothy; Miller, Daniel H.; Xue, Bin; Akshinthala, Sai Dipikaa; Kragelj, Jaka; Jensen, Malene Ringkjoebing; Gauss, Carla-Maria; Page, Rebecca; Blackledge, Martin; Muthuswamy, Senthil K.; Peti, Wolfgang; Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">558-566</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">PTP1B, a validated therapeutic target for diabetes and obesity, has a crit. pos. role in HER2 signaling in breast tumorigenesis.  Efforts to develop therapeutic inhibitors of PTP1B have been frustrated by the chem. properties of the active site.  We define a new mechanism of allosteric inhibition that targets the C-terminal, noncatalytic segment of PTP1B.  We present what is to our knowledge the first ensemble structure of PTP1B contg. this intrinsically disordered segment, within which we identified a binding site for the small-mol. inhibitor MSI-1436.  We demonstrate binding to a second site close to the catalytic domain, with cooperative effects between the two sites locking PTP1B in an inactive state.  MSI-1436 antagonized HER2 signaling, inhibited tumorigenesis in xenografts and abrogated metastasis in the NDL2 mouse model of breast cancer, validating inhibition of PTP1B as a therapeutic strategy in breast cancer.  This new approach to inhibition of PTP1B emphasizes the potential of disordered segments of proteins as specific binding sites for therapeutic small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo526if7ja9XbVg90H21EOLACvtfcHk0lihY1NO2Lc9Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D&md5=10a460f3a5deafb9f7c206246d67a29b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1528%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DN.%26aulast%3DKoveal%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26aulast%3DXue%26aufirst%3DB.%26aulast%3DAkshinthala%26aufirst%3DS.%2BD.%26aulast%3DKragelj%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DBlackledge%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520disordered%2520C%2520terminus%2520of%2520PTP1B%2520with%2520an%2520allosteric%2520inhibitor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D558%26epage%3D566%26doi%3D10.1038%2Fnchembio.1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Gilmartin, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faitg, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seefeld, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federowicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. Y.</span><span> </span><span class="NLM_article-title">Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span><span class="refDoi"> DOI: 10.1038/nchembio.1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnchembio.1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=24390428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=181-187&author=A.+G.+Gilmartinauthor=T.+H.+Faitgauthor=M.+Richterauthor=A.+Groyauthor=M.+A.+Seefeldauthor=M.+G.+Darcyauthor=X.+Pengauthor=K.+Federowiczauthor=J.+Yangauthor=S.+Y.+Zhang&title=Allosteric+Wip1+phosphatase+inhibition+through+flap-subdomain+interaction&doi=10.1038%2Fnchembio.1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction</span></div><div class="casAuthors">Gilmartin, Aidan G.; Faitg, Thomas H.; Richter, Mark; Groy, Arthur; Seefeld, Mark A.; Darcy, Michael G.; Peng, Xin; Federowicz, Kelly; Yang, Jingsong; Zhang, Shu-Yun; Minthorn, Elisabeth; Jaworski, Jon-Paul; Schaber, Michael; Martens, Stan; McNulty, Dean E.; Sinnamon, Robert H.; Zhang, Hong; Kirkpatrick, Robert B.; Nevins, Neysa; Cui, Guanglei; Pietrak, Beth; Diaz, Elsie; Jones, Amber; Brandt, Martin; Schwartz, Benjamin; Heerding, Dirk A.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-187</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although therapeutic interventions of signal-transduction cascades with targeted kinase inhibitors are a well-established strategy, drug-discovery efforts to identify targeted phosphatase inhibitors have proven challenging.  Herein we report a series of allosteric, small-mol. inhibitors of wild-type p53-induced phosphatase (Wip1), an oncogenic phosphatase common to multiple cancers.  Compd. binding to Wip1 is dependent on a 'flap' subdomain located near the Wip1 catalytic site that renders Wip1 structurally divergent from other members of the protein phosphatase 2C (PP2C) family and that thereby confers selectivity for Wip1 over other phosphatases.  Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of Wip1 substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53.  Oral administration of Wip1 inhibitors in mice results in expected pharmacodynamic effects and causes inhibition of lymphoma xenograft growth.  To our knowledge, GSK2830371 is the first orally active, allosteric inhibitor of Wip1 phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jXZXKTKTL7Vg90H21EOLACvtfcHk0lihY1NO2Lc9Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D&md5=47524caa70df233fb152a2d683417e7d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1427%26sid%3Dliteratum%253Aachs%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DFaitg%26aufirst%3DT.%2BH.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DSeefeld%26aufirst%3DM.%2BA.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFederowicz%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DS.%2BY.%26atitle%3DAllosteric%2520Wip1%2520phosphatase%2520inhibition%2520through%2520flap-subdomain%2520interaction%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D181%26epage%3D187%26doi%3D10.1038%2Fnchembio.1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Larochelle, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durzynska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ping, W.</span><span> </span><span class="NLM_article-title">Structural and functional consequences of three cancer-associated mutations of the oncogenic phosphatase SHP2</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2277</span><span class="refDoi"> DOI: 10.1021/acs.biochem.5b01287</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVagtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2269-2277&author=J.+R.+Larochelleauthor=M.+Fodorauthor=X.+Xuauthor=I.+Durzynskaauthor=L.+Fanauthor=T.+Stamsauthor=H.+Chanauthor=M.+J.+Lamarcheauthor=R.+Chopraauthor=W.+Ping&title=Structural+and+functional+consequences+of+three+cancer-associated+mutations+of+the+oncogenic+phosphatase+SHP2&doi=10.1021%2Facs.biochem.5b01287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2</span></div><div class="casAuthors">LaRochelle, Jonathan R.; Fodor, Michelle; Xu, Xiang; Durzynska, Izabela; Fan, Lixin; Stams, Travis; Chan, Ho Man; LaMarche, Matthew J.; Chopra, Rajiv; Wang, Ping; Fortin, Pascal D.; Acker, Michael G.; Blacklow, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2269-2277</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The proto-oncogene PTPN11 encodes a cytoplasmic protein tyrosine phosphatase, SHP2, which is required for normal development and sustained activation of the Ras-MAPK signaling pathway.  Germline mutations in SHP2 cause developmental disorders, and somatic mutations have been identified in childhood and adult cancers and drive leukemia in mice.  Despite our knowledge of the PTPN11 variations assocd. with pathol., the structural and functional consequences of many disease-assocd. mutants remain poorly understood.  Here, we combine X-ray crystallog., small-angle X-ray scattering, and biochem. to elucidate structural and mechanistic features of three cancer-assocd. SHP2 variants harboring single point mutations within the N-SH2:PTP interdomain autoinhibitory interface.  Our findings directly compare the impact of each mutation on autoinhibition of the phosphatase and advance the development of structure-guided and mutation-specific SHP2 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdIaFVGm5lArVg90H21EOLACvtfcHk0lihY1NO2Lc9Pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVagtLw%253D&md5=720b3dd9b18edde2c443d488cfb90dfc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01287%26sid%3Dliteratum%253Aachs%26aulast%3DLarochelle%26aufirst%3DJ.%2BR.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DDurzynska%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DLamarche%26aufirst%3DM.%2BJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DPing%26aufirst%3DW.%26atitle%3DStructural%2520and%2520functional%2520consequences%2520of%2520three%2520cancer-associated%2520mutations%2520of%2520the%2520oncogenic%2520phosphatase%2520SHP2%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D2269%26epage%3D2277%26doi%3D10.1021%2Facs.biochem.5b01287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">22992</span><span class="NLM_x">–</span> <span class="NLM_lpage">22995</span><span class="refDoi"> DOI: 10.1074/jbc.M312498200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1074%2Fjbc.M312498200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15031289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Gisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=22992-22995&author=H.+Hanafusaauthor=S.+Toriiauthor=T.+Yasunagaauthor=K.+Matsumotoauthor=E.+Nishida&title=Shp2%2C+an+SH2-containing+protein-tyrosine+phosphatase%2C+positively+regulates+receptor+tyrosine+kinase+signaling+by+dephosphorylating+and+inactivating+the+inhibitor+Sprouty&doi=10.1074%2Fjbc.M312498200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty</span></div><div class="casAuthors">Hanafusa, Hiroshi; Torii, Satoru; Yasunaga, Takayuki; Matsumoto, Kunihiro; Nishida, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">22992-22995</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">SH2 domain-contg. phosphotyrosine phosphatase Shp2 functions as a pos. effector in receptor tyrosine kinase (RTK) signaling immediately proximal to activated receptors.  However, neither its physiol. substrate(s) nor its mechanism of action in RTK signaling has been defined.  Here, the authors demonstrate that protein Sprouty (Spry), an inhibitor of the Ras-MAP kinase signaling pathway, is a possible target of Shp2.  Spry acts as a conserved inhibitor of RTK signaling, and tyrosine phosphorylation of Spry is indispensable for its inhibitory activity.  Shp2 was able to dephosphorylate fibroblast growth factor (FGF) receptor-induced phosphotyrosines on Spry both in vivo and in vitro.  Shp2-mediated dephosphorylation of Spry resulted in dissocn. of Spry from protein Grb2.  Furthermore, Shp2 could reverse the inhibitory effect of Spry on FGF-induced neurite outgrowth and MAP kinase activation.  These findings suggest that Shp2 acts as a pos. regulator in RTK signaling by dephosphorylating and inactivating Spry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4GxPH8eSOr7Vg90H21EOLACvtfcHk0lip0GrjfyDnPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Gisro%253D&md5=7b08119acef72fe735bf39c972beb70d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312498200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312498200%26sid%3Dliteratum%253Aachs%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DTorii%26aufirst%3DS.%26aulast%3DYasunaga%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DShp2%252C%2520an%2520SH2-containing%2520protein-tyrosine%2520phosphatase%252C%2520positively%2520regulates%2520receptor%2520tyrosine%2520kinase%2520signaling%2520by%2520dephosphorylating%2520and%2520inactivating%2520the%2520inhibitor%2520Sprouty%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D22992%26epage%3D22995%26doi%3D10.1074%2Fjbc.M312498200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcgregor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">30984</span><span class="NLM_x">–</span> <span class="NLM_lpage">30993</span><span class="refDoi"> DOI: 10.1074/jbc.M504699200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1074%2Fjbc.M504699200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15987685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30984-30993&author=H.+Keilhackauthor=F.+S.+Davidauthor=M.+Mcgregorauthor=L.+C.+Cantleyauthor=B.+G.+Neel&title=Diverse+biochemical+properties+of+Shp2+mutants.+Implications+for+disease+phenotypes&doi=10.1074%2Fjbc.M504699200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Biochemical Properties of Shp2 Mutants: implications for disease phenotypes</span></div><div class="casAuthors">Keilhack, Heike; David, Frank S.; McGregor, Malcolm; Cantley, Lewis C.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30984-30993</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mutations in the Src homol. 2 (SH2)-contg. protein-tyrosine phosphatase Shp2 (PTPN11) underlie half of the cases of the autosomal dominant genetic disorder Noonan syndrome, and somatic Shp2 mutations are found in several hematol. and solid malignancies.  Earlier studies of small nos. of mutants suggested that disease-assocd. mutations cause constitutive (SH2 binding-independent) activation and that cancer-assocd. mutants are more active than those assocd. with Noonan syndrome.  We have characterized a larger panel of Shp2 mutants and find that this "activity-centric" model cannot explain the behaviors of all pathogenic Shp2 mutations.  Instead, enzymic, structural, and math. modeling analyses show that these mutants can affect basal activation, SH2 domain-phosphopeptide affinity, and/or substrate specificity to varying degrees.  Furthermore, there is no abs. correlation between the mutants' extents of basal activation and the diseases they induce.  We propose that activated mutants of Shp2 modulate signaling from specific stimuli to a subset of effectors and provide a theor. framework for understanding the complex relationship between Shp2 activation, intracellular signaling, and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJx5YZGoBn6bVg90H21EOLACvtfcHk0lip0GrjfyDnPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D&md5=649d6897855861aa0e6aaaff4ed57125</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504699200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504699200%26sid%3Dliteratum%253Aachs%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DMcgregor%26aufirst%3DM.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DDiverse%2520biochemical%2520properties%2520of%2520Shp2%2520mutants.%2520Implications%2520for%2520disease%2520phenotypes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30984%26epage%3D30993%26doi%3D10.1074%2Fjbc.M504699200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamy, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G. W.</span><span> </span><span class="NLM_article-title">Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2062</span><span class="NLM_x">–</span> <span class="NLM_lpage">2071</span><span class="refDoi"> DOI: 10.1002/jcb.23125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1002%2Fjcb.23125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=21465528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslamtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2011&pages=2062-2071&author=W.+Wangauthor=L.+Liuauthor=X.+Songauthor=Y.+Moauthor=C.+Kommaauthor=H.+D.+Bellamyauthor=Z.+J.+Zhaoauthor=G.+W.+Zhou&title=Crystal+structure+of+human+protein+tyrosine+phosphatase+SHP-1+in+the+open+conformation&doi=10.1002%2Fjcb.23125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation</span></div><div class="casAuthors">Wang, Wei; Liu, Lijun; Song, Xi; Mo, Yi; Komma, Chandrasekhar; Bellamy, Henry D.; Zhao, Zhizhuang Joe; Zhou, G. Wayne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2062-2071</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">SHP-1 belongs to the family of non-receptor protein tyrosine phosphatases (PTPs) and generally acts as a neg. regulator in a variety of cellular signaling pathways.  Previously, the crystal structures of tail-truncated SHP-1 and SHP-2 revealed an autoinhibitory conformation.  To understand the regulatory mechanism of SHP-1, the authors detd. the crystal structure of full-length SHP-1 at 3.1 Å.  Although the tail was disordered in the current structure, the huge conformational rearrangement of the N-SH2 domain and the incorporation of sulfate ions into the ligand-binding site of each domain indicated that SHP-1 was in the open conformation.  The N-SH2 domain in the current structure was shifted away from the active site of the PTP domain to the other side of the C-SH2 domain, resulting in exposure of the active site.  Meanwhile, the C-SH2 domain was twisted anti-clockwise by ∼110°.  In addn., a set of new interactions between 2 SH2 domains and between the N-SH2 and the catalytic domains was identified, which could be responsible for the stabilization of SHP-1 in the open conformation.  Based on the structural comparison, a model for the activation of SHP-1 was proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbClbkZ-6vn7Vg90H21EOLACvtfcHk0lip0GrjfyDnPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslamtLs%253D&md5=7da59a40ae5a36fb3842922de1135744</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fjcb.23125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.23125%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DKomma%26aufirst%3DC.%26aulast%3DBellamy%26aufirst%3DH.%2BD.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26aulast%3DZhou%26aufirst%3DG.%2BW.%26atitle%3DCrystal%2520structure%2520of%2520human%2520protein%2520tyrosine%2520phosphatase%2520SHP-1%2520in%2520the%2520open%2520conformation%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D112%26spage%3D2062%26epage%3D2071%26doi%3D10.1002%2Fjcb.23125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turchi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Targeting SHP2 for EGFR inhibitor resistant non-small cell lung carcinoma</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">439</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2013.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2Fj.bbrc.2013.09.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2013&pages=586-590&author=J.+Xuauthor=L.+F.+Zengauthor=W.+Shenauthor=J.+J.+Turchiauthor=Z.+Y.+Zhang&title=Targeting+SHP2+for+EGFR+inhibitor+resistant+non-small+cell+lung+carcinoma&doi=10.1016%2Fj.bbrc.2013.09.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DL.%2BF.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTurchi%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DTargeting%2520SHP2%2520for%2520EGFR%2520inhibitor%2520resistant%2520non-small%2520cell%2520lung%2520carcinoma%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D439%26spage%3D586%26epage%3D590%26doi%3D10.1016%2Fj.bbrc.2013.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardet, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarinis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelzle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouwmeester, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schübeler, D.</span><span> </span><span class="NLM_article-title">YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers</span> <span class="citation_source-journal">PLoS Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1005465</span><span class="refDoi"> DOI: 10.1371/journal.pgen.1005465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1371%2Fjournal.pgen.1005465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=26295846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVaqsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1005465&author=C.+Steinauthor=A.+F.+Bardetauthor=G.+Romaauthor=S.+Berglingauthor=I.+Clayauthor=A.+Ruchtiauthor=C.+Agarinisauthor=T.+Schmelzleauthor=T.+Bouwmeesterauthor=D.+Sch%C3%BCbeler&title=YAP1+exerts+its+transcriptional+control+via+TEAD-mediated+activation+of+enhancers&doi=10.1371%2Fjournal.pgen.1005465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers</span></div><div class="casAuthors">Stein, Claudia; Flore, Bardet Anais; Roma, Guglielmo; Bergling, Sebastian; Clay, Ieuan; Ruchti, Alexandra; Agarinis, Claudia; Schmelzle, Tobias; Bouwmeester, Tewis; Schubeler, Dirk; Bauer, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e1005465/1-e1005465/28</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">YAP1 is a major effector of the Hippo pathway and a well-established oncogene.  Elevated YAP1 activity due to mutations in Hippo pathway components or YAP1 amplification is obsd. in several types of human cancers.  Here we investigated its genomic binding landscape in YAP1-activated cancer cells, as well as in non-transformed cells.  We demonstrate that TEAD transcription factors mediate YAP1 chromatin-binding genome-wide, further explaining their dominant role as primary mediators of YAP1-transcriptional activity.  Moreover, we show that YAP1 largely exerts its transcriptional control via distal enhancers that are marked by H3K27 acetylation and that YAP1 is necessary for this chromatin mark at bound enhancers and the activity of the assocd. genes.  This work establishes YAP1- mediated transcriptional regulation at distal enhancers and provides an expanded set of target genes resulting in a fundamental source to study YAP1 function in a normal and cancer setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr7GWYG9telbVg90H21EOLACvtfcHk0liZh0jSStArXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVaqsrbI&md5=42f513f83f3667139af5cc416745e704</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1005465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1005465%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DC.%26aulast%3DBardet%26aufirst%3DA.%2BF.%26aulast%3DRoma%26aufirst%3DG.%26aulast%3DBergling%26aufirst%3DS.%26aulast%3DClay%26aufirst%3DI.%26aulast%3DRuchti%26aufirst%3DA.%26aulast%3DAgarinis%26aufirst%3DC.%26aulast%3DSchmelzle%26aufirst%3DT.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DSch%25C3%25BCbeler%26aufirst%3DD.%26atitle%3DYAP1%2520exerts%2520its%2520transcriptional%2520control%2520via%2520TEAD-mediated%2520activation%2520of%2520enhancers%26jtitle%3DPLoS%2520Genet.%26date%3D2015%26volume%3D11%26spage%3De1005465%26doi%3D10.1371%2Fjournal.pgen.1005465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Keshet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricardo Lax, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porat, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuven, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaul, Y.</span><span> </span><span class="NLM_article-title">C-Abl antagonizes the YAP oncogenic function</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span><span class="refDoi"> DOI: 10.1038/cdd.2014.182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fcdd.2014.182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=25361080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKmtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=935-945&author=R.+Keshetauthor=J.+Adlerauthor=I.+Ricardo+Laxauthor=M.+Shanzerauthor=Z.+Poratauthor=N.+Reuvenauthor=Y.+Shaul&title=C-Abl+antagonizes+the+YAP+oncogenic+function&doi=10.1038%2Fcdd.2014.182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">c-Abl antagonizes the YAP oncogenic function</span></div><div class="casAuthors">Keshet, R.; Adler, J.; Ricardo Lax, I.; Shanzer, M.; Porat, Z.; Reuven, N.; Shaul, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">935-945</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">YES-assocd. protein (YAP) is a central transcription coactivator that functions as an oncogene in a no. of exptl. systems.  However, under DNA damage, YAP activates pro-apoptotic genes in conjunction with p73.  This program switching is mediated by c-Abl (Abelson murine leukemia viral oncogene) via phosphorylation of YAP at the Y357 residue (pY357).  YAP as an oncogene coactivates the TEAD (transcriptional enhancer activator domain) family transcription factors.  Here we asked whether c-Abl regulates the YAP-TEAD functional module.  We found that DNA damage, through c-Abl activation, specifically depressed YAP-TEAD-induced transcription.  Remarkably, c-Abl counteracts YAP-induced transformation by interfering with the YAP-TEAD transcriptional program. c-Abl induced TEAD1 phosphorylation, but the YAP-TEAD complex remained unaffected.  In contrast, TEAD coactivation was compromised by phosphomimetic YAP Y357E mutation but not Y357F, as demonstrated at the level of reporter genes and endogenous TEAD target genes.  Furthermore, YAP Y357E also severely compromised the role of YAP in cell transformation, migration, anchorage-independent growth, and epithelial-to-mesenchymal transition (EMT) in human mammary MCF10A cells.  These results suggest that YAP pY357 lost TEAD transcription activation function.  Our results demonstrate that YAP pY357 inactivates YAP oncogenic function and establish a role for YAP Y357 phosphorylation in cell-fate decision.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrziPLM7pc3YrVg90H21EOLACvtfcHk0liZh0jSStArXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKmtb7K&md5=be1b058a8a0f2ada7ebbc8cad39361cf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.182%26sid%3Dliteratum%253Aachs%26aulast%3DKeshet%26aufirst%3DR.%26aulast%3DAdler%26aufirst%3DJ.%26aulast%3DRicardo%2BLax%26aufirst%3DI.%26aulast%3DShanzer%26aufirst%3DM.%26aulast%3DPorat%26aufirst%3DZ.%26aulast%3DReuven%26aufirst%3DN.%26aulast%3DShaul%26aufirst%3DY.%26atitle%3DC-Abl%2520antagonizes%2520the%2520YAP%2520oncogenic%2520function%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2015%26volume%3D22%26spage%3D935%26epage%3D945%26doi%3D10.1038%2Fcdd.2014.182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span><span class="refDoi"> DOI: 10.1107/S0021889893005588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0021889893005588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADyaK2cXptFeltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=795-800&author=W.+Kabsch&title=Automatic+processing+of+rotation+diffraction+data+from+crystals+of+initially+unknown+symmetry+and+cell+constants&doi=10.1107%2FS0021889893005588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">795-800</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">An algorithm was developed for the automatic interpretation of a given set of obsd. reciprocal-lattice points.  It exts. a reduced cell and assigns indexes to each reflection by a graph-theor. implementation of the local indexing method.  All possible symmetries of the obsd. lattice compatible with the metric of the reduced cell are recognized and reported, together with the unit-cell consts. and the linear index transformation relating the conventional to the reduced cell.  This algorithm was incorporated into the program XDS (K., 1988), which is now able to process single-crystal area-detector data without prior knowledge of the symmetry and the unit-cell consts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1lV8_7cDv7Vg90H21EOLACvtfcHk0liZh0jSStArXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXptFeltw%253D%253D&md5=2b703225206ce99af0d7e38acf6d75b3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0021889893005588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889893005588%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DAutomatic%2520processing%2520of%2520rotation%2520diffraction%2520data%2520from%2520crystals%2520of%2520initially%2520unknown%2520symmetry%2520and%2520cell%2520constants%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D795%26epage%3D800%26doi%3D10.1107%2FS0021889893005588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Mccoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossekunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Likelihood-enhanced fast translation functions</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span><span class="refDoi"> DOI: 10.1107/S0907444905001617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0907444905001617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15805601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVeisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=458-464&author=A.+J.+Mccoyauthor=R.+W.+Grossekunstleveauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Likelihood-enhanced+fast+translation+functions&doi=10.1107%2FS0907444905001617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Likelihood-enhanced fast translation functions</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">D61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-464</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">This paper is a companion to a recent paper on fast rotation functions [Storoni et al. (2004), Acta Cryst. D60, 432-438], which showed how a Taylor-series expansion of the max.-likelihood rotation function leads to improved likelihood-enhanced fast rotation functions.  In a similar manner, it is shown here how linear and quadratic Taylor-series expansions and least-squares approxns. of the max.-likelihood translation function lead to likelihood-enhanced translation functions, which can be calcd. by FFT and which are more sensitive to the correct translation than the traditional correlation-coeff. fast translation function.  These likelihood-enhanced translation targets for mol.-replacement searches have been implemented in the program Phaser using the Computational Crystallog. Toolbox (cctbx).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDd3wovyUbWLVg90H21EOLACvtfcHk0liZh0jSStArXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVeisrY%253D&md5=bac9cc121bcc0d5cd314955a0e65e746</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444905001617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905001617%26sid%3Dliteratum%253Aachs%26aulast%3DMccoy%26aufirst%3DA.%2BJ.%26aulast%3DGrossekunstleve%26aufirst%3DR.%2BW.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DLikelihood-enhanced%2520fast%2520translation%2520functions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2005%26volume%3D61%26spage%3D458%26epage%3D464%26doi%3D10.1107%2FS0907444905001617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossekunstleve, R. W.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grossekunstleve&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrossekunstleve%26aufirst%3DR.%2BW.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2005&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2005%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcnicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span> </span><span class="NLM_article-title">The new CCP4 Coordinate Library as a toolkit for the design of coordinate-related applications in protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2250</span><span class="refDoi"> DOI: 10.1107/S0907444904027167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0907444904027167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15572778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2250&author=E.+B.+Krissinelauthor=M.+D.+Winnauthor=C.+C.+Ballardauthor=A.+W.+Ashtonauthor=P.+Patelauthor=E.+A.+Pottertonauthor=S.+J.+Mcnicholasauthor=K.+D.+Cowtanauthor=P.+Emsley&title=The+new+CCP4+Coordinate+Library+as+a+toolkit+for+the+design+of+coordinate-related+applications+in+protein+crystallography&doi=10.1107%2FS0907444904027167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The new CCP4 Coordinate Library as a toolkit for the design of coordinate-related applications in protein crystallography</span></div><div class="casAuthors">Krissinel, E. B.; Winn, M. D.; Ballard, C. C.; Ashton, A. W.; Patel, P.; Potterton, E. A.; McNicholas, S. J.; Cowtan, K. D.; Emsley, P.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2250-2255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The new CCP4 Coordinate Library is a development aiming to provide a common layer of coordinate-related functionality to the existing applications in the CCP4 suite, as well as a variety of tools that can simplify the design of new applications where they relate to at. coordinates.  The Library comprises a wide spectrum of useful functions, ranging from parsing coordinate formats and elementary editing operations on the coordinate hierarchy of biomols., to high-level functionality such as calcn. of secondary structure, interat. bonds, at. contacts, symmetry transformations, structure superposition and many others.  Most of the functions are available in a C++ object interface; however, a Fortran interface is provided for compatibility with older CCP4 applications.  The paper describes the general principles of the Library design and the most important functionality.  The Library, together with documentation, is available under the LGPL license from the CCP4 suite version 5.0 and higher.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2HD6r3NAAsbVg90H21EOLACvtfcHk0lgODpkD0-N7xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars7rK&md5=4443c50d18d560788e36802ca05076c1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444904027167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904027167%26sid%3Dliteratum%253Aachs%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DAshton%26aufirst%3DA.%2BW.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DMcnicholas%26aufirst%3DS.%2BJ.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DEmsley%26aufirst%3DP.%26atitle%3DThe%2520new%2520CCP4%2520Coordinate%2520Library%2520as%2520a%2520toolkit%2520for%2520the%2520design%2520of%2520coordinate-related%2520applications%2520in%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2250%26doi%3D10.1107%2FS0907444904027167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Commons, T. J.; Fensome, A.; Heffernan, G. D.; McComas, C. C.; Woodworth, R. P.; Webb, M. B.; Marella, M. A.; Melenski, E. G.</span><span> </span><span class="NLM_article-title">Pyrrolidine and Related Derivatives Useful as PR Modulators</span>. Patent WO2008021339,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+J.+Commons&author=A.+Fensome&author=G.+D.+Heffernan&author=C.+C.+McComas&author=R.+P.+Woodworth&author=M.+B.+Webb&author=M.+A.+Marella&author=E.+G.+Melenski&title=Pyrrolidine+and+Related+Derivatives+Useful+as+PR+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCommons%26aufirst%3DT.%2BJ.%26atitle%3DPyrrolidine%2520and%2520Related%2520Derivatives%2520Useful%2520as%2520PR%2520Modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 44 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Xinrui Yuan, Hong Bu, Jinpei Zhou, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Huibin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11368-11396. <a href="https://doi.org/10.1021/acs.jmedchem.0c00249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00249%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bof%252BSHP2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BCurrent%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D10062020%26date%3D27052020%26volume%3D63%26issue%3D20%26spage%3D11368%26epage%3D11396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingliang Wang, Jianfeng Lu, Mi Wang, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7510-7528. <a href="https://doi.org/10.1021/acs.jmedchem.0c00471" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00471%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSHP2-D26%252Bas%252Ba%252BFirst%25252C%252BPotent%25252C%252Band%252BEffective%252BPROTAC%252BDegrader%252Bof%252BSHP2%252BProtein%26aulast%3DWang%26aufirst%3DMingliang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20032020%26date%3D21052020%26volume%3D63%26issue%3D14%26spage%3D7510%26epage%3D7528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Rino Ragno, Valeria Esposito, Martina Di Mario, Stefano Masiello, Marco Viscovo, <span class="NLM_string-name hlFld-ContribAuthor">Richard D. Cramer</span>. </span><span class="cited-content_cbyCitation_article-title">Teaching and Learning Computational Drug Design: Student Investigations of 3D Quantitative Structure–Activity Relationships through Web Applications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Education</span><span> <strong>2020,</strong> <em>97 </em>
                                    (7)
                                     , 1922-1930. <a href="https://doi.org/10.1021/acs.jchemed.0c00117" title="DOI URL">https://doi.org/10.1021/acs.jchemed.0c00117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jchemed.0c00117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jchemed.0c00117%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Education%26atitle%3DTeaching%252Band%252BLearning%252BComputational%252BDrug%252BDesign%25253A%252BStudent%252BInvestigations%252Bof%252B3D%252BQuantitative%252BStructure%2525E2%252580%252593Activity%252BRelationships%252Bthrough%252BWeb%252BApplications%26aulast%3DRagno%26aufirst%3DRino%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29022020%26date%3D06062020%26date%3D23062020%26volume%3D97%26issue%3D7%26spage%3D1922%26epage%3D1930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Shaoyong Lu, Xinheng He, Duan Ni, <span class="NLM_string-name hlFld-ContribAuthor">Jian Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulator Discovery: From Serendipity to Structure-Based Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (14)
                                     , 6405-6421. <a href="https://doi.org/10.1021/acs.jmedchem.8b01749" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01749%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulator%252BDiscovery%25253A%252BFrom%252BSerendipity%252Bto%252BStructure-Based%252BDesign%26aulast%3DLu%26aufirst%3DShaoyong%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D11112018%26date%3D07032019%26date%3D28022019%26volume%3D62%26issue%3D14%26spage%3D6405%26epage%3D6421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Patrick Sarver, Michael Acker, Jeffrey T. Bagdanoff, Zhouliang Chen, Ying-Nan Chen, Homan Chan, Brant Firestone, Michelle Fodor, Jorge Fortanet, Huaixiang Hao, Murphy Hentemann, Mitsunori Kato, Robert Koenig, Laura R. LaBonte, Gang Liu, Shumei Liu, Chen Liu, Eric McNeill, Morvarid Mohseni, Martin Sendzik, Travis Stams, Stan Spence, Victoriano Tamez, Ritesh Tichkule, Christopher Towler, Hongyun Wang, Ping Wang, Sarah L. Williams, Bing Yu, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. LaMarche</span>. </span><span class="cited-content_cbyCitation_article-title">6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1793-1802. <a href="https://doi.org/10.1021/acs.jmedchem.8b01726" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01726%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Amino-3-methylpyrimidinones%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BEfficacious%252BSHP2%252BInhibitors%26aulast%3DSarver%26aufirst%3DPatrick%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D05112018%26date%3D16022019%26date%3D28012019%26volume%3D62%26issue%3D4%26spage%3D1793%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michelle Fodor, Edmund Price, Ping Wang, Hengyu Lu, Andreea Argintaru, Zhouliang Chen, Meir Glick, Huai-Xiang Hao, Mitsunori Kato, Robert Koenig, Jonathan R. LaRochelle, Gang Liu, Eric McNeill, Dyuti Majumdar, Gisele A. Nishiguchi, Lawrence B. Perez, Gregory Paris, Christopher M. Quinn, Timothy Ramsey, Martin Sendzik, Michael David Shultz, Sarah L. Williams, Travis Stams, Stephen C. Blacklow, Michael G. Acker, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. LaMarche</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Allosteric Inhibition of SHP2 Phosphatase. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (3)
                                     , 647-656. <a href="https://doi.org/10.1021/acschembio.7b00980" title="DOI URL">https://doi.org/10.1021/acschembio.7b00980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00980%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDual%252BAllosteric%252BInhibition%252Bof%252BSHP2%252BPhosphatase%26aulast%3DFodor%26aufirst%3DMichelle%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D16112017%26date%3D05012018%26date%3D18012018%26date%3D05012018%26volume%3D13%26issue%3D3%26spage%3D647%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silke  Pudewell</span>, <span class="hlFld-ContribAuthor ">Christoph  Wittich</span>, <span class="hlFld-ContribAuthor ">Neda S.  Kazemein Jasemi</span>, <span class="hlFld-ContribAuthor ">Farhad  Bazgir</span>, <span class="hlFld-ContribAuthor ">Mohammad R.  Ahmadian</span>. </span><span class="cited-content_cbyCitation_article-title">Accessory proteins of the RAS-MAPK pathway: moving from the side line to the front line. </span><span class="cited-content_cbyCitation_journal-name">Communications Biology</span><span> <strong>2021,</strong> <em>4 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s42003-021-02149-3" title="DOI URL">https://doi.org/10.1038/s42003-021-02149-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s42003-021-02149-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs42003-021-02149-3%26sid%3Dliteratum%253Aachs%26jtitle%3DCommunications%2520Biology%26atitle%3DAccessory%252Bproteins%252Bof%252Bthe%252BRAS-MAPK%252Bpathway%25253A%252Bmoving%252Bfrom%252Bthe%252Bside%252Bline%252Bto%252Bthe%252Bfront%252Bline%26aulast%3DPudewell%26aufirst%3DSilke%26date%3D2021%26date%3D2021%26volume%3D4%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bing  Yang</span>, <span class="hlFld-ContribAuthor ">Jiahua  Zhou</span>, <span class="hlFld-ContribAuthor ">Fa  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Wei  Hu</span>, <span class="hlFld-ContribAuthor ">Yujun  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazoline derivatives as tubulin polymerization inhibitors with one hit for Vascular Endothelial Growth Factor Receptor 2 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>114 </em>, 105134. <a href="https://doi.org/10.1016/j.bioorg.2021.105134" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.105134</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.105134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.105134%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DPyrazoline%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%252Bwith%252Bone%252Bhit%252Bfor%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252B2%252Binhibition%26aulast%3DYang%26aufirst%3DBing%26date%3D2021%26volume%3D114%26spage%3D105134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Guo</span>, <span class="hlFld-ContribAuthor ">Yaping  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (22)
                                     , 5504-5523. <a href="https://doi.org/10.1002/slct.202100186" title="DOI URL">https://doi.org/10.1002/slct.202100186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100186%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCross%252Bthe%252BUndruggable%252BBarrier%25252C%252Bthe%252BDevelopment%252Bof%252BSHP2%252BInhibitors%25253A%252BFrom%252BCatalytic%252BSite%252BInhibitors%252Bto%252BAllosteric%252BInhibitors%26aulast%3DGuo%26aufirst%3DYu%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D22%26spage%3D5504%26epage%3D5523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Nian</span>, <span class="hlFld-ContribAuthor ">Jinhao  Zeng</span>, <span class="hlFld-ContribAuthor ">Li  He</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Fernando  Rodrigues-Lima</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuanlin  Feng</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">A small molecule inhibitor targeting SHP2 mutations for the lung carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>32 </em>
                                    (5)
                                     , 1645-1652. <a href="https://doi.org/10.1016/j.cclet.2021.01.002" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DA%252Bsmall%252Bmolecule%252Binhibitor%252Btargeting%252BSHP2%252Bmutations%252Bfor%252Bthe%252Blung%252Bcarcinoma%26aulast%3DNian%26aufirst%3DQing%26date%3D2021%26volume%3D32%26issue%3D5%26spage%3D1645%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengzhu  Zheng</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Canrong  Wu</span>, <span class="hlFld-ContribAuthor ">Kaiyin  Yang</span>, <span class="hlFld-ContribAuthor ">Qiqi  Wang</span>, <span class="hlFld-ContribAuthor ">Yirong  Zhou</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Novel PROTACs for degradation of SHP2 protein. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104788. <a href="https://doi.org/10.1016/j.bioorg.2021.104788" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104788</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104788%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNovel%252BPROTACs%252Bfor%252Bdegradation%252Bof%252BSHP2%252Bprotein%26aulast%3DZheng%26aufirst%3DMengzhu%26date%3D2021%26volume%3D110%26spage%3D104788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alessandro  Allegra</span>, <span class="hlFld-ContribAuthor ">Giovanni  Pioggia</span>, <span class="hlFld-ContribAuthor ">Vanessa  Innao</span>, <span class="hlFld-ContribAuthor ">Caterina  Musolino</span>, <span class="hlFld-ContribAuthor ">Sebastiano  Gangemi</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (8)
                                     , 1981. <a href="https://doi.org/10.3390/cancers13081981" title="DOI URL">https://doi.org/10.3390/cancers13081981</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13081981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13081981%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DNew%252BInsights%252Binto%252BYES-Associated%252BProtein%252BSignaling%252BPathways%252Bin%252BHematological%252BMalignancies%25253A%252BDiagnostic%252Band%252BTherapeutic%252BChallenges%26aulast%3DAllegra%26aufirst%3DAlessandro%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D8%26spage%3D1981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingwei  Wu</span>, <span class="hlFld-ContribAuthor ">Weiya  Li</span>, <span class="hlFld-ContribAuthor ">Zhihui  Zheng</span>, <span class="hlFld-ContribAuthor ">Xinhua  Lu</span>, <span class="hlFld-ContribAuthor ">Huan  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Runling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation, common feature pharmacophore model and molecular dynamics simulation studies of ethyl 4-(phenoxymethyl)-2-phenylthiazole-5-carboxylate as Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (4)
                                     , 1174-1188. <a href="https://doi.org/10.1080/07391102.2020.1726817" title="DOI URL">https://doi.org/10.1080/07391102.2020.1726817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1726817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1726817%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Bcommon%252Bfeature%252Bpharmacophore%252Bmodel%252Band%252Bmolecular%252Bdynamics%252Bsimulation%252Bstudies%252Bof%252Bethyl%252B4-%252528phenoxymethyl%252529-2-phenylthiazole-5-carboxylate%252Bas%252BSrc%252Bhomology-2%252Bdomain%252Bcontaining%252Bprotein%252Btyrosine%252Bphosphatase-2%252B%252528SHP2%252529%252Binhibitors%26aulast%3DWu%26aufirst%3DJingwei%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D4%26spage%3D1174%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yihui  Song</span>, <span class="hlFld-ContribAuthor ">Min  Zhao</span>, <span class="hlFld-ContribAuthor ">Yahong  Wu</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A multifunctional cross-validation high-throughput screening protocol enabling the discovery of new SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 750-762. <a href="https://doi.org/10.1016/j.apsb.2020.10.021" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.10.021</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.10.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.10.021%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DA%252Bmultifunctional%252Bcross-validation%252Bhigh-throughput%252Bscreening%252Bprotocol%252Benabling%252Bthe%252Bdiscovery%252Bof%252Bnew%252BSHP2%252Binhibitors%26aulast%3DSong%26aufirst%3DYihui%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D750%26epage%3D762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lan  Luo</span>, <span class="hlFld-ContribAuthor ">Jing Jing  Jia</span>, <span class="hlFld-ContribAuthor ">Qiu  Zhong</span>, <span class="hlFld-ContribAuthor ">Xue  Zhong</span>, <span class="hlFld-ContribAuthor ">Shilong  Zheng</span>, <span class="hlFld-ContribAuthor ">Guangdi  Wang</span>, <span class="hlFld-ContribAuthor ">Ling  He</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and anticancer activity evaluation of naphthalene-substituted triazole spirodienones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113039. <a href="https://doi.org/10.1016/j.ejmech.2020.113039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Banticancer%252Bactivity%252Bevaluation%252Bof%252Bnaphthalene-substituted%252Btriazole%252Bspirodienones%26aulast%3DLuo%26aufirst%3DLan%26date%3D2021%26volume%3D213%26spage%3D113039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Yong  Feng</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Zhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing-Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Hua  Lu</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2 WT and SHP2F285S by molecular dynamics study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2021,</strong> <em>103 </em>, 107807. <a href="https://doi.org/10.1016/j.jmgm.2020.107807" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DExploring%252Bthe%252Bmechanism%252Bof%252Bthe%252Bpotent%252Ballosteric%252Binhibitor%252Bcompound2%252Bon%252BSHP2%252BWT%252Band%252BSHP2F285S%252Bby%252Bmolecular%252Bdynamics%252Bstudy%26aulast%3DZhou%26aufirst%3DLiang%26date%3D2021%26volume%3D103%26spage%3D107807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities – A comprehensive review. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (3)
                                     , 721-773. <a href="https://doi.org/10.1111/cbdd.13807" title="DOI URL">https://doi.org/10.1111/cbdd.13807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13807%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DEmerging%252Bchemical%252Bscaffolds%252Bwith%252Bpotential%252BSHP2%252Bphosphatase%252Binhibitory%252Bcapabilities%252B%2525E2%252580%252593%252BA%252Bcomprehensive%252Breview%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D3%26spage%3D721%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Navid  Sobhani</span>, <span class="hlFld-ContribAuthor ">Dana Rae  Tardiel-Cyril</span>, <span class="hlFld-ContribAuthor ">Aram  Davtyan</span>, <span class="hlFld-ContribAuthor ">Daniele  Generali</span>, <span class="hlFld-ContribAuthor ">Raheleh  Roudi</span>, <span class="hlFld-ContribAuthor ">Yong  Li</span>. </span><span class="cited-content_cbyCitation_article-title">CTLA-4 in Regulatory T Cells for Cancer Immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2021,</strong> <em>13 </em>
                                    (6)
                                     , 1440. <a href="https://doi.org/10.3390/cancers13061440" title="DOI URL">https://doi.org/10.3390/cancers13061440</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers13061440&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers13061440%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCTLA-4%252Bin%252BRegulatory%252BT%252BCells%252Bfor%252BCancer%252BImmunotherapy%26aulast%3DSobhani%26aufirst%3DNavid%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D6%26spage%3D1440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Liu</span>, <span class="hlFld-ContribAuthor ">Shan  Gao</span>, <span class="hlFld-ContribAuthor ">Reham M.  Elhassan</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to overcome drug resistance using SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>27 </em><a href="https://doi.org/10.1016/j.apsb.2021.03.037" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.037%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DStrategies%252Bto%252Bovercome%252Bdrug%252Bresistance%252Busing%252BSHP2%252Binhibitors%26aulast%3DLiu%26aufirst%3DMeng%26date%3D2021%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaohe  Yang</span>, <span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Yueying  Yang</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a therapeutic strategy for inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113264. <a href="https://doi.org/10.1016/j.ejmech.2021.113264" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113264%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252Binflammatory%252Bdiseases%26aulast%3DLiu%26aufirst%3DYang%26date%3D2021%26volume%3D214%26spage%3D113264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Xin-hua  Lu</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Li-Peng  Li</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing-Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the dynamic mechanism of allosteric drug SHP099 inhibiting SHP2E69K. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>24 </em><a href="https://doi.org/10.1007/s11030-020-10179-y" title="DOI URL">https://doi.org/10.1007/s11030-020-10179-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10179-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10179-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DExploring%252Bthe%252Bdynamic%252Bmechanism%252Bof%252Ballosteric%252Bdrug%252BSHP099%252Binhibiting%252BSHP2E69K%26aulast%3DDu%26aufirst%3DShan%26date%3D2021%26date%3D2021%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhendong  Song</span>, <span class="hlFld-ContribAuthor ">Meijing  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Ge</span>, <span class="hlFld-ContribAuthor ">Xue-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Ziyang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 13-29. <a href="https://doi.org/10.1016/j.apsb.2020.07.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.07.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.07.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Bin%252Btumor-targeted%252Btherapies%26aulast%3DSong%26aufirst%3DZhendong%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D13%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">祥东  孟</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Evaluation of Aminobenzoic Acid Derivatives against SHP2. </span><span class="cited-content_cbyCitation_journal-name">Hans Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>09 </em>
                                    (02)
                                     , 87-93. <a href="https://doi.org/10.12677/HJMCe.2021.92011" title="DOI URL">https://doi.org/10.12677/HJMCe.2021.92011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/HJMCe.2021.92011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FHJMCe.2021.92011%26sid%3Dliteratum%253Aachs%26jtitle%3DHans%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiological%252BEvaluation%252Bof%252BAminobenzoic%252BAcid%252BDerivatives%252Bagainst%252BSHP2%26aulast%3D%25E5%25AD%259F%26aufirst%3D%25E7%25A5%25A5%25E4%25B8%259C%26date%3D2021%26volume%3D09%26issue%3D02%26spage%3D87%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youqi  Tao</span>, <span class="hlFld-ContribAuthor ">Jingfei  Xie</span>, <span class="hlFld-ContribAuthor ">Qinglu  Zhong</span>, <span class="hlFld-ContribAuthor ">Yongyao  Wang</span>, <span class="hlFld-ContribAuthor ">Shengnan  Zhang</span>, <span class="hlFld-ContribAuthor ">Feng  Luo</span>, <span class="hlFld-ContribAuthor ">Fengcai  Wen</span>, <span class="hlFld-ContribAuthor ">Jingjing  Xie</span>, <span class="hlFld-ContribAuthor ">Jiawei  Zhao</span>, <span class="hlFld-ContribAuthor ">Xiaoou  Sun</span>, <span class="hlFld-ContribAuthor ">Houfang  Long</span>, <span class="hlFld-ContribAuthor ">Junfeng  Ma</span>, <span class="hlFld-ContribAuthor ">Qian  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiangang  Long</span>, <span class="hlFld-ContribAuthor ">Xianyang  Fang</span>, <span class="hlFld-ContribAuthor ">Ying  Lu</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Ming  Li</span>, <span class="hlFld-ContribAuthor ">Jidong  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Sun</span>, <span class="hlFld-ContribAuthor ">Guohui  Li</span>, <span class="hlFld-ContribAuthor ">Jiajie  Diao</span>, <span class="hlFld-ContribAuthor ">Cong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">A novel partially open state of SHP2 points to a “multiple gear” regulation mechanism. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2021,</strong> <em>296 </em>, 100538. <a href="https://doi.org/10.1016/j.jbc.2021.100538" title="DOI URL">https://doi.org/10.1016/j.jbc.2021.100538</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jbc.2021.100538&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jbc.2021.100538%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DA%252Bnovel%252Bpartially%252Bopen%252Bstate%252Bof%252BSHP2%252Bpoints%252Bto%252Ba%252B%2525E2%252580%25259Cmultiple%252Bgear%2525E2%252580%25259D%252Bregulation%252Bmechanism%26aulast%3DTao%26aufirst%3DYouqi%26date%3D2021%26volume%3D296%26spage%3D100538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjie  Guo</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacological Sciences</span><span> <strong>2020,</strong> <em>144 </em>
                                    (3)
                                     , 139-146. <a href="https://doi.org/10.1016/j.jphs.2020.06.002" title="DOI URL">https://doi.org/10.1016/j.jphs.2020.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphs.2020.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphs.2020.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacological%2520Sciences%26atitle%3DPhosphatase-independent%252Bfunctions%252Bof%252BSHP2%252Band%252Bits%252Bregulation%252Bby%252Bsmall%252Bmolecule%252Bcompounds%26aulast%3DGuo%26aufirst%3DWenjie%26date%3D2020%26volume%3D144%26issue%3D3%26spage%3D139%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Tang</span>, <span class="hlFld-ContribAuthor ">Yao-Nan  Jia</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112657. <a href="https://doi.org/10.1016/j.ejmech.2020.112657" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112657%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Band%252BPROTAC%252Bdegraders%26aulast%3DTang%26aufirst%3DKai%26date%3D2020%26volume%3D204%26spage%3D112657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">EeeLN H.  Buckarma</span>, <span class="hlFld-ContribAuthor ">Nathan W.  Werneburg</span>, <span class="hlFld-ContribAuthor ">Caitlin B.  Conboy</span>, <span class="hlFld-ContribAuthor ">Ayano  Kabashima</span>, <span class="hlFld-ContribAuthor ">Daniel R.  O'Brien</span>, <span class="hlFld-ContribAuthor ">Chen  Wang</span>, <span class="hlFld-ContribAuthor ">Sumera  Rizvi</span>, <span class="hlFld-ContribAuthor ">Rory L.  Smoot</span>. </span><span class="cited-content_cbyCitation_article-title">The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2020,</strong> <em>18 </em>
                                    (10)
                                     , 1574-1588. <a href="https://doi.org/10.1158/1541-7786.MCR-20-0165" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-20-0165</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-20-0165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-20-0165%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DThe%252BYAP-Interacting%252BPhosphatase%252BSHP2%252BCan%252BRegulate%252BTranscriptional%252BCoactivity%252Band%252BModulate%252BSensitivity%252Bto%252BChemotherapy%252Bin%252BCholangiocarcinoma%26aulast%3DBuckarma%26aufirst%3DEeeLN%2BH.%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D10%26spage%3D1574%26epage%3D1588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sahar  Sarmasti Emami</span>, <span class="hlFld-ContribAuthor ">Derek  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Interaction of the Hippo Pathway and Phosphatases in Tumorigenesis. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (9)
                                     , 2438. <a href="https://doi.org/10.3390/cancers12092438" title="DOI URL">https://doi.org/10.3390/cancers12092438</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12092438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12092438%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DInteraction%252Bof%252Bthe%252BHippo%252BPathway%252Band%252BPhosphatases%252Bin%252BTumorigenesis%26aulast%3DSarmasti%2BEmami%26aufirst%3DSahar%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D9%26spage%3D2438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajendran  Satheeshkumar</span>, <span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Feng</span>, <span class="hlFld-ContribAuthor ">Chao  Huang</span>, <span class="hlFld-ContribAuthor ">Ya  Gao</span>, <span class="hlFld-ContribAuthor ">Li-Xin  Gao</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Ting-Jun  Hou</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yun-Long  Zhu</span>, <span class="hlFld-ContribAuthor ">Yu-Bo  Zhou</span>, <span class="hlFld-ContribAuthor ">Wen-Long  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of heterocyclic bis-aryl amides as novel Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (11)
                                     , 127170. <a href="https://doi.org/10.1016/j.bmcl.2020.127170" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127170%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bheterocyclic%252Bbis-aryl%252Bamides%252Bas%252Bnovel%252BSrc%252Bhomology%252B2%252Bdomain%252Bcontaining%252Bprotein%252Btyrosine%252Bphosphatase-2%252B%252528SHP2%252529%252Binhibitors%26aulast%3DSatheeshkumar%26aufirst%3DRajendran%26date%3D2020%26volume%3D30%26issue%3D11%26spage%3D127170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marjorie  Bruder</span>, <span class="hlFld-ContribAuthor ">Gina  Polo</span>, <span class="hlFld-ContribAuthor ">Daniela B. B.  Trivella</span>. </span><span class="cited-content_cbyCitation_article-title">Natural allosteric modulators and their biological targets: molecular signatures and mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2020,</strong> <em>37 </em>
                                    (4)
                                     , 488-514. <a href="https://doi.org/10.1039/C9NP00064J" title="DOI URL">https://doi.org/10.1039/C9NP00064J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NP00064J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NP00064J%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DNatural%252Ballosteric%252Bmodulators%252Band%252Btheir%252Bbiological%252Btargets%25253A%252Bmolecular%252Bsignatures%252Band%252Bmechanisms%26aulast%3DBruder%26aufirst%3DMarjorie%26date%3D2020%26date%3D2020%26volume%3D37%26issue%3D4%26spage%3D488%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui-Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the acting mode and advantages of RMC-4550 as an Src-homology 2 domain-containing protein tyrosine phosphatase (SHP2) inhibitor at molecular level through molecular docking and molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (5)
                                     , 1525-1538. <a href="https://doi.org/10.1080/07391102.2019.1613266" title="DOI URL">https://doi.org/10.1080/07391102.2019.1613266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1613266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1613266%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DProbing%252Bthe%252Bacting%252Bmode%252Band%252Badvantages%252Bof%252BRMC-4550%252Bas%252Ban%252BSrc-homology%252B2%252Bdomain-containing%252Bprotein%252Btyrosine%252Bphosphatase%252B%252528SHP2%252529%252Binhibitor%252Bat%252Bmolecular%252Blevel%252Bthrough%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%26aulast%3DWang%26aufirst%3DRui-Rui%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D5%26spage%3D1525%26epage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dadong  Shen</span>, <span class="hlFld-ContribAuthor ">Wenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guofeng  Wu</span>, <span class="hlFld-ContribAuthor ">Runpu  Shen</span>, <span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of targeting SHP2 in human developmental disorders and cancers. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112117. <a href="https://doi.org/10.1016/j.ejmech.2020.112117" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112117%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bpotential%252Bof%252Btargeting%252BSHP2%252Bin%252Bhuman%252Bdevelopmental%252Bdisorders%252Band%252Bcancers%26aulast%3DShen%26aufirst%3DDadong%26date%3D2020%26volume%3D190%26spage%3D112117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianqian  Liu</span>, <span class="hlFld-ContribAuthor ">Jiao  Qu</span>, <span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a promising strategy for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>152 </em>, 104595. <a href="https://doi.org/10.1016/j.phrs.2019.104595" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104595%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Bpromising%252Bstrategy%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DLiu%26aufirst%3DQianqian%26date%3D2020%26volume%3D152%26spage%3D104595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zi-Juan  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Teng  Chen</span>, <span class="hlFld-ContribAuthor ">Chang  He</span>, <span class="hlFld-ContribAuthor ">Hao-Fan  Luo</span>, <span class="hlFld-ContribAuthor ">Guo-Lin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong-Ping  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Cascade reactions to 2,4-disubstituted thiazoles via ligand-free palladium(II)-catalyzed C(sp)–C(sp2) coupling. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2020,</strong> <em>76 </em>
                                    (9)
                                     , 130953. <a href="https://doi.org/10.1016/j.tet.2020.130953" title="DOI URL">https://doi.org/10.1016/j.tet.2020.130953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2020.130953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2020.130953%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DCascade%252Breactions%252Bto%252B2%25252C4-disubstituted%252Bthiazoles%252Bvia%252Bligand-free%252Bpalladium%252528II%252529-catalyzed%252BC%252528sp%252529%2525E2%252580%252593C%252528sp2%252529%252Bcoupling%26aulast%3DWang%26aufirst%3DZi-Juan%26date%3D2020%26volume%3D76%26issue%3D9%26spage%3D130953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">勃  冯</span>. </span><span class="cited-content_cbyCitation_article-title">Biological Evaluation of Benzo[c]heterocyclic Compounds against SHP2. </span><span class="cited-content_cbyCitation_journal-name">Hans Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>08 </em>
                                    (03)
                                     , 79-83. <a href="https://doi.org/10.12677/HJMCe.2020.83009" title="DOI URL">https://doi.org/10.12677/HJMCe.2020.83009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12677/HJMCe.2020.83009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12677%2FHJMCe.2020.83009%26sid%3Dliteratum%253Aachs%26jtitle%3DHans%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBiological%252BEvaluation%252Bof%252BBenzo%25255Bc%25255Dheterocyclic%252BCompounds%252Bagainst%252BSHP2%26aulast%3D%25E5%2586%25AF%26aufirst%3D%25E5%258B%2583%26date%3D2020%26volume%3D08%26issue%3D03%26spage%3D79%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sitaram</span>, <span class="hlFld-ContribAuthor ">Uyemura</span>, <span class="hlFld-ContribAuthor ">Malarkannan</span>, <span class="hlFld-ContribAuthor ">Riese</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond the Cell Surface: Targeting Intracellular Negative Regulators to Enhance T cell Anti-Tumor Activity. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (23)
                                     , 5821. <a href="https://doi.org/10.3390/ijms20235821" title="DOI URL">https://doi.org/10.3390/ijms20235821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20235821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20235821%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DBeyond%252Bthe%252BCell%252BSurface%25253A%252BTargeting%252BIntracellular%252BNegative%252BRegulators%252Bto%252BEnhance%252BT%252Bcell%252BAnti-Tumor%252BActivity%26aulast%3DSitaram%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D23%26spage%3D5821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panagiotis  Parsonidis</span>, <span class="hlFld-ContribAuthor ">Mahammad  Shaik</span>, <span class="hlFld-ContribAuthor ">Athanasia Panagiota  Serafeim</span>, <span class="hlFld-ContribAuthor ">Ioanna  Vlachou</span>, <span class="hlFld-ContribAuthor ">Vasiliki  Daikopoulou</span>, <span class="hlFld-ContribAuthor ">Ioannis  Papasotiriou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Activity of Pyrazine Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (23)
                                     , 4389. <a href="https://doi.org/10.3390/molecules24234389" title="DOI URL">https://doi.org/10.3390/molecules24234389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24234389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24234389%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BActivity%252Bof%252BPyrazine%252BCompounds%26aulast%3DParsonidis%26aufirst%3DPanagiotis%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D23%26spage%3D4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Lin</span>, <span class="hlFld-ContribAuthor ">Yuwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Huiyuan  Yu</span>, <span class="hlFld-ContribAuthor ">Ruonan  Tian</span>, <span class="hlFld-ContribAuthor ">Guoqing  Wang</span>, <span class="hlFld-ContribAuthor ">Fan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of unique key genes and miRNAs in latent tuberculosis infection by network analysis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Immunology</span><span> <strong>2019,</strong> <em>112 </em>, 103-114. <a href="https://doi.org/10.1016/j.molimm.2019.04.032" title="DOI URL">https://doi.org/10.1016/j.molimm.2019.04.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molimm.2019.04.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molimm.2019.04.032%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Immunology%26atitle%3DIdentification%252Bof%252Bunique%252Bkey%252Bgenes%252Band%252BmiRNAs%252Bin%252Blatent%252Btuberculosis%252Binfection%252Bby%252Bnetwork%252Banalysis%26aulast%3DLin%26aufirst%3DYan%26date%3D2019%26volume%3D112%26spage%3D103%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Han-Qing  Wu</span>, <span class="hlFld-ContribAuthor ">Kai  Yang</span>, <span class="hlFld-ContribAuthor ">Shi-He  Luo</span>, <span class="hlFld-ContribAuthor ">Xin-Yan  Wu</span>, <span class="hlFld-ContribAuthor ">Neng  Wang</span>, <span class="hlFld-ContribAuthor ">Si-Hong  Chen</span>, <span class="hlFld-ContribAuthor ">Zhao-Yang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">C4-Selective Synthesis of Vinyl Thiocyanates and Selenocyanates Through 3,4-Dihalo-2(5
              H
              )-furanones. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (28)
                                     , 4572-4580. <a href="https://doi.org/10.1002/ejoc.201900749" title="DOI URL">https://doi.org/10.1002/ejoc.201900749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201900749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201900749%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DC4-Selective%252BSynthesis%252Bof%252BVinyl%252BThiocyanates%252Band%252BSelenocyanates%252BThrough%252B3%25252C4-Dihalo-2%2525285%252BH%252B%252529-furanones%26aulast%3DWu%26aufirst%3DHan-Qing%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D28%26spage%3D4572%26epage%3D4580" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Na  Li</span>, <span class="hlFld-ContribAuthor ">Xianquan  Zhan</span>. </span><span class="cited-content_cbyCitation_article-title">Signaling pathway network alterations in human ovarian cancers identified with quantitative mitochondrial proteomics. </span><span class="cited-content_cbyCitation_journal-name">EPMA Journal</span><span> <strong>2019,</strong> <em>10 </em>
                                    (2)
                                     , 153-172. <a href="https://doi.org/10.1007/s13167-019-00170-5" title="DOI URL">https://doi.org/10.1007/s13167-019-00170-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13167-019-00170-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13167-019-00170-5%26sid%3Dliteratum%253Aachs%26jtitle%3DEPMA%2520Journal%26atitle%3DSignaling%252Bpathway%252Bnetwork%252Balterations%252Bin%252Bhuman%252Bovarian%252Bcancers%252Bidentified%252Bwith%252Bquantitative%252Bmitochondrial%252Bproteomics%26aulast%3DLi%26aufirst%3DNa%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D2%26spage%3D153%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolkarim  Farrokhzadeh</span>, <span class="hlFld-ContribAuthor ">Farideh Badichi  Akher</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the Dynamic Mechanism of Uncommon Allosteric Inhibitors Optimized to Enhance Drug Selectivity of SHP2 with Therapeutic Potential for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Applied Biochemistry and Biotechnology</span><span> <strong>2019,</strong> <em>188 </em>
                                    (1)
                                     , 260-281. <a href="https://doi.org/10.1007/s12010-018-2914-0" title="DOI URL">https://doi.org/10.1007/s12010-018-2914-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12010-018-2914-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12010-018-2914-0%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Biochemistry%2520and%2520Biotechnology%26atitle%3DProbing%252Bthe%252BDynamic%252BMechanism%252Bof%252BUncommon%252BAllosteric%252BInhibitors%252BOptimized%252Bto%252BEnhance%252BDrug%252BSelectivity%252Bof%252BSHP2%252Bwith%252BTherapeutic%252BPotential%252Bfor%252BCancer%252BTreatment%26aulast%3DFarrokhzadeh%26aufirst%3DAbdolkarim%26date%3D2019%26date%3D2018%26volume%3D188%26issue%3D1%26spage%3D260%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Kun  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhen  Han</span>, <span class="hlFld-ContribAuthor ">Zhijian  Ding</span>, <span class="hlFld-ContribAuthor ">Mingwei  Lv</span>, <span class="hlFld-ContribAuthor ">Pan  Wang</span>, <span class="hlFld-ContribAuthor ">Quanhong  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaobing  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evolution of S-Porphin sodium as a potential antitumor agent for photodynamic therapy against breast cancer. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2019,</strong> <em>6 </em>
                                    (3)
                                     , 362-372. <a href="https://doi.org/10.1039/C8QO00959G" title="DOI URL">https://doi.org/10.1039/C8QO00959G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8QO00959G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8QO00959G%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DSynthesis%252Band%252Bevolution%252Bof%252BS-Porphin%252Bsodium%252Bas%252Ba%252Bpotential%252Bantitumor%252Bagent%252Bfor%252Bphotodynamic%252Btherapy%252Bagainst%252Bbreast%252Bcancer%26aulast%3DWang%26aufirst%3DXiao%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D3%26spage%3D362%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">X  Sun</span>, <span class="hlFld-ContribAuthor ">Y  Ren</span>, <span class="hlFld-ContribAuthor ">S  Gunawan</span>, <span class="hlFld-ContribAuthor ">P  Teng</span>, <span class="hlFld-ContribAuthor ">Z  Chen</span>, <span class="hlFld-ContribAuthor ">HR  Lawrence</span>, <span class="hlFld-ContribAuthor ">J  Cai</span>, <span class="hlFld-ContribAuthor ">NJ  Lawrence</span>, <span class="hlFld-ContribAuthor ">J  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2018,</strong> <em>32 </em>
                                    (5)
                                     , 1246-1249. <a href="https://doi.org/10.1038/s41375-018-0020-5" title="DOI URL">https://doi.org/10.1038/s41375-018-0020-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-018-0020-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-018-0020-5%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DSelective%252Binhibition%252Bof%252Bleukemia-associated%252BSHP2E69K%252Bmutant%252Bby%252Bthe%252Ballosteric%252BSHP2%252Binhibitor%252BSHP099%26aulast%3DSun%26aufirst%3DX%26date%3D2018%26date%3D2018%26volume%3D32%26issue%3D5%26spage%3D1246%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wiljan  Hendriks</span>, <span class="hlFld-ContribAuthor ">Annika  Bourgonje</span>, <span class="hlFld-ContribAuthor ">William  Leenders</span>, <span class="hlFld-ContribAuthor ">Rafael  Pulido</span>. </span><span class="cited-content_cbyCitation_article-title">Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (2)
                                     , 395. <a href="https://doi.org/10.3390/molecules23020395" title="DOI URL">https://doi.org/10.3390/molecules23020395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23020395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23020395%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DProteinaceous%252BRegulators%252Band%252BInhibitors%252Bof%252BProtein%252BTyrosine%252BPhosphatases%26aulast%3DHendriks%26aufirst%3DWiljan%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D2%26spage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative known SHP2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Identification of SHP2 inhibitors through SHP2E76A biochemical screening. (A) Catalytic activity of purified SHP2E76A, SHP2WT, and SHP2C459S. Phosphatase assays were conducted using the artificial substrate DIFMUP, and data represents mean ± SD (<i>n</i> = 3). (B) Structure of <b>9</b>. (C) Compound <b>9</b> inhibited SHP2E76A with moderate potency (a) but had no effect on SHP2PTP (b). Data represents mean ± SD (<i>n</i> = 3). (D) Structures and IC<sub>50</sub>s of <b>10</b>, <b>11</b>, and <b>12</b>. Each IC<sub>50</sub> is the mean of at least three determinations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Structure of SHP2E76A in complex with <b>10</b> and a working model of allosteric inhibition of SHP2 E76A by <b>10</b>. (A) Interaction between E76 and S502 in the structure of SHP2WT (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>) in pale green, which is absent in the structure of SHP2E76A (purple). (B) Compound <b>10</b> settles in the central pocket formed by three domains as shown in the surface representation. (C) Complex structure of SHP2E76A and <b>10</b> (N-SH2 in light blue; PTP in brown; C-SH2 in cyan). The allosteric inhibitor <b>10</b> is in magenta. (D) Proposed model of conformational changes of SHP2E76A upon substrate binding and allosteric inhibition.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9</b>–<b>19</b>, <b>23</b>, and <b>24</b><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) KSCN, EtOH, 85 °C, 2 h, 82–99%; (b) 30% HBr, AcOH, r.t., overnight, 78–90%; (c) NHR1R2, <i>t</i>-BuONa, Xantphos, Pd<sub>2</sub>(dba)<sub>3</sub>, toluene, 120 °C, 2.5–16 h, 32–52%; (d) TFA, DCM, r.t., 2 h, 91%; (e) Zn(CN)<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, DMF, 130 °C, 8 h, 31%.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>20</b>–<b>22</b> and <b>25</b>–<b>35</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TEA, DMF, 90 °C, 8 h, 87%; (b) Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, THF:H<sub>2</sub>O, 80 °C, 16 h, 53–78%; (c) TFA, DCM, r.t., 1–5 h, 85–96%; (d) KOH, 1,4-dioxane:H<sub>2</sub>O, 70 °C, 1 h, 86%; (e) LiAlH<sub>4</sub>, THF, r.t., 3 h, 76%.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Compound <b>23</b> suppresses RAS-MAPK signaling pathway. (A) Western blot of p-ERK1/2, ERK1/2, p-AKT, and AKT from NCI-H661 cells treated with DMSO or indicated concentrations of <b>23</b> for 2 h. Compound <b>34</b> served as a negative control. (B) Western blot of p-ERK1/2, ERK1/2, p-AKT, and AKT from NCI-H661 cells treated with DMSO or 10 μM <b>23</b> at different time points. (C) NCI-H1975 cells treated with DMSO or 10 μM <b>23</b> were stained with p-ERK1/2 antibody and DAPI. The scale bars represent 50 μm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Compound <b>23</b> antagonizes YAP transcriptional activity and promotes phosphorylated Y357 of YAP. (A) Interaction of SHP2 and YAP. Flag-YAP and HA-SHP2 were cotransfected into HEK293T cells. YAP and SHP2 interaction was examined by reciprocal coimmunoprecipitation as indicated. (B) SF268 cells stably expressing a YAP-dependent luciferase reporter were treated with indicated concentrations of <b>23</b>. Compound <b>34</b> served as a negative control. Normalized Luciferase = Renilla luciferase/CellTiter-Glo. Error bars show mean ±SD (<i>n</i> = 3); *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ns = not significant. (C) qPCR analysis of CTGF, CYR61, ANKRD1, and YAP mRNA levels in SF268 cells treated with DMSO and <b>23</b> for 2 h. Error bars show mean ± SD (<i>n</i> = 3); *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001, ns = not significant. (D) SF268 cells were treated with DMSO or <b>23</b> at indicated concentrations for 2 h. The immunoprecipitates with anti-YAP antibody were analyzed by immunoblotting using pY-100 phosphotyrosine antibody. YAP harbors only one tyrosine residue in motif YXXP (tyrosine 357), which can be examined by pY-100 phosphotyrosine antibody. (E) Western blot of indicated proteins from A549 cells treated with DMSO or <b>23</b> for 2 h. (F) In vitro dephosphorylation experiments were performed to examine the putative substrate of SHP2 using 357Y peptide (SGLSMSSYSVPRTPD), phosphorylated 357Y peptide (SGLSMSSpYSVPRTPD) of YAP, and purified SHP2E76A protein. Dot blot results of indicated treatments were analyzed by p-YAP(Y357) antibody. pY357 peptide (100 μM) was incubated with 0.5 nM SHP2E76A (+) and 1.5 nM SHP2E76A (++) for 15 min, and 20 μM <b>23</b> was pretreated with 1.5 nM SHP2E76A (++) for 15 min before the peptide was added.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/medium/jm-2017-01520j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>23</b> inhibits cancer cell proliferation in vitro and tumor growth in vivo. (A) Panel of cancer cell lines was treated with <b>23</b> for 48 h. Cell survival was measured by CellTiter-Glo. Data represent mean ± SD (<i>n</i> = 3). (B) NCI-H1975 cells treated with <b>23</b> at indicated concentrations were subjected to a soft agar assay. The number of colonies is shown in the graph. Error bars show mean ± SD (<i>n</i> = 3); ***<i>p</i> < 0.001. (C) Efficacy study of <b>23</b> on MV4;11 xenograft tumor. Tumor volume was assessed by a caliper in two dimensions for mice treated with vehicle and <b>23</b> (10 or 30 mg/kg, po, qd) twice weekly. Data represents mean ± SEM. (inset) Body weights of mice bearing MV4;11 xenografts. Body weight was measured twice a week for mice treated with vehicle and <b>23</b> (10 or 30 mg/kg po, qd). Data represents mean ± SEM. (D) Statistical significance of the antitumor effect on day 14. Data represents mean ± SEM; *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-24/acs.jmedchem.7b01520/20171221/images/large/jm-2017-01520j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01520&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i72">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Tonks, N. K.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: from genes, to function, to disease</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">833</span><span class="NLM_x">–</span> <span class="NLM_lpage">846</span><span class="refDoi"> DOI: 10.1038/nrm2039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnrm2039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=17057753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=833-846&author=N.+K.+Tonks&title=Protein+tyrosine+phosphatases%3A+from+genes%2C+to+function%2C+to+disease&doi=10.1038%2Fnrm2039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: from genes, to function, to disease</span></div><div class="casAuthors">Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">833-846</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatase (PTP) superfamily of enzymes functions in a coordinated manner with protein tyrosine kinases to control signalling pathways that underlie a broad spectrum of fundamental physiol. processes.  In this review, I describe recent breakthroughs in our understanding of the role of the PTPs in the regulation of signal transduction and the etiol. of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5NdnwoKCC1bVg90H21EOLACvtfcHk0lgoME6VL2dkeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSms77I&md5=20a078267093bb8415d9035a13b8ad17</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnrm2039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm2039%26sid%3Dliteratum%253Aachs%26aulast%3DTonks%26aufirst%3DN.%2BK.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520from%2520genes%252C%2520to%2520function%252C%2520to%2520disease%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2006%26volume%3D7%26spage%3D833%26epage%3D846%26doi%3D10.1038%2Fnrm2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">van Huijsduijnen, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bombrun, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinnen, D.</span><span> </span><span class="NLM_article-title">Selecting protein tyrosine phosphatases as drug targets</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1019</span><span class="refDoi"> DOI: 10.1016/S1359-6446(02)02438-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2FS1359-6446%2802%2902438-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=12546919" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2002&pages=1013-1019&author=R.+H.+van+Huijsduijnenauthor=A.+Bombrunauthor=D.+Swinnen&title=Selecting+protein+tyrosine+phosphatases+as+drug+targets&doi=10.1016%2FS1359-6446%2802%2902438-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2802%2902438-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252802%252902438-8%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BHuijsduijnen%26aufirst%3DR.%2BH.%26aulast%3DBombrun%26aufirst%3DA.%26aulast%3DSwinnen%26aufirst%3DD.%26atitle%3DSelecting%2520protein%2520tyrosine%2520phosphatases%2520as%2520drug%2520targets%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2002%26volume%3D7%26spage%3D1013%26epage%3D1019%26doi%3D10.1016%2FS1359-6446%2802%2902438-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixon, J. E.</span><span> </span><span class="NLM_article-title">Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases ☆</span> <span class="citation_source-journal">Semin. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span><span class="refDoi"> DOI: 10.1006/smim.2000.0209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1006%2Fsmim.2000.0209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10723800" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhvFartrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=75-84&author=L.+Liauthor=J.+E.+Dixon&title=Form%2C+function%2C+and+regulation+of+protein+tyrosine+phosphatases+and+their+involvement+in+human+diseases+%E2%98%86&doi=10.1006%2Fsmim.2000.0209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Form, function, and regulation of protein tyrosine phosphatases and their involvement in human diseases</span></div><div class="casAuthors">Li, Liwu; Dixon, Jack E.</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">75-84</span>CODEN:
                <span class="NLM_cas:coden">SEIME2</span>;
        ISSN:<span class="NLM_cas:issn">1044-5323</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 64 refs.  Protein tyrosine phosphatases (PTPs) are a family of enzymes that modulate the cellular level of tyrosine phosphorylation.  Based on cellular location, they are classified as receptor-like or intracellular PTPs.  Structure and function studies have led to the understanding of the enzymic mechanism of this class of enzymes.  Proper targeting of PTPs is essential for many cellular signaling events including antigen induced proliferative responses of B and T cells.  The physiol. significance of PTPs is further unveiled through mice gene knockout studies and human genome sequencing and mapping projects.  Several PTPs are shown to be crit. in the pathogenesis of human diseases.  (c) 2000 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBF9VyRAs7F7Vg90H21EOLACvtfcHk0lgoME6VL2dkeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhvFartrY%253D&md5=684ff470facfd38cb1c0d8736ec0c135</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1006%2Fsmim.2000.0209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fsmim.2000.0209%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DDixon%26aufirst%3DJ.%2BE.%26atitle%3DForm%252C%2520function%252C%2520and%2520regulation%2520of%2520protein%2520tyrosine%2520phosphatases%2520and%2520their%2520involvement%2520in%2520human%2520diseases%2520%25E2%2598%2586%26jtitle%3DSemin.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D75%26epage%3D84%26doi%3D10.1006%2Fsmim.2000.0209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatases: prospects for therapeutics</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">416</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span><span class="refDoi"> DOI: 10.1016/S1367-5931(00)00223-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2FS1367-5931%2800%2900223-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=11470605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltlyqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2001&pages=416-423&author=Z.+Y.+Zhang&title=Protein+tyrosine+phosphatases%3A+prospects+for+therapeutics&doi=10.1016%2FS1367-5931%2800%2900223-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatases: prospects for therapeutics</span></div><div class="casAuthors">Zhang, Z.-Y.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">416-423</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review, with refs.  Protein tyrosine phosphatases (PTPs) form a large family of enzymes that serve as key regulatory components in signal transduction pathways.  Recent gene knockout studies in mice identify PTP1B as a promising target for anti-diabetes/obesity drug discovery.  PTPs are also implicated in a wide variety of other disorders, including cancer.  Significant progress has been made in identifying small mols. that simultaneously bind both the active site and a unique adjacent site that enables specific inhibition of individual PTP isoenzymes.  As a consequence, there are compelling reasons to believe that PTP inhibitors may ultimately serve as powerful therapeutic weapons in the authors' arsenal for battling human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgujWWYVWfjbVg90H21EOLACvtfcHk0lgoME6VL2dkeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltlyqsLs%253D&md5=eee42d18a57b314321cffca4e3892ac1</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS1367-5931%2800%2900223-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1367-5931%252800%252900223-4%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DProtein%2520tyrosine%2520phosphatases%253A%2520prospects%2520for%2520therapeutics%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2001%26volume%3D5%26spage%3D416%26epage%3D423%26doi%3D10.1016%2FS1367-5931%2800%2900223-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bialy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Inhibitors of protein tyrosine phosphatases: next-generation drugs?</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">3814</span><span class="NLM_x">–</span> <span class="NLM_lpage">3839</span><span class="refDoi"> DOI: 10.1002/anie.200461517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1002%2Fanie.200461517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFGisr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2005&pages=3814-3839&author=L.+Bialyauthor=H.+Waldmann&title=Inhibitors+of+protein+tyrosine+phosphatases%3A+next-generation+drugs%3F&doi=10.1002%2Fanie.200461517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of protein tyrosine phosphatases: Next-generation drugs?</span></div><div class="casAuthors">Bialy, Laurent; Waldmann, Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3814-3839</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The protein tyrosine phosphatases (PTPs) constitute a family of closely related key regulatory enzymes that dephosphorylate phosphotyrosine residues in their protein substrates.  Malfunctions in PTP activity are linked to various diseases, ranging from cancer to neurol. disorders and diabetes.  Consequently, PTPs have emerged as promising targets for therapeutic intervention in recent years.  In this review, general aspects of PTPs and the development of small-mol. inhibitors of PTPs by both academic research groups and pharmaceutical companies are discussed.  Different strategies have been successfully applied to identify potent and selective inhibitors.  These studies constitute the basis for the future development of PTP inhibitors as drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9K3DIu_xX_LVg90H21EOLACvtfcHk0ljc0OySB73yiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFGisr8%253D&md5=a8bcd03851b638cc6d3e6ab2466eb97b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fanie.200461517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200461517%26sid%3Dliteratum%253Aachs%26aulast%3DBialy%26aufirst%3DL.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DInhibitors%2520of%2520protein%2520tyrosine%2520phosphatases%253A%2520next-generation%2520drugs%253F%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2005%26volume%3D44%26spage%3D3814%26epage%3D3839%26doi%3D10.1002%2Fanie.200461517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mohi, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The role of Shp2 (PTPN11) in cancer</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span><span class="refDoi"> DOI: 10.1016/j.gde.2006.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2Fj.gde.2006.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=17227708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslOgtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=23-30&author=M.+G.+Mohiauthor=B.+G.+Neel&title=The+role+of+Shp2+%28PTPN11%29+in+cancer&doi=10.1016%2Fj.gde.2006.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Mohi, M. Golam; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Genetics & Development</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-30</span>CODEN:
                <span class="NLM_cas:coden">COGDET</span>;
        ISSN:<span class="NLM_cas:issn">0959-437X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs), regulates numerous cellular processes.  Altered expression and/or mutations in PTKs are linked to many forms of cancer, yet until recently little was known about the roles of PTPs in normal cells or in cancer.  Earlier work established that a member of the PTP superfamily, PTEN, is an important tumor suppressor gene.  We now know that at least one other PTP, the SH2 domain-contg. phosphatase Shp2, is a bona fide oncogene that is mutated in several types of leukemia and hyperactivated by other mechanisms in some solid tumors.  Understanding how Shp2 and other PTPs contribute to oncogenesis should provide new insights into pathogenesis and might suggest new targets for anti-neoplastic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJ0V_cNPfFwLVg90H21EOLACvtfcHk0ljc0OySB73yiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslOgtQ%253D%253D&md5=a571192d3fffdff69ddfc264bb9108ce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2006.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2006.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DMohi%26aufirst%3DM.%2BG.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520role%2520of%2520Shp2%2520%2528PTPN11%2529%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2007%26volume%3D17%26spage%3D23%26epage%3D30%26doi%3D10.1016%2Fj.gde.2006.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G. S.</span><span> </span><span class="NLM_article-title">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.1182/blood-2006-07-028829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1182%2Fblood-2006-07-028829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=17053061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+first+identified+proto-oncogene+that+encodes+a+tyrosine+phosphatase&doi=10.1182%2Fblood-2006-07-028829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span></div><div class="casAuthors">Chan, Rebecca J.; Feng, Gen-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-867</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Elucidation of the mol. mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes.  One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homol. 2 (SH2) domains (Shp2).  This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis.  More recently, somatic missense PTPN11 gain-of-function mutations were detected in leukemias and rarely in solid tumors, and were found to induce aberrant hyperactivation of the Ras-Erk pathway.  This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the mol. mechanisms underlying cell transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqsuOora-d37Vg90H21EOLACvtfcHk0ljc0OySB73yiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D&md5=8c5760a6ac385635f9794acbf5b64a03</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-028829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-028829%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520first%2520identified%2520proto-oncogene%2520that%2520encodes%2520a%2520tyrosine%2520phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867%26doi%3D10.1182%2Fblood-2006-07-028829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Matozaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okazawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohnishi, H.</span><span> </span><span class="NLM_article-title">Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">1786</span><span class="NLM_x">–</span> <span class="NLM_lpage">1793</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2009.01257.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1111%2Fj.1349-7006.2009.01257.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=19622105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht12qs7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2009&pages=1786-1793&author=T.+Matozakiauthor=Y.+Murataauthor=Y.+Saitoauthor=H.+Okazawaauthor=H.+Ohnishi&title=Protein+tyrosine+phosphatase+SHP-2%3A+a+proto-oncogene+product+that+promotes+Ras+activation&doi=10.1111%2Fj.1349-7006.2009.01257.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatase SHP-2: A protooncogene product that promotes Ras activation</span></div><div class="casAuthors">Matozaki, Takashi; Murata, Yoji; Saito, Yasuyuki; Okazawa, Hideki; Ohnishi, Hiroshi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1786-1793</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  SHP-2 is a cytoplasmic protein tyrosine phosphatase (PTP) that contains two Src homol. 2 (SH2) domains.  Although PTPs are generally considered to be neg. regulators on the basis of their ability to oppose the effects of protein tyrosine kinases, SHP-2 is unusual in that it promotes the activation of the Ras-MAPK signaling pathway by receptors for various growth factors and cytokines.  The mol. basis for the activation of SHP-2 is also unique: In the basal state, the NH2-terminal SH2 domain of SHP-2 interacts with the PTP domain, resulting in autoinhibition of PTP activity; the binding of SHP-2 via its SH2 domains to tyrosine-phosphorylated growth factor receptors or docking proteins, however, results in disruption of this intramol. interaction, leading to exposure of the PTP domain and catalytic activation.  Indeed, SHP-2 proteins with artificial mutations in the NH2-terminal SH2 domain have been shown to act as dominant active mutants in vitro.  Such activating mutations of PTPN11 (human SHP-2 gene) were subsequently identified in individuals with Noonan syndrome, a human developmental disorder that is sometimes assocd. with juvenile myelomonocytic leukemia.  Furthermore, somatic mutations of PTPN11 were found to be assocd. with pediatric leukemia.  SHP-2 is also thought to participate in the development of other malignant disorders, but in a manner independent of such activating mutations.  Biochem. and functional studies of SHP-2 and genetic anal. of PTPN11 in human disorders have thus converged to provide new insight into the pathogenesis of cancer as well as potential new targets for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqagV6o3osbrVg90H21EOLACvtfcHk0ljc0OySB73yiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht12qs7vI&md5=d4f294641af7b4283f0ed30ce0208bee</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2009.01257.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2009.01257.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatozaki%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DY.%26aulast%3DOkazawa%26aufirst%3DH.%26aulast%3DOhnishi%26aufirst%3DH.%26atitle%3DProtein%2520tyrosine%2520phosphatase%2520SHP-2%253A%2520a%2520proto-oncogene%2520product%2520that%2520promotes%2520Ras%2520activation%26jtitle%3DCancer%2520Sci.%26date%3D2009%26volume%3D100%26spage%3D1786%26epage%3D1793%26doi%3D10.1111%2Fj.1349-7006.2009.01257.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway</span> <span class="citation_source-journal">Nat. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">850</span><span class="NLM_x">–</span> <span class="NLM_lpage">858</span><span class="refDoi"> DOI: 10.1038/ncb867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fncb867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=12402043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVKmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2002&pages=850-858&author=H.+Hanafusaauthor=S.+Toriiauthor=T.+Yasunagaauthor=E.+Nishida&title=Sprouty1+and+Sprouty2+provide+a+control+mechanism+for+the+Ras%2FMAPK+signalling+pathway&doi=10.1038%2Fncb867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway</span></div><div class="casAuthors">Hanafusa, Hiroshi; Torii, Satoru; Yasunaga, Takayuki; Nishida, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">850-858</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Sprouty (Spry) inhibits signaling by receptor tyrosine kinases; however, the mol. mechanism underlying this function has not been defined.  Here we show that after stimulation by growth factors Spry1 and Spry2 translocate to the plasma membrane and become phosphorylated on a conserved tyrosine.  Next, they bind to the adaptor protein Grb2 and inhibit the recruitment of the Grb2-Sos complex either to the fibroblast growth factor receptor (FGFR) docking adaptor protein FRS2 or to Shp2.  Membrane translocation of Spry is necessary for its phosphorylation, which is essential for its inhibitor activity.  A tyrosine-phosphorylated octapeptide derived from mouse Spry2 inhibits Grb2 from binding FRS2, Shp2 or mouse Spry2 in vitro and blocks activation of the extracellular-signal-regulated kinase (ERK) in cells stimulated by growth factor.  A non-phosphorylated Spry mutant cannot bind Grb2 and acts as a dominant neg., inducing prolonged activation of ERK in response to FGF and promoting the FGF-induced outgrowth of neurites in PC12 cells.  Our findings suggest that Spry functions in a neg. feedback mechanism in which its inhibitor activity is controlled rapidly and reversibly by post-translational mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpLO_810Tlg7Vg90H21EOLACvtfcHk0lgm7yb_SOpvPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVKmsw%253D%253D&md5=3f496bfc4a46a3e86d6ea1b8b489c04b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fncb867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb867%26sid%3Dliteratum%253Aachs%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DTorii%26aufirst%3DS.%26aulast%3DYasunaga%26aufirst%3DT.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DSprouty1%2520and%2520Sprouty2%2520provide%2520a%2520control%2520mechanism%2520for%2520the%2520Ras%252FMAPK%2520signalling%2520pathway%26jtitle%3DNat.%2520Cell%2520Biol.%26date%3D2002%26volume%3D4%26spage%3D850%26epage%3D858%26doi%3D10.1038%2Fncb867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jove, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Roles of Gab1 and SHP2 in paxillin tyrosine dephosphorylation and Src activation in response to epidermal growth factor</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">8497</span><span class="NLM_x">–</span> <span class="NLM_lpage">8505</span><span class="refDoi"> DOI: 10.1074/jbc.M312575200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1074%2Fjbc.M312575200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=8497-8505&author=Y.+Renauthor=S.+Mengauthor=L.+Meiauthor=Z.+J.+Zhaoauthor=R.+Joveauthor=J.+Wu&title=Roles+of+Gab1+and+SHP2+in+paxillin+tyrosine+dephosphorylation+and+Src+activation+in+response+to+epidermal+growth+factor&doi=10.1074%2Fjbc.M312575200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312575200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312575200%26sid%3Dliteratum%253Aachs%26aulast%3DRen%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DS.%26aulast%3DMei%26aufirst%3DL.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26aulast%3DJove%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DRoles%2520of%2520Gab1%2520and%2520SHP2%2520in%2520paxillin%2520tyrosine%2520dephosphorylation%2520and%2520Src%2520activation%2520in%2520response%2520to%2520epidermal%2520growth%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D8497%26epage%3D8505%26doi%3D10.1074%2Fjbc.M312575200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Montagner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perret, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dance, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salles, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynal, P.</span><span> </span><span class="NLM_article-title">A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">5350</span><span class="NLM_x">–</span> <span class="NLM_lpage">5360</span><span class="refDoi"> DOI: 10.1074/jbc.M410012200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1074%2Fjbc.M410012200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=5350-5360&author=A.+Montagnerauthor=B.+Perretauthor=A.+Yartauthor=M.+Danceauthor=J.+P.+Sallesauthor=P.+Raynal&title=A+novel+role+for+Gab1+and+SHP2+in+epidermal+growth+factor-induced+Ras+activation&doi=10.1074%2Fjbc.M410012200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M410012200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M410012200%26sid%3Dliteratum%253Aachs%26aulast%3DMontagner%26aufirst%3DA.%26aulast%3DPerret%26aufirst%3DB.%26aulast%3DYart%26aufirst%3DA.%26aulast%3DDance%26aufirst%3DM.%26aulast%3DSalles%26aufirst%3DJ.%2BP.%26aulast%3DRaynal%26aufirst%3DP.%26atitle%3DA%2520novel%2520role%2520for%2520Gab1%2520and%2520SHP2%2520in%2520epidermal%2520growth%2520factor-induced%2520Ras%2520activation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D5350%26epage%3D5360%26doi%3D10.1074%2Fjbc.M410012200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Agazie, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayman, M. J.</span><span> </span><span class="NLM_article-title">Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">7875</span><span class="NLM_x">–</span> <span class="NLM_lpage">7886</span><span class="refDoi"> DOI: 10.1128/MCB.23.21.7875-7886.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1128%2FMCB.23.21.7875-7886.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=14560030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosFOgtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=7875-7886&author=Y.+M.+Agazieauthor=M.+J.+Hayman&title=Molecular+mechanism+for+a+role+of+SHP2+in+epidermal+growth+factor+receptor+signaling&doi=10.1128%2FMCB.23.21.7875-7886.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular mechanism for a role of SHP2 in epidermal growth factor receptor signaling</span></div><div class="casAuthors">Agazie, Yehenew M.; Hayman, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7875-7886</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The Src homol. 2-contg. phosphotyrosine phosphatase (SHP2) is primarily a pos. effector of receptor tyrosine kinase signaling.  However, the mol. mechanism by which SHP2 effects its biol. function is unknown.  The authors provide evidence that defines the mol. mechanism and site of action of SHP2 in the epidermal growth factor-induced mitogenic pathway.  The authors demonstrate that SHP2 acts upstream of Ras and functions by increasing the half-life of activated Ras (GTP-Ras) in the cell by interfering with the process of Ras inactivation catalyzed by Ras GTPase-activating protein (RasGAP).  It does so by inhibition of tyrosine phosphorylation-dependent translocation of RasGAP to the plasma membrane, to its substrate (GTP-Ras) microdomain.  Inhibition is achieved through the dephosphorylation of RasGAP binding sites at the level of the plasma membrane.  The authors have identified Tyr 992 of the epidermal growth factor receptor (EGFR) to be one such site, since its mutation to Phe renders the EGFR refractory to the effect of dominant-neg. SHP2.  To the authors' knowledge, this is the first report to outline the site and mol. mechanism of action of SHP2 in EGFR signaling, which may also serve as a model to describe its role in other receptor tyrosine kinase signaling pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA5SXQ45HAFrVg90H21EOLACvtfcHk0lgm7yb_SOpvPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosFOgtLo%253D&md5=23e83e2e6ea24b006daa799b15a95981</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.21.7875-7886.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.21.7875-7886.2003%26sid%3Dliteratum%253Aachs%26aulast%3DAgazie%26aufirst%3DY.%2BM.%26aulast%3DHayman%26aufirst%3DM.%2BJ.%26atitle%3DMolecular%2520mechanism%2520for%2520a%2520role%2520of%2520SHP2%2520in%2520epidermal%2520growth%2520factor%2520receptor%2520signaling%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D7875%26epage%3D7886%26doi%3D10.1128%2FMCB.23.21.7875-7886.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kawabuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satomi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimonishi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakhovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okada, M.</span><span> </span><span class="NLM_article-title">Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">404</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">–</span> <span class="NLM_lpage">1003</span><span class="refDoi"> DOI: 10.1038/35010121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2F35010121" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=404&publication_year=2000&pages=999-1003&author=M.+Kawabuchiauthor=Y.+Satomiauthor=T.+Takaoauthor=Y.+Shimonishiauthor=S.+Nadaauthor=K.+Nagaiauthor=A.+Tarakhovskyauthor=M.+Okada&title=Transmembrane+phosphoprotein+Cbp+regulates+the+activities+of+Src-family+tyrosine+kinases&doi=10.1038%2F35010121"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2F35010121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35010121%26sid%3Dliteratum%253Aachs%26aulast%3DKawabuchi%26aufirst%3DM.%26aulast%3DSatomi%26aufirst%3DY.%26aulast%3DTakao%26aufirst%3DT.%26aulast%3DShimonishi%26aufirst%3DY.%26aulast%3DNada%26aufirst%3DS.%26aulast%3DNagai%26aufirst%3DK.%26aulast%3DTarakhovsky%26aufirst%3DA.%26aulast%3DOkada%26aufirst%3DM.%26atitle%3DTransmembrane%2520phosphoprotein%2520Cbp%2520regulates%2520the%2520activities%2520of%2520Src-family%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2000%26volume%3D404%26spage%3D999%26epage%3D1003%26doi%3D10.1038%2F35010121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Hof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Crystal structure of the tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+structure+of+the+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0lgSH08EErz1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520the%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450%26doi%3D10.1016%2FS0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgt, I. V. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, S.</span><span> </span><span class="NLM_article-title">Mutations in the protein tyrosine kinase gene, PTPN11, cause Noonan syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span><span class="refDoi"> DOI: 10.1038/ng1201-491c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fng1201-491c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGis7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=491-491&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+V.+D.+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jeffery&title=Mutations+in+the+protein+tyrosine+kinase+gene%2C+PTPN11%2C+cause+Noonan+syndrome&doi=10.1038%2Fng1201-491c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in the protein tyrosine kinase gene, PTPN11, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, M.; Mehler, E. L.; Goldberg, R.; Zmapino, G.; Brunner, H. G.; Kremer, H.; van der Burgt, I.; Crosby, A. H.; Ion, A.; Jeffery, S.; Kalidas, K.; Patton, M. A.; Kucherlapati, R. S.; Gelb, B.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">491</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6qhY4DNI0RrVg90H21EOLACvtfcHk0lgSH08EErz1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGis7w%253D&md5=e27d7263f3dde87d622d4b95c8bc47de</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fng1201-491c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1201-491c%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3DBurgt%26aufirst%3DI.%2BV.%2BD.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26atitle%3DMutations%2520in%2520the%2520protein%2520tyrosine%2520kinase%2520gene%252C%2520PTPN11%252C%2520cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D491%26epage%3D491%26doi%3D10.1038%2Fng1201-491c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Bentiresalj, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paez, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naoki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugarbaker, D. J.</span><span> </span><span class="NLM_article-title">Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">8816</span><span class="NLM_x">–</span> <span class="NLM_lpage">8820</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-04-1923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1158%2F0008-5472.CAN-04-1923" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=8816-8820&author=M.+Bentiresaljauthor=J.+G.+Paezauthor=F.+S.+Davidauthor=H.+Keilhackauthor=B.+Halmosauthor=K.+Naokiauthor=J.+M.+Marisauthor=A.+Richardsonauthor=A.+Bardelliauthor=D.+J.+Sugarbaker&title=Activating+mutations+of+the+noonan+syndrome-associated+SHP2%2FPTPN11+gene+in+human+solid+tumors+and+adult+acute+myelogenous+leukemia&doi=10.1158%2F0008-5472.CAN-04-1923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-04-1923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-04-1923%26sid%3Dliteratum%253Aachs%26aulast%3DBentiresalj%26aufirst%3DM.%26aulast%3DPaez%26aufirst%3DJ.%2BG.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DHalmos%26aufirst%3DB.%26aulast%3DNaoki%26aufirst%3DK.%26aulast%3DMaris%26aufirst%3DJ.%2BM.%26aulast%3DRichardson%26aufirst%3DA.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DSugarbaker%26aufirst%3DD.%2BJ.%26atitle%3DActivating%2520mutations%2520of%2520the%2520noonan%2520syndrome-associated%2520SHP2%252FPTPN11%2520gene%2520in%2520human%2520solid%2520tumors%2520and%2520adult%2520acute%2520myelogenous%2520leukemia%26jtitle%3DCancer%2520Res.%26date%3D2004%26volume%3D64%26spage%3D8816%26epage%3D8820%26doi%3D10.1158%2F0008-5472.CAN-04-1923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Miyamoto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomogita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3508</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span><span class="refDoi"> DOI: 10.1038/sj.onc.1211019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+distinct+class+of+gain-of-function+SHP-2+mutants+with+oncogenic+RAS-like+transforming+activity+from+solid+tumors&doi=10.1038%2Fsj.onc.1211019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0lhrtQewgpkdRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520distinct%2520class%2520of%2520gain-of-function%2520SHP-2%2520mutants%2520with%2520oncogenic%2520RAS-like%2520transforming%2520activity%2520from%2520solid%2520tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515%26doi%3D10.1038%2Fsj.onc.1211019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+tyrosine+phosphatase+Shp2+%28PTPN11%29+in+cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0lhrtQewgpkdRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520tyrosine%2520phosphatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Hatakeyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span> </span><span class="NLM_article-title">Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span><span class="refDoi"> DOI: 10.1111/j.1349-7006.2005.00130.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1111%2Fj.1349-7006.2005.00130.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=16367902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFWitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2005&pages=835-843&author=M.+Hatakeyamaauthor=H.+Higashi&title=Helicobacter+pylori+CagA%3A+a+new+paradigm+for+bacterial+carcinogenesis&doi=10.1111%2Fj.1349-7006.2005.00130.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Helicobacter pylori CagA: A new paradigm for bacterial carcinogenesis</span></div><div class="casAuthors">Hatakeyama, Masanori; Higashi, Hideaki</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">835-843</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A review.  Infection with cagA-pos. Helicobacter pylori is assocd. with the development of gastric adenocarcinoma.  The cagA gene product CagA is injected directly from the bacterium into the bacterium-attached gastric epithelial cells via the type-IV secretion system.  Upon membrane localization and subsequent tyrosine phosphorylation by Src family kinases, CagA functions as a scaffolding adaptor and interacts with a no. of host proteins that regulate cell growth, cell motility and cell polarity in both CagA phosphorylation-dependent and phosphorylation-independent manners.  Of special interest is the interaction of CagA with the SHP-2 tyrosine phosphatase, gain-of-function mutations that of which have recently been found in a variety of human malignancies.  The CagA-SHP-2 interaction is entirely dependent on CagA tyrosine phosphorylation and, through the complex formation, SHP-2 is catalytically activated and induces morphol. transformation with elevated cell motility.  Intriguingly, structural diversity of the tyrosine phosphorylation sites of CagA accounts for the differential activity of individual CagA to bind and activate SHP-2.  Deregulation of SHP-2 and other intracellular signaling mols. by H. pylori CagA may predispose cells to accumulate multiple genetic and epigenetic changes involved in gastric carcinogenesis.  Furthermore, the differential potential of individual CagA to disturb cellular functions indicates that H. pylori strains carrying biol. more active CagA are more virulent than those with less active CagA and are more closely assocd. with gastric carcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyPRFMVPCljrVg90H21EOLACvtfcHk0lhaR_h8owylKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFWitg%253D%253D&md5=60a51d84b2dcb7097f193cbb50ca4413</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2005.00130.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2005.00130.x%26sid%3Dliteratum%253Aachs%26aulast%3DHatakeyama%26aufirst%3DM.%26aulast%3DHigashi%26aufirst%3DH.%26atitle%3DHelicobacter%2520pylori%2520CagA%253A%2520a%2520new%2520paradigm%2520for%2520bacterial%2520carcinogenesis%26jtitle%3DCancer%2520Sci.%26date%3D2005%26volume%3D96%26spage%3D835%26epage%3D843%26doi%3D10.1111%2Fj.1349-7006.2005.00130.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Aceto, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausgruber, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brinkhaus, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaidatzis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinybaron, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzarol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Confalonieri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balwierz, P. J.</span><span> </span><span class="NLM_article-title">Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">537</span><span class="refDoi"> DOI: 10.1038/nm.2645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnm.2645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=22388088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1yisrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=529-537&author=N.+Acetoauthor=N.+Sausgruberauthor=H.+Brinkhausauthor=D.+Gaidatzisauthor=G.+Martinybaronauthor=G.+Mazzarolauthor=S.+Confalonieriauthor=M.+Quartoauthor=G.+Huauthor=P.+J.+Balwierz&title=Tyrosine+phosphatase+SHP2+promotes+breast+cancer+progression+and+maintains+tumor-initiating+cells+via+activation+of+key+transcription+factors+and+a+positive+feedback+signaling+loop&doi=10.1038%2Fnm.2645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop</span></div><div class="casAuthors">Aceto, Nicola; Sausgruber, Nina; Brinkhaus, Heike; Gaidatzis, Dimos; Martiny-Baron, Georg; Mazzarol, Giovanni; Confalonieri, Stefano; Quarto, Micaela; Hu, Guang; Balwierz, Piotr J.; Pachkov, Mikhail; Elledge, Stephen J.; van Nimwegen, Erik; Stadler, Michael B.; Bentires-Alj, Mohamed</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">529-537</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">New cancer therapies are likely to arise from an in-depth understanding of the signaling networks influencing tumor initiation, progression and metastasis.  We show a fundamental role for Src-homol. 2 domain-contg. phosphatase 2 (SHP2) in these processes in human epidermal growth factor receptor 2 (HER2)-pos. and triple-neg. breast cancers.  Knockdown of SHP2 eradicated breast tumor-initiating cells in xenograft models, and SHP2 depletion also prevented invasion in three-dimensional cultures and in a transductal invasion assay in vivo.  Notably, SHP2 knockdown in established breast tumors blocked their growth and reduced metastasis.  Mechanistically, SHP2 activated stemness-assocd. transcription factors, including v-myc myelocytomatosis viral oncogene homolog (c-Myc) and zinc finger E-box binding homeobox 1 (ZEB1), which resulted in the repression of let-7 microRNA and the expression of a set of 'SHP2 signature' genes.  We found these genes to be simultaneously activated in a large subset of human primary breast tumors that are assocd. with invasive behavior and poor prognosis.  These results provide new insights into the signaling cascades influencing tumor-initiating cells as well as a rationale for targeting SHP2 in breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGBsjLtiOIWbVg90H21EOLACvtfcHk0lhaR_h8owylKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1yisrg%253D&md5=ea1d756b2f9d21771ca5f25d2dfda798</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnm.2645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm.2645%26sid%3Dliteratum%253Aachs%26aulast%3DAceto%26aufirst%3DN.%26aulast%3DSausgruber%26aufirst%3DN.%26aulast%3DBrinkhaus%26aufirst%3DH.%26aulast%3DGaidatzis%26aufirst%3DD.%26aulast%3DMartinybaron%26aufirst%3DG.%26aulast%3DMazzarol%26aufirst%3DG.%26aulast%3DConfalonieri%26aufirst%3DS.%26aulast%3DQuarto%26aufirst%3DM.%26aulast%3DHu%26aufirst%3DG.%26aulast%3DBalwierz%26aufirst%3DP.%2BJ.%26atitle%3DTyrosine%2520phosphatase%2520SHP2%2520promotes%2520breast%2520cancer%2520progression%2520and%2520maintains%2520tumor-initiating%2520cells%2520via%2520activation%2520of%2520key%2520transcription%2520factors%2520and%2520a%2520positive%2520feedback%2520signaling%2520loop%26jtitle%3DNat.%2520Med.%26date%3D2012%26volume%3D18%26spage%3D529%26epage%3D537%26doi%3D10.1038%2Fnm.2645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Tsutsumi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masoudi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujii, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function</span> <span class="citation_source-journal">Dev. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">665</span><span class="refDoi"> DOI: 10.1016/j.devcel.2013.08.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2Fj.devcel.2013.08.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=24035415" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVCls7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=658-665&author=R.+Tsutsumiauthor=M.+Masoudiauthor=A.+Takahashiauthor=Y.+Fujiiauthor=T.+Hayashiauthor=I.+Kikuchiauthor=Y.+Satouauthor=M.+Tairaauthor=M.+Hatakeyama&title=YAP+and+TAZ%2C+Hippo+signaling+targets%2C+act+as+a+rheostat+for+nuclear+SHP2+function&doi=10.1016%2Fj.devcel.2013.08.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">YAP and TAZ, Hippo Signaling Targets, Act as a Rheostat for Nuclear SHP2 Function</span></div><div class="casAuthors">Tsutsumi, Ryouhei; Masoudi, Mohammad; Takahashi, Atsushi; Fujii, Yumiko; Hayashi, Takeru; Kikuchi, Ippei; Satou, Yumeko; Taira, Masanori; Hatakeyama, Masanori</div><div class="citationInfo"><span class="NLM_cas:title">Developmental Cell</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">658-665</span>CODEN:
                <span class="NLM_cas:coden">DCEEBE</span>;
        ISSN:<span class="NLM_cas:issn">1534-5807</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">SHP2 is a ubiquitously expressed protein tyrosine phosphatase, deregulation of which is assocd. with malignant neoplasms and developmental disorders.  SHP2 is required for full activation of RAS-Erk signaling in the cytoplasm and is also present in the nucleus, where it promotes Wnt target gene activation through dephosphorylation of parafibromin.  SHP2 is distributed both to the cytoplasm and nucleus at low cell d. but is excluded from the nucleus at high cell d.  Here, we show that SHP2 phys. interacts with transcriptional coactivators YAP and TAZ, targets of the cell-d.-sensing Hippo signal.  Through the interaction, nonphosphorylated YAP/TAZ promote nuclear translocalization of SHP2, which in turn stimulates TCF/LEF- and TEAD-regulated genes via parafibromin dephosphorylation.  Conversely, YAP/TAZ phosphorylated by Hippo signaling sequester SHP2 in the cytoplasm, thereby preventing nuclear accumulation of SHP2.  Hence, YAP/TAZ serve as a rheostat for nuclear SHP2 function, which is switched off by the Hippo signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqYS_cEzmS8rVg90H21EOLACvtfcHk0lhaR_h8owylKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVCls7bJ&md5=a97dc2ed314db28cb3594244fff2f5ff</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.devcel.2013.08.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.devcel.2013.08.013%26sid%3Dliteratum%253Aachs%26aulast%3DTsutsumi%26aufirst%3DR.%26aulast%3DMasoudi%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DFujii%26aufirst%3DY.%26aulast%3DHayashi%26aufirst%3DT.%26aulast%3DKikuchi%26aufirst%3DI.%26aulast%3DSatou%26aufirst%3DY.%26aulast%3DTaira%26aufirst%3DM.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DYAP%2520and%2520TAZ%252C%2520Hippo%2520signaling%2520targets%252C%2520act%2520as%2520a%2520rheostat%2520for%2520nuclear%2520SHP2%2520function%26jtitle%3DDev.%2520Cell%26date%3D2013%26volume%3D26%26spage%3D658%26epage%3D665%26doi%3D10.1016%2Fj.devcel.2013.08.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Gavrieli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loftin, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, K. M.</span><span> </span><span class="NLM_article-title">Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">312</span><span class="NLM_x">, </span> <span class="NLM_fpage">1236</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2003.11.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2Fj.bbrc.2003.11.070" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=312&publication_year=2003&pages=1236-1243&author=M.+Gavrieliauthor=N.+Watanabeauthor=S.+K.+Loftinauthor=T.+L.+Murphyauthor=K.+M.+Murphy&title=Characterization+of+phosphotyrosine+binding+motifs+in+the+cytoplasmic+domain+of+B+and+T+lymphocyte+attenuator+required+for+association+with+protein+tyrosine+phosphatases+SHP-1+and+SHP-2&doi=10.1016%2Fj.bbrc.2003.11.070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2003.11.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2003.11.070%26sid%3Dliteratum%253Aachs%26aulast%3DGavrieli%26aufirst%3DM.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DLoftin%26aufirst%3DS.%2BK.%26aulast%3DMurphy%26aufirst%3DT.%2BL.%26aulast%3DMurphy%26aufirst%3DK.%2BM.%26atitle%3DCharacterization%2520of%2520phosphotyrosine%2520binding%2520motifs%2520in%2520the%2520cytoplasmic%2520domain%2520of%2520B%2520and%2520T%2520lymphocyte%2520attenuator%2520required%2520for%2520association%2520with%2520protein%2520tyrosine%2520phosphatases%2520SHP-1%2520and%2520SHP-2%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D312%26spage%3D1236%26epage%3D1243%26doi%3D10.1016%2Fj.bbrc.2003.11.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Yokosuka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamatsu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashiimanishi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimototane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span> </span><span class="NLM_article-title">Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">209</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1217</span><span class="refDoi"> DOI: 10.1084/jem.20112741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1084%2Fjem.20112741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=22641383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC38XoslShsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=209&publication_year=2012&pages=1201-1217&author=T.+Yokosukaauthor=M.+Takamatsuauthor=W.+Kobayashiimanishiauthor=A.+Hashimototaneauthor=M.+Azumaauthor=T.+Saito&title=Programmed+cell+death+1+forms+negative+costimulatory+microclusters+that+directly+inhibit+T+cell+receptor+signaling+by+recruiting+phosphatase+SHP2&doi=10.1084%2Fjem.20112741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2</span></div><div class="casAuthors">Yokosuka, Tadashi; Takamatsu, Masako; Kobayashi-Imanishi, Wakana; Hashimoto-Tane, Akiko; Azuma, Miyuki; Saito, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">209</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1201-1217</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Programmed cell death 1 (PD-1) is a neg. costimulatory receptor crit. for the suppression of T cell activation in vitro and in vivo.  Single cell imaging elucidated a mol. mechanism of PD-1-mediated suppression.  PD-1 becomes clustered with T cell receptors (TCRs) upon binding to its ligand PD-L1 and is transiently assocd. with the phosphatase SHP2 (Src homol. 2 domain-contg. tyrosine phosphatase 2).  These neg. costimulatory microclusters induce the dephosphorylation of the proximal TCR signaling mols.  This results in the suppression of T cell activation and blockade of the TCR-induced stop signal.  In addn. to PD-1 clustering, PD-1-TCR colocalization within microclusters is required for efficient PD-1-mediated suppression.  This inhibitory mechanism also functions in PD-1hi T cells generated in vivo and can be overridden by a neutralizing anti-PD-L1 antibody.  Therefore, PD-1 microcluster formation is important for regulation of T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOfykLUUjaIbVg90H21EOLACvtfcHk0ljPFTmXvIISpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XoslShsr4%253D&md5=5c1fad62b4e3e69e177be5718ce92d41</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1084%2Fjem.20112741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20112741%26sid%3Dliteratum%253Aachs%26aulast%3DYokosuka%26aufirst%3DT.%26aulast%3DTakamatsu%26aufirst%3DM.%26aulast%3DKobayashiimanishi%26aufirst%3DW.%26aulast%3DHashimototane%26aufirst%3DA.%26aulast%3DAzuma%26aufirst%3DM.%26aulast%3DSaito%26aufirst%3DT.%26atitle%3DProgrammed%2520cell%2520death%25201%2520forms%2520negative%2520costimulatory%2520microclusters%2520that%2520directly%2520inhibit%2520T%2520cell%2520receptor%2520signaling%2520by%2520recruiting%2520phosphatase%2520SHP2%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2012%26volume%3D209%26spage%3D1201%26epage%3D1217%26doi%3D10.1084%2Fjem.20112741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Chemnitz, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">June, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riley, J. L.</span><span> </span><span class="NLM_article-title">SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation</span> <span class="citation_source-journal">J. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">954</span><span class="refDoi"> DOI: 10.4049/jimmunol.173.2.945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.4049%2Fjimmunol.173.2.945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15240681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlsVGhurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2004&pages=945-954&author=J.+M.+Chemnitzauthor=R.+V.+Parryauthor=K.+E.+Nicholsauthor=C.+H.+Juneauthor=J.+L.+Riley&title=SHP-1+and+SHP-2+associate+with+immunoreceptor+tyrosine-based+switch+motif+of+programmed+death+1+upon+primary+human+T+cell+stimulation%2C+but+only+receptor+ligation+prevents+T+cell+activation&doi=10.4049%2Fjimmunol.173.2.945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation</span></div><div class="casAuthors">Chemnitz, Jens M.; Parry, Richard V.; Nichols, Kim E.; June, Carl H.; Riley, James L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">945-954</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">To study the cis- and trans-acting factors that mediate programmed death 1 (PD-1) signaling in primary human CD4 T cells, the authors constructed a chimeric mol. consisting of the murine CD28 extracellular domain and human PD-1 cytoplasmic tail.  When introduced into CD4 T cells, this construct mimics the activity of endogenous PD-1 in terms of its ability to suppress T cell expansion and cytokine prodn.  The cytoplasmic tail of PD-1 contains two structural motifs, an ITIM and an immunoreceptor tyrosine-based switch motif (ITSM).  Mutation of the ITIM had little effect on PD-1 signaling or functional activity.  In contrast, mutation of the ITSM abrogated the ability of PD-1 to block cytokine synthesis and to limit T cell expansion.  Further biochem. analyses revealed that the ability of PD-1 to block T cell activation correlated with recruitment of Src homol. region 2 domain-contg. phosphatase-1 (SHP-1) and SHP-2, and not the adaptor Src homol. 2 domain-contg. mol. 1A, to the ITSM domain.  In TCR-stimulated T cells, SHP-2 assocd. with PD-1, even in the absence of PD-1 engagement.  Despite this interaction, the ability of PD-1 to block T cell activation required receptor ligation, suggesting that colocalization of PD-1 with CD3 and/or CD28 may be necessary for inhibition of T cell activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLiPMfGJ1GeLVg90H21EOLACvtfcHk0ljPFTmXvIISpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlsVGhurc%253D&md5=204c373c1a728fc94c10db9de7804f50</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.173.2.945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.173.2.945%26sid%3Dliteratum%253Aachs%26aulast%3DChemnitz%26aufirst%3DJ.%2BM.%26aulast%3DParry%26aufirst%3DR.%2BV.%26aulast%3DNichols%26aufirst%3DK.%2BE.%26aulast%3DJune%26aufirst%3DC.%2BH.%26aulast%3DRiley%26aufirst%3DJ.%2BL.%26atitle%3DSHP-1%2520and%2520SHP-2%2520associate%2520with%2520immunoreceptor%2520tyrosine-based%2520switch%2520motif%2520of%2520programmed%2520death%25201%2520upon%2520primary%2520human%2520T%2520cell%2520stimulation%252C%2520but%2520only%2520receptor%2520ligation%2520prevents%2520T%2520cell%2520activation%26jtitle%3DJ.%2520Immunol.%26date%3D2004%26volume%3D173%26spage%3D945%26epage%3D954%26doi%3D10.4049%2Fjimmunol.173.2.945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Butterworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overduin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, A. J.</span><span> </span><span class="NLM_article-title">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+protein+tyrosine+phosphatase+SHP2+for+therapeutic+intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0ljPFTmXvIISpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520for%2520therapeutic%2520intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pireddu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymanski, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4948</span><span class="NLM_x">–</span> <span class="NLM_lpage">4956</span><span class="refDoi"> DOI: 10.1021/jm8002526</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8002526" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4948-4956&author=H.+R.+Lawrenceauthor=R.+Piredduauthor=L.+Chenauthor=Y.+Luoauthor=S.+S.+Sungauthor=A.+M.+Szymanskiauthor=M.+L.+Yipauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=J.+Wu&title=Inhibitors+of+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28Shp2%29+based+on+oxindole+scaffolds&doi=10.1021%2Fjm8002526"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (Shp2) Based on Oxindole Scaffolds</span></div><div class="casAuthors">Lawrence, Harshani R.; Pireddu, Roberta; Chen, Liwei; Luo, Yunting; Sung, Shen-Shu; Szymanski, Ann Marie; Yip, M. L. Richard; Guida, Wayne C.; Sebti, Said M.; Wu, Jie; Lawrence, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">4948-4956</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of the NCI diversity set of compds. has led to the identification of NSC-117199, which inhibits the protein tyrosine phosphatase (PTP) Shp2 with an IC50 of 47 μM.  A focused library incorporating an isatin scaffold was designed and evaluated for inhibition of Shp2 and Shp1 PTP activities.  Several compds. were identified that selectively inhibit Shp2 over Shp1 and PTP1B with low to submicromolar activity.  A model for the binding of the active compds. is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRqLAauyGNBbVg90H21EOLACvtfcHk0lgmxSEhNmTX2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptl2hu7o%253D&md5=572227c5a8cfffb108388616bd36fdfe</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm8002526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8002526%26sid%3Dliteratum%253Aachs%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DPireddu%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DSzymanski%26aufirst%3DA.%2BM.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528Shp2%2529%2520based%2520on%2520oxindole%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4948%26epage%3D4956%26doi%3D10.1021%2Fjm8002526" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Zeng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mali, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span> </span><span class="NLM_article-title">Therapeutic potential of targeting the oncogenic SHP2 phosphatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6594</span><span class="NLM_x">–</span> <span class="NLM_lpage">6609</span><span class="refDoi"> DOI: 10.1021/jm5006176</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006176" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6594-6609&author=L.+F.+Zengauthor=R.+Y.+Zhangauthor=Z.+H.+Yuauthor=S.+Liauthor=L.+Wuauthor=A.+M.+Gunawanauthor=B.+S.+Laneauthor=R.+S.+Maliauthor=X.+Liauthor=R.+J.+Chan&title=Therapeutic+potential+of+targeting+the+oncogenic+SHP2+phosphatase&doi=10.1021%2Fjm5006176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase</span></div><div class="casAuthors">Zeng, Li-Fan; Zhang, Ruo-Yu; Yu, Zhi-Hong; Li, Sijiu; Wu, Li; Gunawan, Andrea M.; Lane, Brandon S.; Mali, Raghuveer S.; Li, Xingjun; Chan, Rebecca J.; Kapur, Reuben; Wells, Clark D.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6594-6609</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol. 2 domain contg. protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase assocd. with various kinds of leukemia and solid tumors.  Thus, there is substantial interest in developing SHP2 inhibitors as potential anticancer and antileukemia agents.  Using a structure-guided and fragment-based library approach, we identified a novel hydroxyindole carboxylic acid-based SHP2 inhibitor (I), with an IC50 value of 200 nM and greater than 5-fold selectivity against 20 mammalian PTPs.  Structural and modeling studies reveal that the hydroxyindole carboxylic acid anchors the inhibitor to the SHP2 active site, while interactions of the oxalamide linker and the phenylthiophene tail with residues in the β5-β6 loop contribute to I's binding potency and selectivity.  Evidence suggests that I specifically attenuates the SHP2-dependent signaling inside the cell.  Moreover, I blocks growth factor mediated Erk1/2 and Akt activation and exhibits excellent antiproliferative activity in lung cancer and breast cancer as well as leukemia cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ko-q4-PSXbVg90H21EOLACvtfcHk0lgmxSEhNmTX2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtrvO&md5=ac8e5359387e614782c95c02f32fd97d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm5006176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006176%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%2BF.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DYu%26aufirst%3DZ.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DLane%26aufirst%3DB.%2BS.%26aulast%3DMali%26aufirst%3DR.%2BS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26atitle%3DTherapeutic%2520potential%2520of%2520targeting%2520the%2520oncogenic%2520SHP2%2520phosphatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6594%26epage%3D6609%26doi%3D10.1021%2Fjm5006176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sung, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yip, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guida, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Discovery of a novel shp2 protein tyrosine phosphatase inhibitor</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">562</span><span class="NLM_x">–</span> <span class="NLM_lpage">570</span><span class="refDoi"> DOI: 10.1124/mol.106.025536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1124%2Fmol.106.025536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=16717135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=562-570&author=L.+Chenauthor=S.+S.+Sungauthor=M.+L.+Yipauthor=H.+R.+Lawrenceauthor=Y.+Renauthor=W.+C.+Guidaauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Discovery+of+a+novel+shp2+protein+tyrosine+phosphatase+inhibitor&doi=10.1124%2Fmol.106.025536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a novel Shp2 protein tyrosine phosphatase inhibitor</span></div><div class="casAuthors">Chen, Liwei; Sung, Shen-Shu; Yip, M. L. Richard; Lawrence, Harshani R.; Ren, Yuan; Guida, Wayne C.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">562-570</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Shp2 is a non-receptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene.  It is involved in growth factor-induced activation of mitogen-activated protein (MAP) kinases Erk1 and Erk2 (Erk1/2) and has been implicated in the pathogenicity of the oncogenic bacterium Helicobacter pylori.  Moreover, gain-of-function Shp2 mutations have been found in childhood leukemias and Noonan syndrome.  Thus, small mol. Shp2 PTP inhibitors are much needed reagents for evaluation of Shp2 as a therapeutic target and for chem. biol. studies of Shp2 function.  By screening the National Cancer Institute (NCI) Diversity Set chem. library, we identified 8-hydroxy-7-(6-sulfonaphthalen-2-yl)diazenyl-quinoline-5-sulfonic acid (NSC-87877) as a potent Shp2 PTP inhibitor.  Mol. modeling and site-directed mutagenesis studies suggested that NSC-87877 binds to the catalytic cleft of Shp2 PTP.  NSC-87877 cross-inhibited Shp1 in vitro, but it was selective for Shp2 over other PTPs (PTP1B, HePTP, DEP1, CD45, and LAR).  It is noteworthy that NSC-87877 inhibited epidermal growth factor (EGF)-induced activation of Shp2 PTP, Ras, and Erk1/2 in cell cultures but did not block EGF-induced Gab1 tyrosine phosphorylation or Gab1-Shp2 assocn.  Furthermore, NSC-87877 inhibited Erk1/2 activation by a Gab1-Shp2 chimera but did not affect the Shp2-independent Erk1/2 activation by phorbol 12-myristate 13-acetate.  These results identified NSC-87877 as the first PTP inhibitor capable of inhibiting Shp2 PTP in cell cultures without a detectable off-target effect.  Our study also provides the first pharmacol. evidence that Shp2 mediates EGF-induced Erk1/2 MAP kinase activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoA4XVGUjw3W7Vg90H21EOLACvtfcHk0lgmxSEhNmTX2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnslyjsrk%253D&md5=a2ce03150ecbe6937876bb292ced30dc</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025536%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSung%26aufirst%3DS.%2BS.%26aulast%3DYip%26aufirst%3DM.%2BL.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DRen%26aufirst%3DY.%26aulast%3DGuida%26aufirst%3DW.%2BC.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520shp2%2520protein%2520tyrosine%2520phosphatase%2520inhibitor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D562%26epage%3D570%26doi%3D10.1124%2Fmol.106.025536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Nören-Müller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Corrêa, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prinz, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenbaum, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saxena, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwalbe, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vestweber, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, O.</span><span> </span><span class="NLM_article-title">Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">10606</span><span class="NLM_x">–</span> <span class="NLM_lpage">10611</span><span class="refDoi"> DOI: 10.1073/pnas.0601490103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1073%2Fpnas.0601490103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=16809424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A280%3ADC%252BD28vhsVentg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=10606-10611&author=A.+N%C3%B6ren-M%C3%BCllerauthor=I.+Reis-Corr%C3%AAaauthor=H.+Prinzauthor=C.+Rosenbaumauthor=K.+Saxenaauthor=H.+J.+Schwalbeauthor=D.+Vestweberauthor=G.+Cagnaauthor=S.+Schunkauthor=O.+Schwarz&title=Discovery+of+protein+phosphatase+inhibitor+classes+by+biology-oriented+synthesis&doi=10.1073%2Fpnas.0601490103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of protein phosphatase inhibitor classes by biology-oriented synthesis</span></div><div class="casAuthors">Noren-Muller Andrea; Reis-Correa Ivan Jr; Prinz Heino; Rosenbaum Claudia; Saxena Krishna; Schwalbe Harald J; Vestweber Dietmar; Cagna Guiseppe; Schunk Stefan; Schwarz Oliver; Schiewe Hajo; Waldmann Herbert</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">10606-11</span>
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Protein phosphatases have very recently emerged as important targets for chemical biology and medicinal chemistry research, and new phosphatase inhibitor classes are in high demand.  The underlying frameworks of natural products represent the evolutionarily selected fractions of chemical space explored by nature so far and meet the criteria of relevance to nature and biological prevalidation most crucial to inhibitor development.  We refer to synthesis efforts and compound collection development based on these criteria as biology-oriented synthesis.  For the discovery of phosphatase inhibitor classes by means of this approach, four natural product-derived or -inspired medium-sized compound collections were synthesized and investigated for inhibition of the tyrosine phosphatases VE-PTP, Shp-2, PTP1B, MptpA, and MptpB and the dual-specificity phosphatases Cdc25A and VHR.  The screen yielded four unprecedented and selective phosphatase inhibitor classes for four phosphatases with high hit rates.  For VE-PTP and MptpB the first inhibitors were discovered.  These results demonstrate that biology-oriented synthesis is an efficient approach to the discovery of new compound classes for medicinal chemistry and chemical biology research that opens up new opportunities for the study of phosphatases, which may lead to the development of new drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQNf4ONKii5590Q2ypr7jHkfW6udTcc2eaz81jVTZBG4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vhsVentg%253D%253D&md5=76f28f79227b8261fd23e7dbf3e2d8e7</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0601490103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0601490103%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25B6ren-M%25C3%25BCller%26aufirst%3DA.%26aulast%3DReis-Corr%25C3%25AAa%26aufirst%3DI.%26aulast%3DPrinz%26aufirst%3DH.%26aulast%3DRosenbaum%26aufirst%3DC.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DSchwalbe%26aufirst%3DH.%2BJ.%26aulast%3DVestweber%26aufirst%3DD.%26aulast%3DCagna%26aufirst%3DG.%26aulast%3DSchunk%26aufirst%3DS.%26aulast%3DSchwarz%26aufirst%3DO.%26atitle%3DDiscovery%2520of%2520protein%2520phosphatase%2520inhibitor%2520classes%2520by%2520biology-oriented%2520synthesis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D10606%26epage%3D10611%26doi%3D10.1073%2Fpnas.0601490103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Hellmuth, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosskopf, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lum, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Würtele, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Röder, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kries, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosario, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rademann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, W.</span><span> </span><span class="NLM_article-title">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">105</span><span class="NLM_x">, </span> <span class="NLM_fpage">7275</span><span class="NLM_x">–</span> <span class="NLM_lpage">7280</span><span class="refDoi"> DOI: 10.1073/pnas.0710468105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1073%2Fpnas.0710468105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=18480264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=7275-7280&author=K.+Hellmuthauthor=S.+Grosskopfauthor=C.+T.+Lumauthor=M.+W%C3%BCrteleauthor=N.+R%C3%B6derauthor=J.+P.+von+Kriesauthor=M.+Rosarioauthor=J.+Rademannauthor=W.+Birchmeier&title=Specific+inhibitors+of+the+protein+tyrosine+phosphatase+Shp2+identified+by+high-throughput+docking&doi=10.1073%2Fpnas.0710468105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking</span></div><div class="casAuthors">Hellmuth, Klaus; Grosskopf, Stefanie; Lum, Ching Tung; Wuertele, Martin; Roeder, Nadine; von Kries, Jens Peter; Rosario, Marta; Rademann, Jorg; Birchmeier, Walter</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">7275-7280</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The protein tyrosine phosphatase Shp2 is a pos. regulator of growth factor signaling.  Gain-of-function mutations in several types of leukemia define Shp2 as a bona fide oncogene.  We performed a high-throughput in silico screen for small-mol.-wt. compds. that bind the catalytic site of Shp2.  We have identified the phenylhydrazonopyrazolone sulfonate PHPS1 as a potent and cell-permeable inhibitor, which is specific for Shp2 over the closely related tyrosine phosphatases Shp1 and PTP1 B.  PHPS1 inhibits Shp2-dependent cellular events such as hepatocyte growth factor/scatter factor (HGF/SF)-induced epithelial cell scattering and branching morphogenesis.  PHPS1 also blocks Shp2-dependent downstream signaling, namely HGF/SF-induced sustained phosphorylation of the Erk1/2 MAP kinases and dephosphorylation of paxillin.  Furthermore, PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-assocd. Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines.  The PHPS compd. class is therefore suitable for further development of therapeutics for the treatment of Shp2-dependent diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGponh1kw_h7jrVg90H21EOLACvtfcHk0ljJHoBIl3GOaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFCqsLs%253D&md5=39c7dda94e32134c305e135e4c48b9d1</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710468105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710468105%26sid%3Dliteratum%253Aachs%26aulast%3DHellmuth%26aufirst%3DK.%26aulast%3DGrosskopf%26aufirst%3DS.%26aulast%3DLum%26aufirst%3DC.%2BT.%26aulast%3DW%25C3%25BCrtele%26aufirst%3DM.%26aulast%3DR%25C3%25B6der%26aufirst%3DN.%26aulast%3Dvon%2BKries%26aufirst%3DJ.%2BP.%26aulast%3DRosario%26aufirst%3DM.%26aulast%3DRademann%26aufirst%3DJ.%26aulast%3DBirchmeier%26aufirst%3DW.%26atitle%3DSpecific%2520inhibitors%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520Shp2%2520identified%2520by%2520high-throughput%2520docking%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D7275%26epage%3D7280%26doi%3D10.1073%2Fpnas.0710468105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span> </span><span class="NLM_article-title">Salicylic acid based small molecule inhibitor for the oncogenic Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2482</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span><span class="refDoi"> DOI: 10.1021/jm901645u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-2493&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.+X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawan&title=Salicylic+acid+based+small+molecule+inhibitor+for+the+oncogenic+Src+homology-2+domain+containing+protein+tyrosine+phosphatase-2+%28SHP2%29&doi=10.1021%2Fjm901645u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)</span></div><div class="casAuthors">Zhang, Xian; He, Yantao; Liu, Sijiu; Yu, Zhihong; Jiang, Zhong-Xing; Yang, Zhenyun; Dong, Yuanshu; Nabinger, Sarah C.; Wu, Li; Gunawan, Andrea M.; Wang, Lina; Chan, Rebecca J.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2482-2493</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol.-2 domain contg. protein tyrosine phosphatase-2 (SHP2) plays a pivotal role in growth factor and cytokine signaling.  Gain-of-function SHP2 mutations are assocd. with Noonan syndrome, various kinds of leukemias, and solid tumors.  Thus, there is considerable interest in SHP2 as a potential target for anticancer and antileukemia therapy.  We report a salicylic acid based combinatorial library approach aimed at binding both active site and unique nearby subpockets for enhanced affinity and selectivity.  Screening of the library led to the identification of a SHP2 inhibitor II-B08 (compd. 9) with highly efficacious cellular activity.  Compd. 9 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation, providing supporting evidence that chem. inhibition of SHP2 may be therapeutically useful for anticancer and antileukemia treatment.  X-ray crystallog. anal. of the structure of SHP2 in complex with 9 reveals mol. determinants that can be exploited for the acquisition of more potent and selective SHP2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC82T5JpCRArVg90H21EOLACvtfcHk0ljJHoBIl3GOaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D&md5=6f87897eda38ea485dc08e189f1b5ca8</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26atitle%3DSalicylic%2520acid%2520based%2520small%2520molecule%2520inhibitor%2520for%2520the%2520oncogenic%2520Src%2520homology-2%2520domain%2520containing%2520protein%2520tyrosine%2520phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D2493%26doi%3D10.1021%2Fjm901645u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loh, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, C. K.</span><span> </span><span class="NLM_article-title">Identification of Cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">7212</span><span class="NLM_x">–</span> <span class="NLM_lpage">7221</span><span class="refDoi"> DOI: 10.1021/jm400474r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400474r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=7212-7221&author=W.+Liuauthor=B.+Yuauthor=G.+Xuauthor=W.+R.+Xuauthor=M.+L.+Lohauthor=L.+D.+Tangauthor=C.+K.+Qu&title=Identification+of+Cryptotanshinone+as+an+inhibitor+of+oncogenic+protein+tyrosine+phosphatase+SHP2+%28PTPN11%29&doi=10.1021%2Fjm400474r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Cryptotanshinone as an Inhibitor of Oncogenic Protein Tyrosine Phosphatase SHP2 (PTPN11)</span></div><div class="casAuthors">Liu, Wei; Yu, Bing; Xu, Gang; Xu, Wei-Ren; Loh, Mignon L.; Tang, Li-Da; Qu, Cheng-Kui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7212-7221</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Activating mutations of PTPN11 (encoding the SHP2 phosphatase) are assocd. with Noonan syndrome, childhood leukemias, and sporadic solid tumors.  Virtual screening combined with exptl. assays was performed to identify inhibitors of SHP2 from a database of natural products.  This effort led to the identification of cryptotanshinone as an inhibitor of SHP2.  Cryptotanshinone inhibited SHP2 with an IC50 of 22.50 μM.  Fluorescence titrn. expts. confirmed that it directly bound to SHP2.  Enzymic kinetic analyses showed that cryptotanshinone was a mixed-type and irreversible inhibitor.  This drug was further verified for its ability to block SHP2-mediated cell signaling and cellular functions.  Furthermore, mouse myeloid progenitors and patient leukemic cells with the activating mutation E76K in PTPN11 were found to be sensitive to this inhibitor.  Since cryptotanshinone is used to treat cardiovascular diseases in Asian countries, this drug has a potential to be used directly or to be further developed to treat PTPN11-assocd. malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJYelS47QYHLVg90H21EOLACvtfcHk0ljdGGzCNbb-lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlSjurvN&md5=3bbbae68159ae4227bbf74d5573ca77a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm400474r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400474r%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DW.%2BR.%26aulast%3DLoh%26aufirst%3DM.%2BL.%26aulast%3DTang%26aufirst%3DL.%2BD.%26aulast%3DQu%26aufirst%3DC.%2BK.%26atitle%3DIdentification%2520of%2520Cryptotanshinone%2520as%2520an%2520inhibitor%2520of%2520oncogenic%2520protein%2520tyrosine%2520phosphatase%2520SHP2%2520%2528PTPN11%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D7212%26epage%3D7221%26doi%3D10.1021%2Fjm400474r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Chen, Y. N. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fekkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garciafortanet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonakos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cooke, V. G.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">535</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-152&author=Y.+N.+P.+Chenauthor=M.+J.+Lamarcheauthor=H.+M.+Chanauthor=P.+Fekkesauthor=J.+Garciafortanetauthor=M.+G.+Ackerauthor=B.+Antonakosauthor=H.+T.+Chenauthor=Z.+Chenauthor=V.+G.+Cooke&title=Allosteric+inhibition+of+SHP2+phosphatase+inhibits+cancers+driven+by+receptor+tyrosine+kinases&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 μM), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0ljdGGzCNbb-lQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BN.%2BP.%26aulast%3DLamarche%26aufirst%3DM.%2BJ.%26aulast%3DChan%26aufirst%3DH.%2BM.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarciafortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%2BG.%26aulast%3DAntonakos%26aufirst%3DB.%26aulast%3DChen%26aufirst%3DH.%2BT.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DCooke%26aufirst%3DV.%2BG.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%2520phosphatase%2520inhibits%2520cancers%2520driven%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D152%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Garcia Fortanet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fekkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fridrich, C.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2: identification of a potent, selective, and orally efficacious phosphatase inhibitor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">7773</span><span class="NLM_x">–</span> <span class="NLM_lpage">7782</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00680</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00680" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7773-7782&author=J.+Garcia+Fortanetauthor=C.+H.+Chenauthor=Y.+P.+Chenauthor=Z.+Chenauthor=Z.+Dengauthor=B.+Firestoneauthor=P.+Fekkesauthor=M.+Fodorauthor=P.+D.+Fortinauthor=C.+Fridrich&title=Allosteric+inhibition+of+SHP2%3A+identification+of+a+potent%2C+selective%2C+and+orally+efficacious+phosphatase+inhibitor&doi=10.1021%2Facs.jmedchem.6b00680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span></div><div class="casAuthors">Garcia Fortanet, Jorge; Chen, Christine Hiu-Tung; Chen, Ying-Nan P.; Chen, Zhouliang; Deng, Zhan; Firestone, Brant; Fekkes, Peter; Fodor, Michelle; Fortin, Pascal D.; Fridrich, Cary; Grunenfelder, Denise; Ho, Samuel; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Keen, Nick; LaBonte, Laura R.; Larrow, Jay; Lenoir, Francois; Liu, Gang; Liu, Shumei; Lombardo, Franco; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Ramsey, Timothy; Sellers, William R.; Shultz, Michael D.; Stams, Travis; Towler, Christopher; Wang, Ping; Williams, Sarah L.; Zhang, Ji-Hu; LaMarche, Matthew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7773-7782</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway.  SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1).  Because it is an oncoprotein assocd. with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest.  Recently in our labs., a small mol. inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2.  A high throughput screen was performed to identify progressable chem. matter, and X-ray crystallog. revealed the location of binding in a previously undisclosed allosteric binding pocket.  Structure-based drug design was employed to optimize for SHP2 inhibition, and several new protein-ligand interactions were characterized.  These studies culminated in the discovery of 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (SHP099, 1), a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6RT7zfZnvfLVg90H21EOLACvtfcHk0lhk71ne2-EZSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKju7fP&md5=dfe43b5253e172576386f86797087f7b</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%2BFortanet%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DC.%2BH.%26aulast%3DChen%26aufirst%3DY.%2BP.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26aulast%3DFridrich%26aufirst%3DC.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%253A%2520identification%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520efficacious%2520phosphatase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7773%26epage%3D7782%26doi%3D10.1021%2Facs.jmedchem.6b00680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Krishnan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koveal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akshinthala, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kragelj, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauss, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackledge, M.</span><span> </span><span class="NLM_article-title">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">558</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span><span class="refDoi"> DOI: 10.1038/nchembio.1528</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnchembio.1528" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=24845231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=558-566&author=N.+Krishnanauthor=D.+Kovealauthor=D.+H.+Millerauthor=B.+Xueauthor=S.+D.+Akshinthalaauthor=J.+Krageljauthor=M.+R.+Jensenauthor=C.+M.+Gaussauthor=R.+Pageauthor=M.+Blackledge&title=Targeting+the+disordered+C+terminus+of+PTP1B+with+an+allosteric+inhibitor&doi=10.1038%2Fnchembio.1528"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the disordered C terminus of PTP1B with an allosteric inhibitor</span></div><div class="casAuthors">Krishnan, Navasona; Koveal, Dorothy; Miller, Daniel H.; Xue, Bin; Akshinthala, Sai Dipikaa; Kragelj, Jaka; Jensen, Malene Ringkjoebing; Gauss, Carla-Maria; Page, Rebecca; Blackledge, Martin; Muthuswamy, Senthil K.; Peti, Wolfgang; Tonks, Nicholas K.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">558-566</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">PTP1B, a validated therapeutic target for diabetes and obesity, has a crit. pos. role in HER2 signaling in breast tumorigenesis.  Efforts to develop therapeutic inhibitors of PTP1B have been frustrated by the chem. properties of the active site.  We define a new mechanism of allosteric inhibition that targets the C-terminal, noncatalytic segment of PTP1B.  We present what is to our knowledge the first ensemble structure of PTP1B contg. this intrinsically disordered segment, within which we identified a binding site for the small-mol. inhibitor MSI-1436.  We demonstrate binding to a second site close to the catalytic domain, with cooperative effects between the two sites locking PTP1B in an inactive state.  MSI-1436 antagonized HER2 signaling, inhibited tumorigenesis in xenografts and abrogated metastasis in the NDL2 mouse model of breast cancer, validating inhibition of PTP1B as a therapeutic strategy in breast cancer.  This new approach to inhibition of PTP1B emphasizes the potential of disordered segments of proteins as specific binding sites for therapeutic small mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo526if7ja9XbVg90H21EOLACvtfcHk0lhk71ne2-EZSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXot1ylsL8%253D&md5=10a460f3a5deafb9f7c206246d67a29b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1528%26sid%3Dliteratum%253Aachs%26aulast%3DKrishnan%26aufirst%3DN.%26aulast%3DKoveal%26aufirst%3DD.%26aulast%3DMiller%26aufirst%3DD.%2BH.%26aulast%3DXue%26aufirst%3DB.%26aulast%3DAkshinthala%26aufirst%3DS.%2BD.%26aulast%3DKragelj%26aufirst%3DJ.%26aulast%3DJensen%26aufirst%3DM.%2BR.%26aulast%3DGauss%26aufirst%3DC.%2BM.%26aulast%3DPage%26aufirst%3DR.%26aulast%3DBlackledge%26aufirst%3DM.%26atitle%3DTargeting%2520the%2520disordered%2520C%2520terminus%2520of%2520PTP1B%2520with%2520an%2520allosteric%2520inhibitor%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D558%26epage%3D566%26doi%3D10.1038%2Fnchembio.1528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Gilmartin, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faitg, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seefeld, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federowicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. Y.</span><span> </span><span class="NLM_article-title">Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span><span class="refDoi"> DOI: 10.1038/nchembio.1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fnchembio.1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=24390428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=181-187&author=A.+G.+Gilmartinauthor=T.+H.+Faitgauthor=M.+Richterauthor=A.+Groyauthor=M.+A.+Seefeldauthor=M.+G.+Darcyauthor=X.+Pengauthor=K.+Federowiczauthor=J.+Yangauthor=S.+Y.+Zhang&title=Allosteric+Wip1+phosphatase+inhibition+through+flap-subdomain+interaction&doi=10.1038%2Fnchembio.1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction</span></div><div class="casAuthors">Gilmartin, Aidan G.; Faitg, Thomas H.; Richter, Mark; Groy, Arthur; Seefeld, Mark A.; Darcy, Michael G.; Peng, Xin; Federowicz, Kelly; Yang, Jingsong; Zhang, Shu-Yun; Minthorn, Elisabeth; Jaworski, Jon-Paul; Schaber, Michael; Martens, Stan; McNulty, Dean E.; Sinnamon, Robert H.; Zhang, Hong; Kirkpatrick, Robert B.; Nevins, Neysa; Cui, Guanglei; Pietrak, Beth; Diaz, Elsie; Jones, Amber; Brandt, Martin; Schwartz, Benjamin; Heerding, Dirk A.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-187</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although therapeutic interventions of signal-transduction cascades with targeted kinase inhibitors are a well-established strategy, drug-discovery efforts to identify targeted phosphatase inhibitors have proven challenging.  Herein we report a series of allosteric, small-mol. inhibitors of wild-type p53-induced phosphatase (Wip1), an oncogenic phosphatase common to multiple cancers.  Compd. binding to Wip1 is dependent on a 'flap' subdomain located near the Wip1 catalytic site that renders Wip1 structurally divergent from other members of the protein phosphatase 2C (PP2C) family and that thereby confers selectivity for Wip1 over other phosphatases.  Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of Wip1 substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53.  Oral administration of Wip1 inhibitors in mice results in expected pharmacodynamic effects and causes inhibition of lymphoma xenograft growth.  To our knowledge, GSK2830371 is the first orally active, allosteric inhibitor of Wip1 phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jXZXKTKTL7Vg90H21EOLACvtfcHk0lhk71ne2-EZSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D&md5=47524caa70df233fb152a2d683417e7d</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1427%26sid%3Dliteratum%253Aachs%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DFaitg%26aufirst%3DT.%2BH.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DSeefeld%26aufirst%3DM.%2BA.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFederowicz%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DS.%2BY.%26atitle%3DAllosteric%2520Wip1%2520phosphatase%2520inhibition%2520through%2520flap-subdomain%2520interaction%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D181%26epage%3D187%26doi%3D10.1038%2Fnchembio.1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Larochelle, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durzynska, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ping, W.</span><span> </span><span class="NLM_article-title">Structural and functional consequences of three cancer-associated mutations of the oncogenic phosphatase SHP2</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">2269</span><span class="NLM_x">–</span> <span class="NLM_lpage">2277</span><span class="refDoi"> DOI: 10.1021/acs.biochem.5b01287</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.biochem.5b01287" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC28XltVagtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2016&pages=2269-2277&author=J.+R.+Larochelleauthor=M.+Fodorauthor=X.+Xuauthor=I.+Durzynskaauthor=L.+Fanauthor=T.+Stamsauthor=H.+Chanauthor=M.+J.+Lamarcheauthor=R.+Chopraauthor=W.+Ping&title=Structural+and+functional+consequences+of+three+cancer-associated+mutations+of+the+oncogenic+phosphatase+SHP2&doi=10.1021%2Facs.biochem.5b01287"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Consequences of Three Cancer-Associated Mutations of the Oncogenic Phosphatase SHP2</span></div><div class="casAuthors">LaRochelle, Jonathan R.; Fodor, Michelle; Xu, Xiang; Durzynska, Izabela; Fan, Lixin; Stams, Travis; Chan, Ho Man; LaMarche, Matthew J.; Chopra, Rajiv; Wang, Ping; Fortin, Pascal D.; Acker, Michael G.; Blacklow, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2269-2277</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The proto-oncogene PTPN11 encodes a cytoplasmic protein tyrosine phosphatase, SHP2, which is required for normal development and sustained activation of the Ras-MAPK signaling pathway.  Germline mutations in SHP2 cause developmental disorders, and somatic mutations have been identified in childhood and adult cancers and drive leukemia in mice.  Despite our knowledge of the PTPN11 variations assocd. with pathol., the structural and functional consequences of many disease-assocd. mutants remain poorly understood.  Here, we combine X-ray crystallog., small-angle X-ray scattering, and biochem. to elucidate structural and mechanistic features of three cancer-assocd. SHP2 variants harboring single point mutations within the N-SH2:PTP interdomain autoinhibitory interface.  Our findings directly compare the impact of each mutation on autoinhibition of the phosphatase and advance the development of structure-guided and mutation-specific SHP2 therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdIaFVGm5lArVg90H21EOLACvtfcHk0lhp2H3qj-d4SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltVagtLw%253D&md5=720b3dd9b18edde2c443d488cfb90dfc</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.biochem.5b01287&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.biochem.5b01287%26sid%3Dliteratum%253Aachs%26aulast%3DLarochelle%26aufirst%3DJ.%2BR.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DDurzynska%26aufirst%3DI.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DLamarche%26aufirst%3DM.%2BJ.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DPing%26aufirst%3DW.%26atitle%3DStructural%2520and%2520functional%2520consequences%2520of%2520three%2520cancer-associated%2520mutations%2520of%2520the%2520oncogenic%2520phosphatase%2520SHP2%26jtitle%3DBiochemistry%26date%3D2016%26volume%3D55%26spage%3D2269%26epage%3D2277%26doi%3D10.1021%2Facs.biochem.5b01287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Hanafusa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torii, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasunaga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishida, E.</span><span> </span><span class="NLM_article-title">Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">279</span><span class="NLM_x">, </span> <span class="NLM_fpage">22992</span><span class="NLM_x">–</span> <span class="NLM_lpage">22995</span><span class="refDoi"> DOI: 10.1074/jbc.M312498200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1074%2Fjbc.M312498200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15031289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkt1Gisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=279&publication_year=2004&pages=22992-22995&author=H.+Hanafusaauthor=S.+Toriiauthor=T.+Yasunagaauthor=K.+Matsumotoauthor=E.+Nishida&title=Shp2%2C+an+SH2-containing+protein-tyrosine+phosphatase%2C+positively+regulates+receptor+tyrosine+kinase+signaling+by+dephosphorylating+and+inactivating+the+inhibitor+Sprouty&doi=10.1074%2Fjbc.M312498200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Shp2, an SH2-containing protein-tyrosine phosphatase, positively regulates receptor tyrosine kinase signaling by dephosphorylating and inactivating the inhibitor Sprouty</span></div><div class="casAuthors">Hanafusa, Hiroshi; Torii, Satoru; Yasunaga, Takayuki; Matsumoto, Kunihiro; Nishida, Eisuke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">279</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">22992-22995</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">SH2 domain-contg. phosphotyrosine phosphatase Shp2 functions as a pos. effector in receptor tyrosine kinase (RTK) signaling immediately proximal to activated receptors.  However, neither its physiol. substrate(s) nor its mechanism of action in RTK signaling has been defined.  Here, the authors demonstrate that protein Sprouty (Spry), an inhibitor of the Ras-MAP kinase signaling pathway, is a possible target of Shp2.  Spry acts as a conserved inhibitor of RTK signaling, and tyrosine phosphorylation of Spry is indispensable for its inhibitory activity.  Shp2 was able to dephosphorylate fibroblast growth factor (FGF) receptor-induced phosphotyrosines on Spry both in vivo and in vitro.  Shp2-mediated dephosphorylation of Spry resulted in dissocn. of Spry from protein Grb2.  Furthermore, Shp2 could reverse the inhibitory effect of Spry on FGF-induced neurite outgrowth and MAP kinase activation.  These findings suggest that Shp2 acts as a pos. regulator in RTK signaling by dephosphorylating and inactivating Spry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4GxPH8eSOr7Vg90H21EOLACvtfcHk0lhp2H3qj-d4SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkt1Gisro%253D&md5=7b08119acef72fe735bf39c972beb70d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M312498200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M312498200%26sid%3Dliteratum%253Aachs%26aulast%3DHanafusa%26aufirst%3DH.%26aulast%3DTorii%26aufirst%3DS.%26aulast%3DYasunaga%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DNishida%26aufirst%3DE.%26atitle%3DShp2%252C%2520an%2520SH2-containing%2520protein-tyrosine%2520phosphatase%252C%2520positively%2520regulates%2520receptor%2520tyrosine%2520kinase%2520signaling%2520by%2520dephosphorylating%2520and%2520inactivating%2520the%2520inhibitor%2520Sprouty%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2004%26volume%3D279%26spage%3D22992%26epage%3D22995%26doi%3D10.1074%2Fjbc.M312498200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Keilhack, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcgregor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantley, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Diverse biochemical properties of Shp2 mutants. Implications for disease phenotypes</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">30984</span><span class="NLM_x">–</span> <span class="NLM_lpage">30993</span><span class="refDoi"> DOI: 10.1074/jbc.M504699200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1074%2Fjbc.M504699200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15987685" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=30984-30993&author=H.+Keilhackauthor=F.+S.+Davidauthor=M.+Mcgregorauthor=L.+C.+Cantleyauthor=B.+G.+Neel&title=Diverse+biochemical+properties+of+Shp2+mutants.+Implications+for+disease+phenotypes&doi=10.1074%2Fjbc.M504699200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Diverse Biochemical Properties of Shp2 Mutants: implications for disease phenotypes</span></div><div class="casAuthors">Keilhack, Heike; David, Frank S.; McGregor, Malcolm; Cantley, Lewis C.; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">30984-30993</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Mutations in the Src homol. 2 (SH2)-contg. protein-tyrosine phosphatase Shp2 (PTPN11) underlie half of the cases of the autosomal dominant genetic disorder Noonan syndrome, and somatic Shp2 mutations are found in several hematol. and solid malignancies.  Earlier studies of small nos. of mutants suggested that disease-assocd. mutations cause constitutive (SH2 binding-independent) activation and that cancer-assocd. mutants are more active than those assocd. with Noonan syndrome.  We have characterized a larger panel of Shp2 mutants and find that this "activity-centric" model cannot explain the behaviors of all pathogenic Shp2 mutations.  Instead, enzymic, structural, and math. modeling analyses show that these mutants can affect basal activation, SH2 domain-phosphopeptide affinity, and/or substrate specificity to varying degrees.  Furthermore, there is no abs. correlation between the mutants' extents of basal activation and the diseases they induce.  We propose that activated mutants of Shp2 modulate signaling from specific stimuli to a subset of effectors and provide a theor. framework for understanding the complex relationship between Shp2 activation, intracellular signaling, and pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJx5YZGoBn6bVg90H21EOLACvtfcHk0lhp2H3qj-d4SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsVCmtL8%253D&md5=649d6897855861aa0e6aaaff4ed57125</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M504699200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M504699200%26sid%3Dliteratum%253Aachs%26aulast%3DKeilhack%26aufirst%3DH.%26aulast%3DDavid%26aufirst%3DF.%2BS.%26aulast%3DMcgregor%26aufirst%3DM.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DDiverse%2520biochemical%2520properties%2520of%2520Shp2%2520mutants.%2520Implications%2520for%2520disease%2520phenotypes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D30984%26epage%3D30993%26doi%3D10.1074%2Fjbc.M504699200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komma, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamy, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, G. W.</span><span> </span><span class="NLM_article-title">Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation</span> <span class="citation_source-journal">J. Cell. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">112</span><span class="NLM_x">, </span> <span class="NLM_fpage">2062</span><span class="NLM_x">–</span> <span class="NLM_lpage">2071</span><span class="refDoi"> DOI: 10.1002/jcb.23125</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1002%2Fjcb.23125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=21465528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC3MXoslamtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2011&pages=2062-2071&author=W.+Wangauthor=L.+Liuauthor=X.+Songauthor=Y.+Moauthor=C.+Kommaauthor=H.+D.+Bellamyauthor=Z.+J.+Zhaoauthor=G.+W.+Zhou&title=Crystal+structure+of+human+protein+tyrosine+phosphatase+SHP-1+in+the+open+conformation&doi=10.1002%2Fjcb.23125"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of human protein tyrosine phosphatase SHP-1 in the open conformation</span></div><div class="casAuthors">Wang, Wei; Liu, Lijun; Song, Xi; Mo, Yi; Komma, Chandrasekhar; Bellamy, Henry D.; Zhao, Zhizhuang Joe; Zhou, G. Wayne</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2062-2071</span>CODEN:
                <span class="NLM_cas:coden">JCEBD5</span>;
        ISSN:<span class="NLM_cas:issn">0730-2312</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">SHP-1 belongs to the family of non-receptor protein tyrosine phosphatases (PTPs) and generally acts as a neg. regulator in a variety of cellular signaling pathways.  Previously, the crystal structures of tail-truncated SHP-1 and SHP-2 revealed an autoinhibitory conformation.  To understand the regulatory mechanism of SHP-1, the authors detd. the crystal structure of full-length SHP-1 at 3.1 Å.  Although the tail was disordered in the current structure, the huge conformational rearrangement of the N-SH2 domain and the incorporation of sulfate ions into the ligand-binding site of each domain indicated that SHP-1 was in the open conformation.  The N-SH2 domain in the current structure was shifted away from the active site of the PTP domain to the other side of the C-SH2 domain, resulting in exposure of the active site.  Meanwhile, the C-SH2 domain was twisted anti-clockwise by ∼110°.  In addn., a set of new interactions between 2 SH2 domains and between the N-SH2 and the catalytic domains was identified, which could be responsible for the stabilization of SHP-1 in the open conformation.  Based on the structural comparison, a model for the activation of SHP-1 was proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbClbkZ-6vn7Vg90H21EOLACvtfcHk0liRTQav0R4V3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXoslamtLs%253D&md5=7da59a40ae5a36fb3842922de1135744</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fjcb.23125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcb.23125%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DMo%26aufirst%3DY.%26aulast%3DKomma%26aufirst%3DC.%26aulast%3DBellamy%26aufirst%3DH.%2BD.%26aulast%3DZhao%26aufirst%3DZ.%2BJ.%26aulast%3DZhou%26aufirst%3DG.%2BW.%26atitle%3DCrystal%2520structure%2520of%2520human%2520protein%2520tyrosine%2520phosphatase%2520SHP-1%2520in%2520the%2520open%2520conformation%26jtitle%3DJ.%2520Cell.%2520Biochem.%26date%3D2011%26volume%3D112%26spage%3D2062%26epage%3D2071%26doi%3D10.1002%2Fjcb.23125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Xu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turchi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Targeting SHP2 for EGFR inhibitor resistant non-small cell lung carcinoma</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">439</span><span class="NLM_x">, </span> <span class="NLM_fpage">586</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1016/j.bbrc.2013.09.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1016%2Fj.bbrc.2013.09.028" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=439&publication_year=2013&pages=586-590&author=J.+Xuauthor=L.+F.+Zengauthor=W.+Shenauthor=J.+J.+Turchiauthor=Z.+Y.+Zhang&title=Targeting+SHP2+for+EGFR+inhibitor+resistant+non-small+cell+lung+carcinoma&doi=10.1016%2Fj.bbrc.2013.09.028"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2013.09.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2013.09.028%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DL.%2BF.%26aulast%3DShen%26aufirst%3DW.%26aulast%3DTurchi%26aufirst%3DJ.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DTargeting%2520SHP2%2520for%2520EGFR%2520inhibitor%2520resistant%2520non-small%2520cell%2520lung%2520carcinoma%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2013%26volume%3D439%26spage%3D586%26epage%3D590%26doi%3D10.1016%2Fj.bbrc.2013.09.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Stein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardet, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roma, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruchti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agarinis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmelzle, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouwmeester, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schübeler, D.</span><span> </span><span class="NLM_article-title">YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers</span> <span class="citation_source-journal">PLoS Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1005465</span><span class="refDoi"> DOI: 10.1371/journal.pgen.1005465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1371%2Fjournal.pgen.1005465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=26295846" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVaqsrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=e1005465&author=C.+Steinauthor=A.+F.+Bardetauthor=G.+Romaauthor=S.+Berglingauthor=I.+Clayauthor=A.+Ruchtiauthor=C.+Agarinisauthor=T.+Schmelzleauthor=T.+Bouwmeesterauthor=D.+Sch%C3%BCbeler&title=YAP1+exerts+its+transcriptional+control+via+TEAD-mediated+activation+of+enhancers&doi=10.1371%2Fjournal.pgen.1005465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers</span></div><div class="casAuthors">Stein, Claudia; Flore, Bardet Anais; Roma, Guglielmo; Bergling, Sebastian; Clay, Ieuan; Ruchti, Alexandra; Agarinis, Claudia; Schmelzle, Tobias; Bouwmeester, Tewis; Schubeler, Dirk; Bauer, Andreas</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Genetics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e1005465/1-e1005465/28</span>CODEN:
                <span class="NLM_cas:coden">PGLEB5</span>;
        ISSN:<span class="NLM_cas:issn">1553-7404</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">YAP1 is a major effector of the Hippo pathway and a well-established oncogene.  Elevated YAP1 activity due to mutations in Hippo pathway components or YAP1 amplification is obsd. in several types of human cancers.  Here we investigated its genomic binding landscape in YAP1-activated cancer cells, as well as in non-transformed cells.  We demonstrate that TEAD transcription factors mediate YAP1 chromatin-binding genome-wide, further explaining their dominant role as primary mediators of YAP1-transcriptional activity.  Moreover, we show that YAP1 largely exerts its transcriptional control via distal enhancers that are marked by H3K27 acetylation and that YAP1 is necessary for this chromatin mark at bound enhancers and the activity of the assocd. genes.  This work establishes YAP1- mediated transcriptional regulation at distal enhancers and provides an expanded set of target genes resulting in a fundamental source to study YAP1 function in a normal and cancer setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr7GWYG9telbVg90H21EOLACvtfcHk0liRTQav0R4V3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVaqsrbI&md5=42f513f83f3667139af5cc416745e704</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pgen.1005465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pgen.1005465%26sid%3Dliteratum%253Aachs%26aulast%3DStein%26aufirst%3DC.%26aulast%3DBardet%26aufirst%3DA.%2BF.%26aulast%3DRoma%26aufirst%3DG.%26aulast%3DBergling%26aufirst%3DS.%26aulast%3DClay%26aufirst%3DI.%26aulast%3DRuchti%26aufirst%3DA.%26aulast%3DAgarinis%26aufirst%3DC.%26aulast%3DSchmelzle%26aufirst%3DT.%26aulast%3DBouwmeester%26aufirst%3DT.%26aulast%3DSch%25C3%25BCbeler%26aufirst%3DD.%26atitle%3DYAP1%2520exerts%2520its%2520transcriptional%2520control%2520via%2520TEAD-mediated%2520activation%2520of%2520enhancers%26jtitle%3DPLoS%2520Genet.%26date%3D2015%26volume%3D11%26spage%3De1005465%26doi%3D10.1371%2Fjournal.pgen.1005465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Keshet, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ricardo Lax, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porat, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reuven, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaul, Y.</span><span> </span><span class="NLM_article-title">C-Abl antagonizes the YAP oncogenic function</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">935</span><span class="NLM_x">–</span> <span class="NLM_lpage">945</span><span class="refDoi"> DOI: 10.1038/cdd.2014.182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1038%2Fcdd.2014.182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=25361080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVKmtb7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=935-945&author=R.+Keshetauthor=J.+Adlerauthor=I.+Ricardo+Laxauthor=M.+Shanzerauthor=Z.+Poratauthor=N.+Reuvenauthor=Y.+Shaul&title=C-Abl+antagonizes+the+YAP+oncogenic+function&doi=10.1038%2Fcdd.2014.182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">c-Abl antagonizes the YAP oncogenic function</span></div><div class="casAuthors">Keshet, R.; Adler, J.; Ricardo Lax, I.; Shanzer, M.; Porat, Z.; Reuven, N.; Shaul, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">935-945</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">YES-assocd. protein (YAP) is a central transcription coactivator that functions as an oncogene in a no. of exptl. systems.  However, under DNA damage, YAP activates pro-apoptotic genes in conjunction with p73.  This program switching is mediated by c-Abl (Abelson murine leukemia viral oncogene) via phosphorylation of YAP at the Y357 residue (pY357).  YAP as an oncogene coactivates the TEAD (transcriptional enhancer activator domain) family transcription factors.  Here we asked whether c-Abl regulates the YAP-TEAD functional module.  We found that DNA damage, through c-Abl activation, specifically depressed YAP-TEAD-induced transcription.  Remarkably, c-Abl counteracts YAP-induced transformation by interfering with the YAP-TEAD transcriptional program. c-Abl induced TEAD1 phosphorylation, but the YAP-TEAD complex remained unaffected.  In contrast, TEAD coactivation was compromised by phosphomimetic YAP Y357E mutation but not Y357F, as demonstrated at the level of reporter genes and endogenous TEAD target genes.  Furthermore, YAP Y357E also severely compromised the role of YAP in cell transformation, migration, anchorage-independent growth, and epithelial-to-mesenchymal transition (EMT) in human mammary MCF10A cells.  These results suggest that YAP pY357 lost TEAD transcription activation function.  Our results demonstrate that YAP pY357 inactivates YAP oncogenic function and establish a role for YAP Y357 phosphorylation in cell-fate decision.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrziPLM7pc3YrVg90H21EOLACvtfcHk0liKBV_vmW4kcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVKmtb7K&md5=be1b058a8a0f2ada7ebbc8cad39361cf</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2014.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2014.182%26sid%3Dliteratum%253Aachs%26aulast%3DKeshet%26aufirst%3DR.%26aulast%3DAdler%26aufirst%3DJ.%26aulast%3DRicardo%2BLax%26aufirst%3DI.%26aulast%3DShanzer%26aufirst%3DM.%26aulast%3DPorat%26aufirst%3DZ.%26aulast%3DReuven%26aufirst%3DN.%26aulast%3DShaul%26aufirst%3DY.%26atitle%3DC-Abl%2520antagonizes%2520the%2520YAP%2520oncogenic%2520function%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2015%26volume%3D22%26spage%3D935%26epage%3D945%26doi%3D10.1038%2Fcdd.2014.182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">795</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span><span class="refDoi"> DOI: 10.1107/S0021889893005588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0021889893005588" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADyaK2cXptFeltw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1993&pages=795-800&author=W.+Kabsch&title=Automatic+processing+of+rotation+diffraction+data+from+crystals+of+initially+unknown+symmetry+and+cell+constants&doi=10.1107%2FS0021889893005588"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">795-800</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    </div><div class="casAbstract">An algorithm was developed for the automatic interpretation of a given set of obsd. reciprocal-lattice points.  It exts. a reduced cell and assigns indexes to each reflection by a graph-theor. implementation of the local indexing method.  All possible symmetries of the obsd. lattice compatible with the metric of the reduced cell are recognized and reported, together with the unit-cell consts. and the linear index transformation relating the conventional to the reduced cell.  This algorithm was incorporated into the program XDS (K., 1988), which is now able to process single-crystal area-detector data without prior knowledge of the symmetry and the unit-cell consts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD1lV8_7cDv7Vg90H21EOLACvtfcHk0liKBV_vmW4kcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXptFeltw%253D%253D&md5=2b703225206ce99af0d7e38acf6d75b3</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS0021889893005588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889893005588%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DAutomatic%2520processing%2520of%2520rotation%2520diffraction%2520data%2520from%2520crystals%2520of%2520initially%2520unknown%2520symmetry%2520and%2520cell%2520constants%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D1993%26volume%3D26%26spage%3D795%26epage%3D800%26doi%3D10.1107%2FS0021889893005588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Mccoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossekunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Likelihood-enhanced fast translation functions</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span><span class="refDoi"> DOI: 10.1107/S0907444905001617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0907444905001617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15805601" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVeisrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=458-464&author=A.+J.+Mccoyauthor=R.+W.+Grossekunstleveauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Likelihood-enhanced+fast+translation+functions&doi=10.1107%2FS0907444905001617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Likelihood-enhanced fast translation functions</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">D61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-464</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">This paper is a companion to a recent paper on fast rotation functions [Storoni et al. (2004), Acta Cryst. D60, 432-438], which showed how a Taylor-series expansion of the max.-likelihood rotation function leads to improved likelihood-enhanced fast rotation functions.  In a similar manner, it is shown here how linear and quadratic Taylor-series expansions and least-squares approxns. of the max.-likelihood translation function lead to likelihood-enhanced translation functions, which can be calcd. by FFT and which are more sensitive to the correct translation than the traditional correlation-coeff. fast translation function.  These likelihood-enhanced translation targets for mol.-replacement searches have been implemented in the program Phaser using the Computational Crystallog. Toolbox (cctbx).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDd3wovyUbWLVg90H21EOLACvtfcHk0liKBV_vmW4kcw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVeisrY%253D&md5=bac9cc121bcc0d5cd314955a0e65e746</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1107%2FS0907444905001617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444905001617%26sid%3Dliteratum%253Aachs%26aulast%3DMccoy%26aufirst%3DA.%2BJ.%26aulast%3DGrossekunstleve%26aufirst%3DR.%2BW.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DLikelihood-enhanced%2520fast%2520translation%2520functions%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2005%26volume%3D61%26spage%3D458%26epage%3D464%26doi%3D10.1107%2FS0907444905001617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkóczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossekunstleve, R. W.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span><span class="refDoi"> DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=213-221&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.+W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grossekunstleve&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.%2BW.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrossekunstleve%26aufirst%3DR.%2BW.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D66%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Coot: model-building tools for molecular graphics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2126</span><span class="NLM_x">–</span> <span class="NLM_lpage">2132</span><span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2005&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2005%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashton, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mcnicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span> </span><span class="NLM_article-title">The new CCP4 Coordinate Library as a toolkit for the design of coordinate-related applications in protein crystallography</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">2250</span><span class="refDoi"> DOI: 10.1107/S0907444904027167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=10.1107%2FS0907444904027167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=15572778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2250&author=E.+B.+Krissinelauthor=M.+D.+Winnauthor=C.+C.+Ballardauthor=A.+W.+Ashtonauthor=P.+Patelauthor=E.+A.+Pottertonauthor=S.+J.+Mcnicholasauthor=K.+D.+Cowtanauthor=P.+Emsley&title=The+new+CCP4+Coordinate+Library+as+a+toolkit+for+the+design+of+coordinate-related+applications+in+protein+crystallography&doi=10.1107%2FS0907444904027167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The new CCP4 Coordinate Library as a toolkit for the design of coordinate-related applications in protein crystallography</span></div><div class="casAuthors">Krissinel, E. B.; Winn, M. D.; Ballard, C. C.; Ashton, A. W.; Patel, P.; Potterton, E. A.; McNicholas, S. J.; Cowtan, K. D.; Emsley, P.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2250-2255</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The new CCP4 Coordinate Library is a development aiming to provide a common layer of coordinate-related functionality to the existing applications in the CCP4 suite, as well as a variety of tools that can simplify the design of new applications where they relate to at. coordinates.  The Library comprises a wide spectrum of useful functions, ranging from parsing coordinate formats and elementary editing operations on the coordinate hierarchy of biomols., to high-level functionality such as calcn. of secondary structure, interat. bonds, at. contacts, symmetry transformations, structure superposition and many others.  Most of the functions are available in a C++ object interface; however, a Fortran interface is provided for compatibility with older CCP4 applications.  The paper describes the general principles of the Library design and the most important functionality.  The Library, together with documentation, is available under the LGPL license from the CCP4 suite version 5.0 and higher.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2HD6r3NAAsbVg90H21EOLACvtfcHk0li2cUvIZdDBOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars7rK&md5=4443c50d18d560788e36802ca05076c1</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444904027167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904027167%26sid%3Dliteratum%253Aachs%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DAshton%26aufirst%3DA.%2BW.%26aulast%3DPatel%26aufirst%3DP.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DMcnicholas%26aufirst%3DS.%2BJ.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DEmsley%26aufirst%3DP.%26atitle%3DThe%2520new%2520CCP4%2520Coordinate%2520Library%2520as%2520a%2520toolkit%2520for%2520the%2520design%2520of%2520coordinate-related%2520applications%2520in%2520protein%2520crystallography%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2250%26doi%3D10.1107%2FS0907444904027167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Commons, T. J.; Fensome, A.; Heffernan, G. D.; McComas, C. C.; Woodworth, R. P.; Webb, M. B.; Marella, M. A.; Melenski, E. G.</span><span> </span><span class="NLM_article-title">Pyrrolidine and Related Derivatives Useful as PR Modulators</span>. Patent WO2008021339,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=T.+J.+Commons&author=A.+Fensome&author=G.+D.+Heffernan&author=C.+C.+McComas&author=R.+P.+Woodworth&author=M.+B.+Webb&author=M.+A.+Marella&author=E.+G.+Melenski&title=Pyrrolidine+and+Related+Derivatives+Useful+as+PR+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCommons%26aufirst%3DT.%2BJ.%26atitle%3DPyrrolidine%2520and%2520Related%2520Derivatives%2520Useful%2520as%2520PR%2520Modulators%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP','PDB','2SHP'); return false;">PDB: 2SHP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XZR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XZR','PDB','5XZR'); return false;">PDB: 5XZR</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i66"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01520">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_75538"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01520">10.1021/acs.jmedchem.7b01520</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Additional pharmacology results and NMR spectra for final compound (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_001.pdf">jm7b01520_si_001.pdf (5.77 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01520/suppl_file/jm7b01520_si_002.csv">jm7b01520_si_002.csv (1.6 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB ID Code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5XZR">5XZR</a> for SHP2 in complex with compound <b>10</b>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01520&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01520%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01520" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677aa4301ab324eb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
